CONSOLIDATED SCHEDULE OF INVESTMENTS £ in Thousands, $ in Thousands |
Dec. 31, 2022
USD ($)
shares
|
Dec. 31, 2022
GBP (£)
shares
|
Dec. 31, 2021
USD ($)
shares
|
Dec. 31, 2021
GBP (£)
shares
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
|
7.50%
|
|
7.50%
|
|
|
|
|
|
Investment cost |
|
$ 3,005,696
|
|
|
|
$ 2,390,984
|
|
|
|
Total investments at fair value |
|
2,963,955
|
|
|
|
2,434,522
|
|
|
|
Investment Funds & Vehicles [Member] |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
2,032
|
|
|
|
Total investments at fair value |
|
3,893
|
|
|
|
1,814
|
|
|
|
Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Total investments at fair value |
|
2,741,388
|
|
|
|
2,156,709
|
|
|
|
Unsecured |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Total investments at fair value |
|
54,056
|
|
|
|
52,890
|
|
|
|
Debt Investments |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
2,818,060
|
[2] |
|
|
2,219,586
|
[1] |
|
|
Total investments at fair value |
|
2,795,444
|
|
|
|
2,209,599
|
|
|
|
Equity |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
153,173
|
[2] |
|
|
142,219
|
|
|
|
Total investments at fair value |
|
133,972
|
|
|
|
184,710
|
|
|
|
Equity | Preferred Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Total investments at fair value |
|
41,488
|
|
|
|
69,439
|
|
|
|
Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Total investments at fair value |
|
92,484
|
|
|
|
115,271
|
|
|
|
Warrant Investment |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
30,964
|
[2] |
|
|
27,147
|
[1] |
|
|
Total investments at fair value |
|
30,646
|
|
|
|
38,399
|
|
|
|
Investments in Securities |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
3,002,197
|
[2] |
|
|
2,388,952
|
[1] |
|
|
Total investments at fair value |
|
2,960,062
|
|
|
|
2,432,708
|
|
|
|
Investment |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
3,005,696
|
[2] |
|
|
2,390,984
|
[1] |
|
|
Total investments at fair value |
|
2,963,955
|
|
|
|
2,434,522
|
|
|
|
Forbion Growth Opportunities Fund I C V | Investment Funds & Vehicles [Member] |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[3],[4],[5] |
|
|
|
|
2,032
|
|
|
|
Total investments at fair value |
[3],[4],[5] |
|
|
|
|
$ 1,814
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Nov. 16, 2020
|
|
Nov. 16, 2020
|
|
Black Crow AI, Inc. affiliates |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Principal Amount |
|
|
|
|
|
$ 3,000
|
|
|
|
Medrobotics Corporation [Member] | Warrant Investment | Preferred Series E |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Mar. 13, 2013
|
|
Mar. 13, 2013
|
|
Biotechnology Tools |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Total investments at fair value |
|
32,825
|
|
|
|
$ 0
|
|
|
|
Biotechnology Tools | Debt Investments |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
32,339
|
|
|
|
|
|
|
|
Total investments at fair value |
|
32,339
|
|
|
|
|
|
|
|
Biotechnology Tools | Warrant Investment |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
485
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 486
|
|
|
|
|
|
|
|
Biotechnology Tools | Alamar Biosciences, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-06
|
|
2026-06
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
6.50%
|
|
6.50%
|
|
|
|
|
|
Investment Interest Rate Paid in Kind |
[7] |
1.00%
|
|
1.00%
|
|
|
|
|
|
Principal Amount |
[8] |
$ 5,000
|
|
|
|
|
|
|
|
Investment cost |
[2],[8] |
4,951
|
|
|
|
|
|
|
|
Total investments at fair value |
[8] |
$ 4,951
|
|
|
|
|
|
|
|
Biotechnology Tools | Alamar Biosciences, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
5.95%
|
|
5.95%
|
|
|
|
|
|
Biotechnology Tools | Alamar Biosciences, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
3.00%
|
|
3.00%
|
|
|
|
|
|
Biotechnology Tools | Alamar Biosciences, Inc. | Warrant Investment | Preferred Series B |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 24
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 23
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Jun. 21, 2022
|
|
Jun. 21, 2022
|
|
|
|
|
|
Shares | shares |
|
15,399
|
|
15,399
|
|
|
|
|
|
Biotechnology Tools | PathAI, Inc | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-01
|
|
2027-01
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
9.15%
|
|
9.15%
|
|
|
|
|
|
Principal Amount |
[8] |
$ 28,000
|
|
|
|
|
|
|
|
Investment cost |
[2],[8] |
27,388
|
|
|
|
|
|
|
|
Total investments at fair value |
[8] |
$ 27,388
|
|
|
|
|
|
|
|
Biotechnology Tools | PathAI, Inc | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
11.21%
|
|
11.21%
|
|
|
|
|
|
Biotechnology Tools | PathAI, Inc | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
2.15%
|
|
2.15%
|
|
|
|
|
|
Biotechnology Tools | PathAI, Inc | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 461
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 463
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Dec. 23, 2022
|
|
Dec. 23, 2022
|
|
|
|
|
|
Shares | shares |
|
53,418
|
|
53,418
|
|
|
|
|
|
Communications & Networking |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 101,833
|
|
|
|
105,490
|
|
|
|
Communications & Networking | Debt Investments |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
99,167
|
[2] |
|
|
97,088
|
[1] |
|
|
Total investments at fair value |
|
101,734
|
|
|
|
99,230
|
|
|
|
Communications & Networking | Equity |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
1,230
|
|
|
|
Total investments at fair value |
|
|
|
|
|
6,260
|
|
|
|
Communications & Networking | Warrant Investment |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
541
|
[2] |
|
|
418
|
|
|
|
Total investments at fair value |
|
$ 99
|
|
|
|
$ 0
|
|
|
|
Communications & Networking | Aryaka Networks, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-07
|
|
2026-07
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
6.75%
|
|
6.75%
|
|
|
|
|
|
Investment Interest Rate Paid in Kind |
[7] |
1.05%
|
|
1.05%
|
|
|
|
|
|
Principal Amount |
[8],[10],[11] |
$ 5,023
|
|
|
|
|
|
|
|
Investment cost |
[2],[8],[10],[11] |
4,969
|
|
|
|
|
|
|
|
Total investments at fair value |
[8],[10],[11] |
$ 5,053
|
|
|
|
|
|
|
|
Communications & Networking | Aryaka Networks, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
3.55%
|
|
3.55%
|
|
|
|
|
|
Communications & Networking | Aryaka Networks, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
3.25%
|
|
3.25%
|
|
|
|
|
|
Communications & Networking | Aryaka Networks, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 123
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 99
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Jun. 28, 2022
|
|
Jun. 28, 2022
|
|
|
|
|
|
Shares | shares |
|
229,611
|
|
229,611
|
|
|
|
|
|
Communications & Networking | Cytracom Holdings LLC | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-02
|
|
2025-02
|
|
2025-02
|
|
2025-02
|
|
Investment Interest Rate Floor |
|
10.31%
|
[7] |
10.31%
|
[7] |
10.31%
|
[12] |
10.31%
|
[12] |
Principal Amount |
|
$ 8,910
|
[8],[13],[14] |
|
|
$ 9,000
|
[3],[15],[16] |
|
|
Investment cost |
|
8,768
|
[2],[8],[13],[14] |
|
|
8,802
|
[1],[3],[15],[16] |
|
|
Total investments at fair value |
|
$ 8,748
|
[8],[13],[14] |
|
|
$ 8,725
|
[3],[15],[16] |
|
|
Communications & Networking | Cytracom Holdings LLC | Senior Secured Debt | LIBOR |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
|
9.31%
|
[7] |
9.31%
|
[7] |
9.31%
|
[12] |
9.31%
|
[12] |
Communications & Networking | Spring Mobile Solutions, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 418
|
[2] |
|
|
$ 418
|
|
|
|
Total investments at fair value |
|
|
|
|
|
$ 0
|
|
|
|
Acquisition Date |
|
Apr. 19, 2013
|
[9] |
Apr. 19, 2013
|
[9] |
Apr. 19, 2013
|
[6] |
Apr. 19, 2013
|
[6] |
Shares | shares |
|
2,834,375
|
|
2,834,375
|
|
2,834,375
|
|
2,834,375
|
|
Communications & Networking | Rocket Lab Global Services, LLC | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2024-06
|
|
2024-06
|
|
2024-06
|
|
2024-06
|
|
Investment Interest Rate Floor |
|
8.15%
|
[7] |
8.15%
|
[7] |
8.15%
|
[12] |
8.15%
|
[12] |
Investment Interest Rate Paid in Kind |
|
1.25%
|
[7] |
1.25%
|
[7] |
1.25%
|
[12] |
1.25%
|
[12] |
Principal Amount |
|
$ 84,581
|
[11],[13],[17],[18],[19] |
|
|
$ 88,542
|
[20],[21] |
|
|
Investment cost |
|
85,430
|
[2],[11],[13],[17],[18],[19] |
|
|
88,286
|
[1],[20],[21] |
|
|
Total investments at fair value |
|
$ 87,933
|
[11],[13],[17],[18],[19] |
|
|
$ 90,505
|
[20],[21] |
|
|
Communications & Networking | Rocket Lab Global Services, LLC | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
|
3.25%
|
[7] |
3.25%
|
[7] |
3.25%
|
[12] |
3.25%
|
[12] |
Communications & Networking | Rocket Lab Global Services, LLC | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
|
4.90%
|
[7] |
4.90%
|
[7] |
4.90%
|
[12] |
4.90%
|
[12] |
Communications & Networking | Peerless Network Holdings, Inc. | Equity |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
$ 1,230
|
|
|
|
Total investments at fair value |
|
|
|
|
|
$ 6,260
|
|
|
|
Shares | shares |
|
|
|
|
|
1,138,328
|
|
1,138,328
|
|
Communications & Networking | Peerless Network Holdings, Inc. | Equity | Preferred Series A |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
$ 1,230
|
|
|
|
Total investments at fair value |
|
|
|
|
|
$ 6,242
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Apr. 11, 2008
|
|
Apr. 11, 2008
|
|
Shares | shares |
|
|
|
|
|
1,135,000
|
|
1,135,000
|
|
Communications & Networking | Peerless Network Holdings, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
$ 0
|
|
|
|
Total investments at fair value |
|
|
|
|
|
$ 18
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Oct. 21, 2020
|
|
Oct. 21, 2020
|
|
Shares | shares |
|
|
|
|
|
3,328
|
|
3,328
|
|
Consumer & Business Products |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 2,821
|
|
|
|
$ 28,099
|
|
|
|
Consumer & Business Products | Debt Investments |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
23,162
|
|
|
|
Total investments at fair value |
|
|
|
|
|
23,298
|
|
|
|
Consumer & Business Products | Equity |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
663
|
[2] |
|
|
128
|
[1] |
|
|
Total investments at fair value |
|
498
|
|
|
|
447
|
|
|
|
Consumer & Business Products | Warrant Investment |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
1,712
|
[2] |
|
|
2,145
|
[1] |
|
|
Total investments at fair value |
|
2,323
|
|
|
|
4,354
|
|
|
|
Consumer & Business Products | TechStyle, Inc. | Warrant Investment | Preferred Series B |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
1,101
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 745
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Jul. 16, 2013
|
|
Jul. 16, 2013
|
|
|
|
|
|
Shares | shares |
|
206,185
|
|
206,185
|
|
|
|
|
|
Consumer & Business Products | Whoop, Inc. | Warrant Investment | Preferred Series C |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 18
|
[2] |
|
|
18
|
[1] |
|
|
Total investments at fair value |
|
$ 475
|
|
|
|
$ 1,847
|
|
|
|
Acquisition Date |
|
Jun. 27, 2018
|
[9] |
Jun. 27, 2018
|
[9] |
Jun. 27, 2018
|
[6] |
Jun. 27, 2018
|
[6] |
Shares | shares |
|
686,270
|
|
686,270
|
|
686,270
|
|
686,270
|
|
Consumer & Business Products | The Neat Company | Common Stock | Preferred Series C |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Total investments at fair value |
|
|
|
|
|
$ 0
|
|
|
|
Consumer & Business Products | The Neat Company | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 365
|
[2] |
|
|
$ 365
|
[1] |
|
|
Total investments at fair value |
|
|
|
|
|
|
|
|
|
Acquisition Date |
|
Aug. 13, 2014
|
[9] |
Aug. 13, 2014
|
[9] |
Aug. 13, 2014
|
[6] |
Aug. 13, 2014
|
[6] |
Shares | shares |
|
54,054
|
|
54,054
|
|
54,054
|
|
54,054
|
|
Consumer & Business Products | Grove Collaborative, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
|
|
2025-04
|
|
2025-04
|
|
Investment Interest Rate Floor |
[12] |
|
|
|
|
8.75%
|
|
8.75%
|
|
Principal Amount |
[22] |
|
|
|
|
$ 23,520
|
|
|
|
Investment cost |
[1],[22] |
|
|
|
|
23,162
|
|
|
|
Total investments at fair value |
[22] |
|
|
|
|
$ 23,298
|
|
|
|
Consumer & Business Products | Grove Collaborative, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[12] |
|
|
|
|
6.75%
|
|
6.75%
|
|
Consumer & Business Products | Grove Collaborative, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[12] |
|
|
|
|
5.50%
|
|
5.50%
|
|
Consumer & Business Products | Grove Collaborative, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[9] |
$ 433
|
|
|
|
|
|
|
|
Total investments at fair value |
[9] |
$ 24
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Apr. 30, 2021
|
|
Apr. 30, 2021
|
|
|
|
|
|
Shares | shares |
[9] |
61,300
|
|
61,300
|
|
|
|
|
|
Consumer & Business Products | Grove Collaborative, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
$ 433
|
|
|
|
Total investments at fair value |
|
|
|
|
|
$ 326
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Apr. 30, 2021
|
|
Apr. 30, 2021
|
|
Shares | shares |
|
|
|
|
|
83,625
|
|
83,625
|
|
Consumer & Business Products | Penumbra Brands, LLC (p.k.a. Gadget Guard) | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
$ 228
|
|
|
|
Total investments at fair value |
|
|
|
|
|
$ 0
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Jun. 03, 2014
|
|
Jun. 03, 2014
|
|
Shares | shares |
|
|
|
|
|
1,662,441
|
|
1,662,441
|
|
Consumer & Business Products | TFG Holding, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 89
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 116
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Apr. 30, 2010
|
|
Apr. 30, 2010
|
|
|
|
|
|
Shares | shares |
|
42,989
|
|
42,989
|
|
|
|
|
|
Consumer & Business Products | TFG Holding, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 0
|
|
|
|
|
|
|
|
Total investments at fair value |
|
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Jun. 27, 2014
|
|
Jun. 27, 2014
|
|
|
|
|
|
Shares | shares |
|
206,185
|
|
206,185
|
|
|
|
|
|
Consumer & Business Products | Savage X Holding, LLC | Equity | Class A Units |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 13
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 226
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Apr. 30, 2010
|
|
Apr. 30, 2010
|
|
|
|
|
|
Shares | shares |
|
42,137
|
|
42,137
|
|
|
|
|
|
Consumer & Business Products | Savage X Holding, LLC | Warrant Investment | Class A Units |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 0
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 1,103
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Jun. 27, 2014
|
|
Jun. 27, 2014
|
|
|
|
|
|
Shares | shares |
|
206,185
|
|
206,185
|
|
|
|
|
|
Consumer & Business Products | TechStyle, Inc. (p.k.a. Just Fabulous, Inc.) | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 128
|
[2] |
|
|
$ 128
|
[1] |
|
|
Total investments at fair value |
|
$ 132
|
|
|
|
$ 447
|
|
|
|
Acquisition Date |
|
Apr. 30, 2010
|
[9] |
Apr. 30, 2010
|
[9] |
Apr. 30, 2010
|
[6] |
Apr. 30, 2010
|
[6] |
Shares | shares |
|
42,989
|
|
42,989
|
|
42,989
|
|
42,989
|
|
Consumer & Business Products | TechStyle, Inc. (p.k.a. Just Fabulous, Inc.) | Warrant Investment | Preferred Series B |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
$ 1,101
|
|
|
|
Total investments at fair value |
|
|
|
|
|
$ 2,181
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Jul. 16, 2013
|
|
Jul. 16, 2013
|
|
Shares | shares |
|
|
|
|
|
206,185
|
|
206,185
|
|
Consumer & Business Products | Gadget Guard, LLC | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 228
|
|
|
|
|
|
|
|
Total investments at fair value |
|
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Jun. 03, 2014
|
|
Jun. 03, 2014
|
|
|
|
|
|
Shares | shares |
|
1,662,441
|
|
1,662,441
|
|
|
|
|
|
Consumer & Business Services | Debt Investments |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 444,703
|
|
|
|
|
|
|
|
Total investments at fair value |
|
428,750
|
|
|
|
|
|
|
|
Consumer & Business Services | Equity |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
13,488
|
|
|
|
|
|
|
|
Total investments at fair value |
|
7,995
|
|
|
|
|
|
|
|
Consumer & Business Services | Warrant Investment |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
4,248
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 2,639
|
|
|
|
|
|
|
|
Consumer & Business Services | Jobandtalent USA, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-02
|
|
2025-02
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
9.75%
|
|
9.75%
|
|
|
|
|
|
Principal Amount |
[23],[24] |
$ 14,000
|
|
|
|
|
|
|
|
Investment cost |
[2],[23],[24] |
13,853
|
|
|
|
|
|
|
|
Total investments at fair value |
[23],[24] |
$ 13,904
|
|
|
|
|
|
|
|
Consumer & Business Services | Jobandtalent USA, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
3.00%
|
|
3.00%
|
|
|
|
|
|
Consumer & Business Services | Jobandtalent USA, Inc. | Senior Secured Debt | SOFR |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
8.86%
|
|
8.86%
|
|
|
|
|
|
Consumer & Business Services | Provi | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-12
|
|
2026-12
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
10.65%
|
|
10.65%
|
|
|
|
|
|
Principal Amount |
[25] |
$ 15,000
|
|
|
|
|
|
|
|
Investment cost |
[2],[25] |
14,739
|
|
|
|
|
|
|
|
Total investments at fair value |
[25] |
$ 14,739
|
|
|
|
|
|
|
|
Consumer & Business Services | Provi | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
2.95%
|
|
2.95%
|
|
|
|
|
|
Consumer & Business Services | Provi | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
4.40%
|
|
4.40%
|
|
|
|
|
|
Consumer & Business Services | Provi | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[25] |
$ 166
|
|
|
|
|
|
|
|
Total investments at fair value |
[25] |
$ 155
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Dec. 22, 2022
|
|
Dec. 22, 2022
|
|
|
|
|
|
Shares | shares |
[25] |
117,042
|
|
117,042
|
|
|
|
|
|
Consumer & Business Services | Veem, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-03
|
|
2025-03
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
7.25%
|
|
7.25%
|
|
|
|
|
|
Investment Interest Rate Paid in Kind |
[7] |
1.25%
|
|
1.25%
|
|
|
|
|
|
Principal Amount |
[11],[17] |
$ 5,043
|
|
|
|
|
|
|
|
Investment cost |
[2],[11],[17] |
5,000
|
|
|
|
|
|
|
|
Total investments at fair value |
[11],[17] |
$ 5,042
|
|
|
|
|
|
|
|
Consumer & Business Services | Veem, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
4.50%
|
|
4.50%
|
|
|
|
|
|
Consumer & Business Services | Veem, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
4.00%
|
|
4.00%
|
|
|
|
|
|
Consumer & Business Services | Veem, Inc. | Debt Investments |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Principal Amount |
|
$ 10,076
|
|
|
|
|
|
|
|
Investment cost |
[2] |
9,988
|
|
|
|
|
|
|
|
Total investments at fair value |
|
10,166
|
|
|
|
|
|
|
|
Consumer & Business Services | Veem, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
126
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 25
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Mar. 31, 2022
|
|
Mar. 31, 2022
|
|
|
|
|
|
Shares | shares |
|
98,428
|
|
98,428
|
|
|
|
|
|
Consumer & Business Services | Veem, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-03
|
|
2025-03
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
7.95%
|
|
7.95%
|
|
|
|
|
|
Investment Interest Rate Paid in Kind |
[7] |
1.50%
|
|
1.50%
|
|
|
|
|
|
Principal Amount |
[11] |
$ 5,033
|
|
|
|
|
|
|
|
Investment cost |
[2],[11] |
4,988
|
|
|
|
|
|
|
|
Total investments at fair value |
[11] |
$ 5,124
|
|
|
|
|
|
|
|
Consumer & Business Services | Veem, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
4.50%
|
|
4.50%
|
|
|
|
|
|
Consumer & Business Services | Veem, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
4.70%
|
|
4.70%
|
|
|
|
|
|
Consumer & Business Services | RVShare, LLC | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-12
|
|
2026-12
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
6.50%
|
|
6.50%
|
|
|
|
|
|
Investment Interest Rate Paid in Kind |
[7] |
4.00%
|
|
4.00%
|
|
|
|
|
|
Principal Amount |
[8],[11],[17],[25] |
$ 27,730
|
|
|
|
|
|
|
|
Investment cost |
[2],[8],[11],[17],[25] |
27,265
|
|
|
|
|
|
|
|
Total investments at fair value |
[8],[11],[17],[25] |
$ 27,256
|
|
|
|
|
|
|
|
Consumer & Business Services | RVShare, LLC | Senior Secured Debt | LIBOR |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
5.50%
|
|
5.50%
|
|
|
|
|
|
Consumer & Business Services | Snagajobcom Inc | Warrant Investment |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 860
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 118
|
|
|
|
|
|
|
|
Shares | shares |
|
3,611,537
|
|
3,611,537
|
|
|
|
|
|
Consumer & Business Services | Snagajobcom Inc | Warrant Investment | Preferred Series A |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 782
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 50
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Jun. 30, 2016
|
|
Jun. 30, 2016
|
|
|
|
|
|
Shares | shares |
|
1,800,000
|
|
1,800,000
|
|
|
|
|
|
Consumer & Business Services | Snagajobcom Inc | Warrant Investment | Preferred Series B |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 62
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 25
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Aug. 01, 2018
|
|
Aug. 01, 2018
|
|
|
|
|
|
Shares | shares |
|
1,211,537
|
|
1,211,537
|
|
|
|
|
|
Consumer & Business Services | Snagajobcom Inc | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 16
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 43
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Apr. 20, 2020
|
|
Apr. 20, 2020
|
|
|
|
|
|
Shares | shares |
|
600,000
|
|
600,000
|
|
|
|
|
|
Consumer & Business Services | RumbleON, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[9] |
$ 88
|
|
|
|
|
|
|
|
Total investments at fair value |
[9] |
$ 0
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Apr. 30, 2018
|
|
Apr. 30, 2018
|
|
|
|
|
|
Shares | shares |
[9] |
5,139
|
|
5,139
|
|
|
|
|
|
Consumer & Business Services | Lendio, Inc. | Warrant Investment | Preferred Series D |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 39
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 19
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Mar. 29, 2019
|
|
Mar. 29, 2019
|
|
|
|
|
|
Shares | shares |
|
127,032
|
|
127,032
|
|
|
|
|
|
Consumer & Business Services | Landing Holdings Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[25] |
$ 116
|
|
|
|
|
|
|
|
Total investments at fair value |
[25] |
$ 127
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Mar. 12, 2021
|
|
Mar. 12, 2021
|
|
|
|
|
|
Shares | shares |
[25] |
11,806
|
|
11,806
|
|
|
|
|
|
Consumer & Business Services | Lyft Inc | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[9] |
$ 5,263
|
|
|
|
|
|
|
|
Total investments at fair value |
[9] |
$ 1,110
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Dec. 26, 2018
|
|
Dec. 26, 2018
|
|
|
|
|
|
Shares | shares |
[9] |
100,738
|
|
100,738
|
|
|
|
|
|
Consumer & Business Services | Uber Technologies, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[9] |
$ 318
|
|
|
|
|
|
|
|
Total investments at fair value |
[9] |
$ 816
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Dec. 01, 2020
|
|
Dec. 01, 2020
|
|
|
|
|
|
Shares | shares |
[9] |
32,991
|
|
32,991
|
|
|
|
|
|
Consumer & Business Services | Nerdy Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[9] |
$ 1,000
|
|
|
|
|
|
|
|
Total investments at fair value |
[9] |
$ 225
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Sep. 17, 2021
|
|
Sep. 17, 2021
|
|
|
|
|
|
Shares | shares |
[9] |
100,000
|
|
100,000
|
|
|
|
|
|
Consumer & Business Services | DoorDash, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[9] |
$ 945
|
|
|
|
|
|
|
|
Total investments at fair value |
[9] |
$ 4,003
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Dec. 20, 2018
|
|
Dec. 20, 2018
|
|
|
|
|
|
Shares | shares |
[9] |
81,996
|
|
81,996
|
|
|
|
|
|
Consumer & Business Services | OfferUp, Inc. | Equity |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 2,295
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 513
|
|
|
|
|
|
|
|
Shares | shares |
|
394,790
|
|
394,790
|
|
|
|
|
|
Consumer & Business Services | OfferUp, Inc. | Equity | Preferred Series A |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 1,663
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 372
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Oct. 25, 2016
|
|
Oct. 25, 2016
|
|
|
|
|
|
Shares | shares |
|
286,080
|
|
286,080
|
|
|
|
|
|
Consumer & Business Services | OfferUp, Inc. | Equity | Preferred Series A-1 |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 632
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 141
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Oct. 25, 2016
|
|
Oct. 25, 2016
|
|
|
|
|
|
Shares | shares |
|
108,710
|
|
108,710
|
|
|
|
|
|
Consumer & Business Services | Oportun | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[9] |
$ 577
|
|
|
|
|
|
|
|
Total investments at fair value |
[9] |
$ 266
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Jun. 28, 2013
|
|
Jun. 28, 2013
|
|
|
|
|
|
Shares | shares |
[9] |
48,365
|
|
48,365
|
|
|
|
|
|
Consumer & Business Services | Reischling Press, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 39
|
|
|
|
|
|
|
|
Total investments at fair value |
|
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Jul. 31, 2020
|
|
Jul. 31, 2020
|
|
|
|
|
|
Shares | shares |
|
3,095
|
|
3,095
|
|
|
|
|
|
Consumer & Business Services | App Direct Incorporation | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-04
|
|
2026-04
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
8.75%
|
|
8.75%
|
|
|
|
|
|
Principal Amount |
[8],[18] |
$ 40,790
|
|
|
|
|
|
|
|
Investment cost |
[2],[8],[18] |
41,856
|
|
|
|
|
|
|
|
Total investments at fair value |
[8],[18] |
$ 42,426
|
|
|
|
|
|
|
|
Consumer & Business Services | App Direct Incorporation | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
8.29%
|
|
8.29%
|
|
|
|
|
|
Consumer & Business Services | App Direct Incorporation | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
5.50%
|
|
5.50%
|
|
|
|
|
|
Consumer & Business Services | Carwow LTD | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2024-12
|
|
2024-12
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
7.95%
|
|
7.95%
|
|
|
|
|
|
Investment Interest Rate Paid in Kind |
[7] |
1.45%
|
|
1.45%
|
|
|
|
|
|
Principal Amount | £ |
[11],[23],[24] |
|
|
£ 18,890
|
|
|
|
|
|
Investment cost |
[2],[11],[23],[24] |
$ 26,024
|
|
|
|
|
|
|
|
Total investments at fair value |
[11],[23],[24] |
$ 22,971
|
|
|
|
|
|
|
|
Consumer & Business Services | Carwow LTD | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
4.95%
|
|
4.95%
|
|
|
|
|
|
Consumer & Business Services | Carwow LTD | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
4.70%
|
|
4.70%
|
|
|
|
|
|
Consumer & Business Services | Carwow LTD | Equity | Preferred Series D-4 |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[23],[24] |
$ 1,151
|
|
|
|
|
|
|
|
Total investments at fair value |
[23],[24] |
$ 257
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Dec. 15, 2021
|
|
Dec. 15, 2021
|
|
|
|
|
|
Shares | shares |
[23],[24] |
199,742
|
|
199,742
|
|
|
|
|
|
Consumer & Business Services | Carwow LTD | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[23],[24] |
$ 164
|
|
|
|
|
|
|
|
Total investments at fair value |
[23],[24] |
$ 34
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Dec. 14, 2021
|
|
Dec. 14, 2021
|
|
|
|
|
|
Shares | shares |
[23],[24] |
174,163
|
|
174,163
|
|
|
|
|
|
Consumer & Business Services | Houzz, Inc. | Convertible Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2028-05
|
|
2028-05
|
|
|
|
|
|
Investment Interest Rate Paid in Kind |
[7] |
5.50%
|
|
5.50%
|
|
|
|
|
|
Principal Amount |
[11],[26] |
$ 21,853
|
|
|
|
|
|
|
|
Investment cost |
[2],[11],[26] |
21,853
|
|
|
|
|
|
|
|
Total investments at fair value |
[11],[26] |
20,356
|
|
|
|
|
|
|
|
Consumer & Business Services | Houzz, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
20
|
|
|
|
|
|
|
|
Total investments at fair value |
|
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Oct. 29, 2019
|
|
Oct. 29, 2019
|
|
|
|
|
|
Shares | shares |
|
529,661
|
|
529,661
|
|
|
|
|
|
Consumer & Business Services | Rhino Labs Incorporation | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2024-03
|
|
2024-03
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
8.75%
|
|
8.75%
|
|
|
|
|
|
Investment Interest Rate Paid in Kind |
[7] |
2.25%
|
|
2.25%
|
|
|
|
|
|
Principal Amount |
[11],[25] |
$ 16,500
|
|
|
|
|
|
|
|
Investment cost |
[2],[11],[25] |
16,328
|
|
|
|
|
|
|
|
Total investments at fair value |
[11],[25] |
$ 16,496
|
|
|
|
|
|
|
|
Consumer & Business Services | Rhino Labs Incorporation | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
5.50%
|
|
5.50%
|
|
|
|
|
|
Consumer & Business Services | Rhino Labs Incorporation | Equity | Preferred Series B-2 |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 1,000
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 805
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Jan. 24, 2022
|
|
Jan. 24, 2022
|
|
|
|
|
|
Shares | shares |
|
7,063
|
|
7,063
|
|
|
|
|
|
Consumer & Business Services | Rhino Labs Incorporation | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[25] |
$ 470
|
|
|
|
|
|
|
|
Total investments at fair value |
[25] |
$ 308
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Mar. 12, 2021
|
|
Mar. 12, 2021
|
|
|
|
|
|
Shares | shares |
[25] |
13,106
|
|
13,106
|
|
|
|
|
|
Consumer & Business Services | SeatGeek, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2023-06
|
|
2023-06
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
10.50%
|
|
10.50%
|
|
|
|
|
|
Investment Interest Rate Paid in Kind |
[7] |
0.50%
|
|
0.50%
|
|
|
|
|
|
Principal Amount |
[11],[17],[18],[19] |
$ 60,915
|
|
|
|
|
|
|
|
Investment cost |
[2],[11],[17],[18],[19] |
60,721
|
|
|
|
|
|
|
|
Total investments at fair value |
[11],[17],[18],[19] |
$ 60,721
|
|
|
|
|
|
|
|
Consumer & Business Services | SeatGeek, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
5.00%
|
|
5.00%
|
|
|
|
|
|
Consumer & Business Services | SeatGeek, Inc. | Debt Investments |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Principal Amount |
|
$ 85,986
|
|
|
|
|
|
|
|
Investment cost |
[2] |
85,633
|
|
|
|
|
|
|
|
Total investments at fair value |
|
86,544
|
|
|
|
|
|
|
|
Consumer & Business Services | SeatGeek, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[18],[19] |
842
|
|
|
|
|
|
|
|
Total investments at fair value |
[18],[19] |
$ 1,332
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Jun. 12, 2019
|
|
Jun. 12, 2019
|
|
|
|
|
|
Shares | shares |
[18],[19] |
1,379,761
|
|
1,379,761
|
|
|
|
|
|
Consumer & Business Services | SeatGeek, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-05
|
|
2026-05
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
10.50%
|
|
10.50%
|
|
|
|
|
|
Investment Interest Rate Paid in Kind |
[7] |
0.50%
|
|
0.50%
|
|
|
|
|
|
Principal Amount |
[11],[13],[19] |
$ 25,071
|
|
|
|
|
|
|
|
Investment cost |
[2],[11],[13],[19] |
24,912
|
|
|
|
|
|
|
|
Total investments at fair value |
[11],[13],[19] |
$ 25,823
|
|
|
|
|
|
|
|
Consumer & Business Services | SeatGeek, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
7.00%
|
|
7.00%
|
|
|
|
|
|
Consumer & Business Services | Skyword, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-11
|
|
2026-11
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
9.25%
|
|
9.25%
|
|
|
|
|
|
Investment Interest Rate Paid in Kind |
[7] |
1.75%
|
|
1.75%
|
|
|
|
|
|
Principal Amount |
[11],[17] |
$ 9,007
|
|
|
|
|
|
|
|
Investment cost |
[2],[11],[17] |
8,918
|
|
|
|
|
|
|
|
Total investments at fair value |
[11],[17] |
$ 8,870
|
|
|
|
|
|
|
|
Consumer & Business Services | Skyword, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
3.00%
|
|
3.00%
|
|
|
|
|
|
Consumer & Business Services | Skyword, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
2.75%
|
|
2.75%
|
|
|
|
|
|
Consumer & Business Services | Skyword, Inc. | Warrant Investment |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 140
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 43
|
|
|
|
|
|
|
|
Shares | shares |
|
2,051,587
|
|
2,051,587
|
|
|
|
|
|
Consumer & Business Services | Skyword, Inc. | Warrant Investment | Preferred Series B |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 83
|
|
|
|
|
|
|
|
Total investments at fair value |
|
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Aug. 23, 2019
|
|
Aug. 23, 2019
|
|
|
|
|
|
Shares | shares |
|
444,444
|
|
444,444
|
|
|
|
|
|
Consumer & Business Services | Skyword, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 57
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 43
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Nov. 14, 2022
|
|
Nov. 14, 2022
|
|
|
|
|
|
Shares | shares |
|
1,607,143
|
|
1,607,143
|
|
|
|
|
|
Consumer & Business Services | Tectura Corporation | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2024-07
|
|
2024-07
|
|
|
|
|
|
Investment Interest Rate Paid in Kind |
[7] |
5.00%
|
|
5.00%
|
|
|
|
|
|
Principal Amount |
[11],[27],[28] |
$ 10,680
|
|
|
|
|
|
|
|
Investment cost |
[2],[11],[27],[28] |
240
|
|
|
|
|
|
|
|
Total investments at fair value |
[11],[27],[28] |
0
|
|
|
|
|
|
|
|
Consumer & Business Services | Tectura Corporation | Debt Investments |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Principal Amount |
|
31,953
|
|
|
|
|
|
|
|
Investment cost |
[2] |
21,513
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 8,042
|
|
|
|
|
|
|
|
Consumer & Business Services | Tectura Corporation | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2024-07
|
|
2024-07
|
|
|
|
|
|
Principal Amount |
[11],[27],[28] |
$ 8,250
|
|
|
|
|
|
|
|
Investment Interest Rate Paid in Cash |
[7] |
8.25%
|
|
8.25%
|
|
|
|
|
|
Investment cost |
[2],[11],[27],[28] |
$ 8,250
|
|
|
|
|
|
|
|
Total investments at fair value |
[11],[27],[28] |
$ 8,042
|
|
|
|
|
|
|
|
Consumer & Business Services | Tectura Corporation | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2024-07
|
|
2024-07
|
|
|
|
|
|
Investment Interest Rate Paid in Kind |
[7] |
5.00%
|
|
5.00%
|
|
|
|
|
|
Principal Amount |
[11],[27],[28] |
$ 13,023
|
|
|
|
|
|
|
|
Investment cost |
[2],[11],[27],[28] |
13,023
|
|
|
|
|
|
|
|
Total investments at fair value |
[11],[27],[28] |
0
|
|
|
|
|
|
|
|
Consumer & Business Services | Tectura Corporation | Equity |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
900
|
|
|
|
|
|
|
|
Total investments at fair value |
|
|
|
|
|
|
|
|
|
Shares | shares |
|
415,994,863
|
|
415,994,863
|
|
|
|
|
|
Consumer & Business Services | Tectura Corporation | Equity | Preferred Series BB |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[27] |
$ 0
|
|
|
|
|
|
|
|
Total investments at fair value |
[27] |
$ 0
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Jun. 06, 2016
|
|
Jun. 06, 2016
|
|
|
|
|
|
Shares | shares |
[27] |
1,000,000
|
|
1,000,000
|
|
|
|
|
|
Consumer & Business Services | Tectura Corporation | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[27] |
$ 900
|
|
|
|
|
|
|
|
Total investments at fair value |
[27] |
$ 0
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
May 23, 2018
|
|
May 23, 2018
|
|
|
|
|
|
Shares | shares |
[27] |
414,994,863
|
|
414,994,863
|
|
|
|
|
|
Consumer & Business Services | Thumbtack, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-04
|
|
2026-04
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
8.20%
|
|
8.20%
|
|
|
|
|
|
Investment Interest Rate Paid in Kind |
[7] |
1.50%
|
|
1.50%
|
|
|
|
|
|
Principal Amount |
[8],[11],[18] |
$ 10,103
|
|
|
|
|
|
|
|
Investment cost |
[2],[8],[11],[18] |
10,050
|
|
|
|
|
|
|
|
Total investments at fair value |
[8],[11],[18] |
$ 10,167
|
|
|
|
|
|
|
|
Consumer & Business Services | Thumbtack, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
3.95%
|
|
3.95%
|
|
|
|
|
|
Consumer & Business Services | Thumbtack, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
4.95%
|
|
4.95%
|
|
|
|
|
|
Consumer & Business Services | Thumbtack, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[18] |
$ 844
|
|
|
|
|
|
|
|
Total investments at fair value |
[18] |
$ 280
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
May 01, 2018
|
|
May 01, 2018
|
|
|
|
|
|
Shares | shares |
[18] |
267,225
|
|
267,225
|
|
|
|
|
|
Consumer & Business Services | Worldremit Group Limited | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-02
|
|
2025-02
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
10.25%
|
|
10.25%
|
|
|
|
|
|
Principal Amount |
[10],[13],[18],[19],[23],[24] |
$ 94,500
|
|
|
|
|
|
|
|
Investment cost |
[2],[10],[13],[18],[19],[23],[24] |
94,418
|
|
|
|
|
|
|
|
Total investments at fair value |
[10],[13],[18],[19],[23],[24] |
$ 93,837
|
|
|
|
|
|
|
|
Consumer & Business Services | Worldremit Group Limited | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
3.00%
|
|
3.00%
|
|
|
|
|
|
Consumer & Business Services | Worldremit Group Limited | Senior Secured Debt | LIBOR |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
9.25%
|
|
9.25%
|
|
|
|
|
|
Consumer & Business Services | Worldremit Group Limited | Warrant Investment |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 155
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 194
|
|
|
|
|
|
|
|
Shares | shares |
|
79,083
|
|
79,083
|
|
|
|
|
|
Consumer & Business Services | Worldremit Group Limited | Warrant Investment | Preferred Series D |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[18],[19],[23],[24] |
$ 129
|
|
|
|
|
|
|
|
Total investments at fair value |
[18],[19],[23],[24] |
$ 192
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Feb. 11, 2021
|
|
Feb. 11, 2021
|
|
|
|
|
|
Shares | shares |
[18],[19],[23],[24] |
77,215
|
|
77,215
|
|
|
|
|
|
Consumer & Business Services | Worldremit Group Limited | Warrant Investment | Preferred Series E |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[19],[23],[24] |
$ 26
|
|
|
|
|
|
|
|
Total investments at fair value |
[19],[23],[24] |
$ 2
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Aug. 27, 2021
|
|
Aug. 27, 2021
|
|
|
|
|
|
Shares | shares |
[19],[23],[24] |
1,868
|
|
1,868
|
|
|
|
|
|
Consumer & Business Services | Udacity, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2024-09
|
|
2024-09
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
7.75%
|
|
7.75%
|
|
|
|
|
|
Investment Interest Rate Paid in Kind |
[7] |
2.00%
|
|
2.00%
|
|
|
|
|
|
Principal Amount |
[11],[18] |
$ 51,937
|
|
|
|
|
|
|
|
Investment cost |
[2],[11],[18] |
52,265
|
|
|
|
|
|
|
|
Total investments at fair value |
[11],[18] |
$ 52,976
|
|
|
|
|
|
|
|
Consumer & Business Services | Udacity, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
3.00%
|
|
3.00%
|
|
|
|
|
|
Consumer & Business Services | Udacity, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
4.50%
|
|
4.50%
|
|
|
|
|
|
Consumer & Business Services | Udacity, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[18] |
$ 218
|
|
|
|
|
|
|
|
Total investments at fair value |
[18] |
$ 4
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Sep. 25, 2020
|
|
Sep. 25, 2020
|
|
|
|
|
|
Shares | shares |
[18] |
486,359
|
|
486,359
|
|
|
|
|
|
Diversified Financial Services |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 68,569
|
|
|
|
$ 65,073
|
|
|
|
Diversified Financial Services | Debt Investments |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
36,567
|
[2] |
|
|
33,738
|
[1] |
|
|
Total investments at fair value |
|
33,700
|
|
|
|
32,465
|
|
|
|
Diversified Financial Services | Equity |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
28,444
|
[2] |
|
|
28,041
|
[1] |
|
|
Total investments at fair value |
|
$ 34,869
|
|
|
|
$ 32,608
|
|
|
|
Diversified Financial Services | Gibraltar Business Capital, LLC | Unsecured |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-09
|
|
2026-09
|
|
2026-09
|
|
2026-09
|
|
Principal Amount |
|
$ 15,000
|
[27] |
|
|
$ 15,000
|
[29] |
|
|
Investment Interest Rate Paid in Cash |
|
14.50%
|
[7] |
14.50%
|
[7] |
14.50%
|
[12] |
14.50%
|
[12] |
Investment cost |
|
$ 14,715
|
[2],[27] |
|
|
$ 14,662
|
[1],[29] |
|
|
Total investments at fair value |
|
12,802
|
[27] |
|
|
13,818
|
[29] |
|
|
Diversified Financial Services | Gibraltar Business Capital, LLC | Debt Investments |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Principal Amount |
|
25,000
|
|
|
|
25,000
|
|
|
|
Investment cost |
|
24,567
|
[2] |
|
|
24,485
|
[1] |
|
|
Total investments at fair value |
|
21,700
|
|
|
|
23,212
|
|
|
|
Diversified Financial Services | Gibraltar Business Capital, LLC | Equity |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
28,006
|
[2] |
|
|
28,006
|
[1] |
|
|
Total investments at fair value |
|
$ 15,244
|
|
|
|
$ 20,618
|
|
|
|
Shares | shares |
|
11,432,752
|
|
11,432,752
|
|
11,432,752
|
|
11,432,752
|
|
Diversified Financial Services | Gibraltar Business Capital, LLC | Equity | Preferred Series A |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[27] |
$ 26,122
|
|
|
|
|
|
|
|
Total investments at fair value |
[27] |
$ 14,137
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Mar. 01, 2018
|
|
Mar. 01, 2018
|
|
|
|
|
|
Shares | shares |
[27] |
10,602,752
|
|
10,602,752
|
|
|
|
|
|
Diversified Financial Services | Gibraltar Business Capital, LLC | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,884
|
[2],[27] |
|
|
$ 1,884
|
[1],[29] |
|
|
Total investments at fair value |
|
$ 1,107
|
[27] |
|
|
$ 1,225
|
[29] |
|
|
Acquisition Date |
|
Mar. 01, 2018
|
[9] |
Mar. 01, 2018
|
[9] |
Mar. 01, 2018
|
[6] |
Mar. 01, 2018
|
[6] |
Shares | shares |
|
830,000
|
[27] |
830,000
|
[27] |
830,000
|
[29] |
830,000
|
[29] |
Diversified Financial Services | Gibraltar Business Capital L L C One | Unsecured |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-09
|
|
2026-09
|
|
2026-09
|
|
2026-09
|
|
Principal Amount |
|
$ 10,000
|
[27] |
|
|
$ 10,000
|
[29] |
|
|
Investment Interest Rate Paid in Cash |
|
11.50%
|
[7] |
11.50%
|
[7] |
11.50%
|
[12] |
11.50%
|
[12] |
Investment cost |
|
$ 9,852
|
[2],[27] |
|
|
$ 9,823
|
[1],[29] |
|
|
Total investments at fair value |
|
$ 8,898
|
[27] |
|
|
9,394
|
[29] |
|
|
Diversified Financial Services | Gibraltar Business Capital L L C One | Equity | Preferred Series A |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[29] |
|
|
|
|
26,122
|
|
|
|
Total investments at fair value |
[29] |
|
|
|
|
$ 19,393
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Mar. 01, 2018
|
|
Mar. 01, 2018
|
|
Shares | shares |
[29] |
|
|
|
|
10,602,752
|
|
10,602,752
|
|
Diversified Financial Services | Hercules Adviser LLC | Unsecured |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-06
|
|
2025-06
|
|
2023-05
|
|
2023-05
|
|
Principal Amount |
|
$ 12,000
|
[27] |
|
|
$ 8,850
|
[29] |
|
|
Investment Interest Rate Paid in Cash |
|
5.00%
|
[7] |
5.00%
|
[7] |
5.00%
|
[12] |
5.00%
|
[12] |
Investment cost |
|
$ 12,000
|
[2],[27] |
|
|
$ 8,850
|
[1],[29] |
|
|
Total investments at fair value |
|
12,000
|
[27] |
|
|
8,850
|
[29] |
|
|
Diversified Financial Services | Hercules Adviser LLC | Equity | Member Units |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
35
|
[2],[27] |
|
|
35
|
[1],[29] |
|
|
Total investments at fair value |
|
$ 19,153
|
[27] |
|
|
$ 11,990
|
[29] |
|
|
Acquisition Date |
|
Mar. 26, 2021
|
[9] |
Mar. 26, 2021
|
[9] |
Mar. 26, 2021
|
[6] |
Mar. 26, 2021
|
[6] |
Shares | shares |
|
1
|
[27] |
1
|
[27] |
1
|
[29] |
1
|
[29] |
Diversified Financial Services | Newfront Insurance Holdings, Inc. | Convertible Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
|
|
2022-08
|
|
2022-08
|
|
Investment Interest Rate Floor |
[12] |
|
|
|
|
0.19%
|
|
0.19%
|
|
Investment Interest Rate Paid in Kind |
[12] |
|
|
|
|
0.19%
|
|
0.19%
|
|
Principal Amount |
[30] |
|
|
|
|
$ 403
|
|
|
|
Investment cost |
[1],[30] |
|
|
|
|
403
|
|
|
|
Total investments at fair value |
[30] |
|
|
|
|
403
|
|
|
|
Diversified Financial Services | Newfront Insurance Holdings, Inc. | Equity | Preferred Series D-2 |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 403
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 472
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Sep. 30, 2021
|
|
Sep. 30, 2021
|
|
|
|
|
|
Shares | shares |
|
210,282
|
|
210,282
|
|
|
|
|
|
Drug Delivery |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 90
|
|
|
|
368
|
|
|
|
Drug Delivery | Equity |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
3,638
|
[2] |
|
|
3,638
|
[1] |
|
|
Total investments at fair value |
|
89
|
|
|
|
305
|
|
|
|
Drug Delivery | Warrant Investment |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
465
|
[2] |
|
|
465
|
[1] |
|
|
Total investments at fair value |
|
1
|
|
|
|
63
|
|
|
|
Drug Delivery | PDS Biotechnology Corporation | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[9] |
390
|
|
|
|
|
|
|
|
Total investments at fair value |
[9] |
$ 1
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Aug. 28, 2014
|
|
Aug. 28, 2014
|
|
|
|
|
|
Shares | shares |
[9] |
3,929
|
|
3,929
|
|
|
|
|
|
Drug Delivery | Aerami Therapeutics Holdings, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 74
|
[2] |
|
|
74
|
[1] |
|
|
Total investments at fair value |
|
|
|
|
|
$ 0
|
|
|
|
Acquisition Date |
|
Sep. 30, 2015
|
[9] |
Sep. 30, 2015
|
[9] |
Sep. 30, 2015
|
[6] |
Sep. 30, 2015
|
[6] |
Shares | shares |
|
110,882
|
|
110,882
|
|
110,882
|
|
110,882
|
|
Drug Delivery | PDS Biotechnology Corporation (p.k.a. Edge Therapeutics, Inc.) | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 309
|
[2],[9] |
|
|
$ 309
|
[1],[6] |
|
|
Total investments at fair value |
|
$ 33
|
[9] |
|
|
$ 20
|
[6] |
|
|
Acquisition Date |
|
Apr. 06, 2015
|
[9] |
Apr. 06, 2015
|
[9] |
Apr. 06, 2015
|
[6] |
Apr. 06, 2015
|
[6] |
Shares | shares |
|
2,498
|
[9] |
2,498
|
[9] |
2,498
|
[6] |
2,498
|
[6] |
Drug Delivery | PDS Biotechnology Corporation (p.k.a. Edge Therapeutics, Inc.) | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[6] |
|
|
|
|
$ 390
|
|
|
|
Total investments at fair value |
[6] |
|
|
|
|
$ 1
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Aug. 28, 2014
|
|
Aug. 28, 2014
|
|
Shares | shares |
[6] |
|
|
|
|
3,929
|
|
3,929
|
|
Drug Delivery | BioQ Pharma Incorporated | Equity | Preferred Series D |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 500
|
[2] |
|
|
$ 500
|
[1] |
|
|
Total investments at fair value |
|
$ 33
|
|
|
|
$ 168
|
|
|
|
Acquisition Date |
|
Dec. 08, 2015
|
[9] |
Dec. 08, 2015
|
[9] |
Dec. 08, 2015
|
[6] |
Dec. 08, 2015
|
[6] |
Shares | shares |
|
165,000
|
|
165,000
|
|
165,000
|
|
165,000
|
|
Drug Delivery | BioQ Pharma Incorporated | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1
|
[2] |
|
|
$ 1
|
[1] |
|
|
Total investments at fair value |
|
|
|
|
|
$ 62
|
|
|
|
Acquisition Date |
|
Oct. 27, 2014
|
[9] |
Oct. 27, 2014
|
[9] |
Oct. 27, 2014
|
[6] |
Oct. 27, 2014
|
[6] |
Shares | shares |
|
459,183
|
|
459,183
|
|
459,183
|
|
459,183
|
|
Drug Delivery | Aytu BioScience, Inc. (p.k.a. Neos Therapeutics, Inc.) | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,500
|
[2],[9] |
|
|
$ 1,500
|
[1],[6] |
|
|
Total investments at fair value |
|
$ 3
|
[9] |
|
|
$ 18
|
[6] |
|
|
Acquisition Date |
|
Mar. 28, 2014
|
[9] |
Mar. 28, 2014
|
[9] |
Mar. 28, 2014
|
[6] |
Mar. 28, 2014
|
[6] |
Shares | shares |
|
13,600
|
[9] |
13,600
|
[9] |
13,600
|
[6] |
13,600
|
[6] |
Drug Delivery | AcelRx Pharmaceuticals, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,329
|
[2],[9] |
|
|
$ 1,329
|
[1],[6] |
|
|
Total investments at fair value |
|
$ 20
|
[9] |
|
|
$ 99
|
[6] |
|
|
Acquisition Date |
|
Dec. 10, 2018
|
[9] |
Dec. 10, 2018
|
[9] |
Dec. 10, 2018
|
[6] |
Dec. 10, 2018
|
[6] |
Shares | shares |
|
8,836
|
[9] |
8,836
|
[9] |
176,730
|
[6] |
176,730
|
[6] |
Drug Discovery & Development |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 1,150,707
|
|
|
|
$ 967,383
|
|
|
|
Drug Discovery & Development | Investment Funds & Vehicles [Member] |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
3,118
|
|
|
|
|
|
|
|
Total investments at fair value |
|
3,518
|
|
|
|
|
|
|
|
Drug Discovery & Development | Debt Investments |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
1,107,352
|
[2] |
|
|
936,457
|
[1] |
|
|
Total investments at fair value |
|
1,101,430
|
|
|
|
935,964
|
|
|
|
Drug Discovery & Development | Equity |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
43,971
|
[2] |
|
|
33,401
|
[1] |
|
|
Total investments at fair value |
|
37,315
|
|
|
|
24,860
|
|
|
|
Drug Discovery & Development | Warrant Investment |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
7,466
|
[2] |
|
|
7,393
|
[1] |
|
|
Total investments at fair value |
|
8,444
|
|
|
|
4,745
|
|
|
|
Drug Discovery & Development | Forbion Growth Opportunities Fund I I C V | Investment Funds & Vehicles [Member] |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[8],[23],[24] |
419
|
|
|
|
|
|
|
|
Total investments at fair value |
[8],[23],[24] |
$ 438
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Jun. 23, 2022
|
|
Jun. 23, 2022
|
|
|
|
|
|
Drug Discovery & Development | Kineta, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[9] |
$ 110
|
|
|
|
|
|
|
|
Total investments at fair value |
[9] |
$ 0
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Dec. 20, 2019
|
|
Dec. 20, 2019
|
|
|
|
|
|
Shares | shares |
[9] |
2,202
|
|
2,202
|
|
|
|
|
|
Drug Discovery & Development | Akero Therapeutics, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-01
|
|
2027-01
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
7.65%
|
|
7.65%
|
|
|
|
|
|
Principal Amount |
[8],[17],[23] |
$ 5,000
|
|
|
|
|
|
|
|
Investment cost |
[2],[8],[17],[23] |
4,986
|
|
|
|
|
|
|
|
Total investments at fair value |
[8],[17],[23] |
$ 5,039
|
|
|
|
|
|
|
|
Drug Discovery & Development | Akero Therapeutics, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
5.85%
|
|
5.85%
|
|
|
|
|
|
Drug Discovery & Development | Akero Therapeutics, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
3.65%
|
|
3.65%
|
|
|
|
|
|
Drug Discovery & Development | Akero Therapeutics, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[9],[23] |
$ 1,000
|
|
|
|
|
|
|
|
Total investments at fair value |
[9],[23] |
$ 2,108
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Sep. 19, 2022
|
|
Sep. 19, 2022
|
|
|
|
|
|
Shares | shares |
[9],[23] |
38,461
|
|
38,461
|
|
|
|
|
|
Drug Discovery & Development | Akero Therapeutics, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[9],[23] |
$ 56
|
|
|
|
|
|
|
|
Total investments at fair value |
[9],[23] |
$ 674
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Jun. 15, 2022
|
|
Jun. 15, 2022
|
|
|
|
|
|
Shares | shares |
[9],[23] |
18,360
|
|
18,360
|
|
|
|
|
|
Drug Discovery & Development | Alladapt Immunotherapeutics Inc | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-09
|
|
2026-09
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
8.40%
|
|
8.40%
|
|
|
|
|
|
Principal Amount |
[8],[17] |
$ 15,000
|
|
|
|
|
|
|
|
Investment cost |
[2],[8],[17] |
14,920
|
|
|
|
|
|
|
|
Total investments at fair value |
[8],[17] |
$ 14,920
|
|
|
|
|
|
|
|
Drug Discovery & Development | Alladapt Immunotherapeutics Inc | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
10.60%
|
|
10.60%
|
|
|
|
|
|
Drug Discovery & Development | Alladapt Immunotherapeutics Inc | Senior Secured Debt | Cap rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
10.90%
|
|
10.90%
|
|
|
|
|
|
Drug Discovery & Development | Alladapt Immunotherapeutics Inc | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
3.65%
|
|
3.65%
|
|
|
|
|
|
Drug Discovery & Development | ATAI Life Sciences N.V. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-08
|
|
2026-08
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
8.55%
|
|
8.55%
|
|
|
|
|
|
Principal Amount |
[23],[24] |
$ 10,500
|
|
|
|
|
|
|
|
Investment cost |
[2],[23],[24] |
10,513
|
|
|
|
|
|
|
|
Total investments at fair value |
[23],[24] |
$ 10,513
|
|
|
|
|
|
|
|
Drug Discovery & Development | ATAI Life Sciences N.V. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
6.95%
|
|
6.95%
|
|
|
|
|
|
Drug Discovery & Development | ATAI Life Sciences N.V. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
4.55%
|
|
4.55%
|
|
|
|
|
|
Drug Discovery & Development | Provention Bio, Inc. [Member] | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-09
|
|
2027-09
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
8.20%
|
|
8.20%
|
|
|
|
|
|
Principal Amount |
[8] |
$ 25,000
|
|
|
|
|
|
|
|
Investment cost |
[2],[8] |
24,670
|
|
|
|
|
|
|
|
Total investments at fair value |
[8] |
$ 24,670
|
|
|
|
|
|
|
|
Drug Discovery & Development | Provention Bio, Inc. [Member] | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
6.60%
|
|
6.60%
|
|
|
|
|
|
Drug Discovery & Development | Provention Bio, Inc. [Member] | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
2.70%
|
|
2.70%
|
|
|
|
|
|
Drug Discovery & Development | Provention Bio, Inc. [Member] | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[9] |
$ 281
|
|
|
|
|
|
|
|
Total investments at fair value |
[9] |
$ 677
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Sep. 15, 2022
|
|
Sep. 15, 2022
|
|
|
|
|
|
Shares | shares |
[9] |
111,934
|
|
111,934
|
|
|
|
|
|
Drug Discovery & Development | Redshift Bioanalytics, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-01
|
|
2026-01
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
7.50%
|
|
7.50%
|
|
|
|
|
|
Principal Amount |
[25] |
$ 5,000
|
|
|
|
|
|
|
|
Investment cost |
[2],[25] |
4,957
|
|
|
|
|
|
|
|
Total investments at fair value |
[25] |
$ 4,946
|
|
|
|
|
|
|
|
Drug Discovery & Development | Redshift Bioanalytics, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
3.80%
|
|
3.80%
|
|
|
|
|
|
Drug Discovery & Development | Redshift Bioanalytics, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
4.25%
|
|
4.25%
|
|
|
|
|
|
Drug Discovery & Development | Redshift Bioanalytics, Inc. | Warrant Investment | Preferred Series E |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[25] |
$ 20
|
|
|
|
|
|
|
|
Total investments at fair value |
[25] |
$ 21
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Mar. 23, 2022
|
|
Mar. 23, 2022
|
|
|
|
|
|
Shares | shares |
[25] |
475,510
|
|
475,510
|
|
|
|
|
|
Drug Discovery & Development | Replimune Group, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-10
|
|
2027-10
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
7.25%
|
|
7.25%
|
|
|
|
|
|
Investment Interest Rate Paid in Kind |
[7] |
1.50%
|
|
1.50%
|
|
|
|
|
|
Principal Amount |
[8],[11],[23] |
$ 20,754
|
|
|
|
|
|
|
|
Investment cost |
[2],[8],[11],[23] |
20,656
|
|
|
|
|
|
|
|
Total investments at fair value |
[8],[11],[23] |
$ 20,656
|
|
|
|
|
|
|
|
Drug Discovery & Development | Replimune Group, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
4.95%
|
|
4.95%
|
|
|
|
|
|
Drug Discovery & Development | Replimune Group, Inc. | Senior Secured Debt | Cap rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
9.00%
|
|
9.00%
|
|
|
|
|
|
Drug Discovery & Development | Replimune Group, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
1.75%
|
|
1.75%
|
|
|
|
|
|
Drug Discovery & Development | Tarsus Pharmaceuticals, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-02
|
|
2027-02
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
8.45%
|
|
8.45%
|
|
|
|
|
|
Principal Amount |
[8],[17],[23] |
$ 8,250
|
|
|
|
|
|
|
|
Investment cost |
[2],[8],[17],[23] |
8,274
|
|
|
|
|
|
|
|
Total investments at fair value |
[8],[17],[23] |
$ 8,423
|
|
|
|
|
|
|
|
Drug Discovery & Development | Tarsus Pharmaceuticals, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
4.75%
|
|
4.75%
|
|
|
|
|
|
Drug Discovery & Development | Tarsus Pharmaceuticals, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
5.20%
|
|
5.20%
|
|
|
|
|
|
Drug Discovery & Development | Tarsus Pharmaceuticals, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[9],[23] |
$ 2,100
|
|
|
|
|
|
|
|
Total investments at fair value |
[9],[23] |
$ 2,280
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
May 05, 2022
|
|
May 05, 2022
|
|
|
|
|
|
Shares | shares |
[9],[23] |
155,555
|
|
155,555
|
|
|
|
|
|
Drug Discovery & Development | Iveric Bio, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-08
|
|
2027-08
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
8.75%
|
|
8.75%
|
|
|
|
|
|
Principal Amount |
[18],[23] |
$ 49,500
|
|
|
|
|
|
|
|
Investment cost |
[2],[18],[23] |
49,090
|
|
|
|
|
|
|
|
Total investments at fair value |
[18],[23] |
$ 49,090
|
|
|
|
|
|
|
|
Drug Discovery & Development | Iveric Bio, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
4.25%
|
|
4.25%
|
|
|
|
|
|
Drug Discovery & Development | Iveric Bio, Inc. | Senior Secured Debt | Cap rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
10.25%
|
|
10.25%
|
|
|
|
|
|
Drug Discovery & Development | Iveric Bio, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
4.00%
|
|
4.00%
|
|
|
|
|
|
Drug Discovery & Development | AmplifyBio, LLC | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-01
|
|
2027-01
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
9.50%
|
|
9.50%
|
|
|
|
|
|
Principal Amount |
[25] |
$ 24,000
|
|
|
|
|
|
|
|
Investment cost |
[2],[25] |
23,663
|
|
|
|
|
|
|
|
Total investments at fair value |
[25] |
$ 23,663
|
|
|
|
|
|
|
|
Drug Discovery & Development | AmplifyBio, LLC | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
5.85%
|
|
5.85%
|
|
|
|
|
|
Drug Discovery & Development | AmplifyBio, LLC | Senior Secured Debt | Cap rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
10.75%
|
|
10.75%
|
|
|
|
|
|
Drug Discovery & Development | AmplifyBio, LLC | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
2.50%
|
|
2.50%
|
|
|
|
|
|
Drug Discovery & Development | AmplifyBio, LLC | Warrant Investment | Class A Units |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[25] |
$ 238
|
|
|
|
|
|
|
|
Total investments at fair value |
[25] |
$ 256
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Dec. 27, 2022
|
|
Dec. 27, 2022
|
|
|
|
|
|
Shares | shares |
[25] |
69,239
|
|
69,239
|
|
|
|
|
|
Drug Discovery & Development | HilleVax, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-05
|
|
2027-05
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
4.55%
|
|
4.55%
|
|
|
|
|
|
Investment Interest Rate Paid in Kind |
[7] |
2.85%
|
|
2.85%
|
|
|
|
|
|
Principal Amount |
[8],[11],[25] |
$ 12,072
|
|
|
|
|
|
|
|
Investment cost |
[2],[8],[11],[25] |
12,043
|
|
|
|
|
|
|
|
Total investments at fair value |
[8],[11],[25] |
$ 11,333
|
|
|
|
|
|
|
|
Drug Discovery & Development | HilleVax, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
7.15%
|
|
7.15%
|
|
|
|
|
|
Drug Discovery & Development | HilleVax, Inc. | Senior Secured Debt | Cap rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
6.05%
|
|
6.05%
|
|
|
|
|
|
Drug Discovery & Development | HilleVax, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
1.05%
|
|
1.05%
|
|
|
|
|
|
Drug Discovery & Development | HilleVax, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[9] |
$ 4,000
|
|
|
|
|
|
|
|
Total investments at fair value |
[9] |
$ 3,937
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
May 03, 2022
|
|
May 03, 2022
|
|
|
|
|
|
Shares | shares |
[9] |
235,295
|
|
235,295
|
|
|
|
|
|
Drug Discovery & Development | Kura Oncology, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-11
|
|
2027-11
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
8.65%
|
|
8.65%
|
|
|
|
|
|
Principal Amount |
[8],[23],[25] |
$ 5,500
|
|
|
|
|
|
|
|
Investment cost |
[2],[8],[23],[25] |
5,448
|
|
|
|
|
|
|
|
Total investments at fair value |
[8],[23],[25] |
$ 5,448
|
|
|
|
|
|
|
|
Drug Discovery & Development | Kura Oncology, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
15.13%
|
|
15.13%
|
|
|
|
|
|
Drug Discovery & Development | Kura Oncology, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
2.40%
|
|
2.40%
|
|
|
|
|
|
Drug Discovery & Development | Kura Oncology, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[9],[23],[25] |
$ 88
|
|
|
|
|
|
|
|
Total investments at fair value |
[9],[23],[25] |
$ 59
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Nov. 02, 2022
|
|
Nov. 02, 2022
|
|
|
|
|
|
Shares | shares |
[9],[23],[25] |
14,342
|
|
14,342
|
|
|
|
|
|
Drug Discovery & Development | Madrigal Pharmaceutical, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-05
|
|
2026-05
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
7.45%
|
|
7.45%
|
|
|
|
|
|
Principal Amount |
[8],[23] |
$ 34,000
|
|
|
|
|
|
|
|
Investment cost |
[2],[8],[23] |
33,945
|
|
|
|
|
|
|
|
Total investments at fair value |
[8],[23] |
$ 33,987
|
|
|
|
|
|
|
|
Drug Discovery & Development | Madrigal Pharmaceutical, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
5.35%
|
|
5.35%
|
|
|
|
|
|
Drug Discovery & Development | Madrigal Pharmaceutical, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
3.95%
|
|
3.95%
|
|
|
|
|
|
Drug Discovery & Development | Madrigal Pharmaceutical, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[9],[23] |
$ 177
|
|
|
|
|
|
|
|
Total investments at fair value |
[9],[23] |
$ 1,977
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
May 09, 2022
|
|
May 09, 2022
|
|
|
|
|
|
Shares | shares |
[9],[23] |
10,131
|
|
10,131
|
|
|
|
|
|
Drug Discovery & Development | Forbion Growth Opportunities Fund I C V | Investment Funds & Vehicles [Member] |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[8],[23],[24] |
$ 2,699
|
|
|
|
|
|
|
|
Total investments at fair value |
[8],[23],[24] |
$ 3,080
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Nov. 16, 2020
|
|
Nov. 16, 2020
|
|
|
|
|
|
Drug Discovery & Development | Dynavax Technologies | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 550
|
[2],[9],[23] |
|
|
550
|
[1],[4],[6] |
|
|
Total investments at fair value |
|
$ 213
|
[9],[23] |
|
|
$ 281
|
[4],[6] |
|
|
Acquisition Date |
|
Jul. 22, 2015
|
[9] |
Jul. 22, 2015
|
[9] |
Jul. 22, 2015
|
[6] |
Jul. 22, 2015
|
[6] |
Shares | shares |
|
20,000
|
[9],[23] |
20,000
|
[9],[23] |
20,000
|
[4],[6] |
20,000
|
[4],[6] |
Drug Discovery & Development | Genocea Biosciences Inc | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[6] |
|
|
|
|
$ 2,000
|
|
|
|
Total investments at fair value |
[6] |
|
|
|
|
$ 32
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Nov. 20, 2014
|
|
Nov. 20, 2014
|
|
Shares | shares |
[6] |
|
|
|
|
27,933
|
|
27,933
|
|
Drug Discovery & Development | Genocea Biosciences Inc | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[6] |
|
|
|
|
$ 165
|
|
|
|
Total investments at fair value |
[6] |
|
|
|
|
$ 1
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Apr. 24, 2018
|
|
Apr. 24, 2018
|
|
Shares | shares |
[6] |
|
|
|
|
41,176
|
|
41,176
|
|
Drug Discovery & Development | NorthSea Therapeutics | Equity | Preferred Series C |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 2,000
|
[2],[23],[24] |
|
|
$ 2,000
|
[1],[4],[5] |
|
|
Total investments at fair value |
|
$ 1,476
|
[23],[24] |
|
|
$ 2,000
|
[4],[5] |
|
|
Acquisition Date |
|
Dec. 15, 2021
|
[9] |
Dec. 15, 2021
|
[9] |
Dec. 15, 2021
|
[6] |
Dec. 15, 2021
|
[6] |
Shares | shares |
|
983
|
[23],[24] |
983
|
[23],[24] |
983
|
[4],[5] |
983
|
[4],[5] |
Drug Discovery & Development | Sio Gene Therapies, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,269
|
[2],[9] |
|
|
$ 1,269
|
[1],[4],[6] |
|
|
Total investments at fair value |
|
$ 7
|
[9] |
|
|
$ 21
|
[4],[6] |
|
|
Acquisition Date |
|
Feb. 02, 2017
|
[9] |
Feb. 02, 2017
|
[9] |
Feb. 02, 2017
|
[6] |
Feb. 02, 2017
|
[6] |
Shares | shares |
|
16,228
|
[9] |
16,228
|
[9] |
16,228
|
[4],[6] |
16,228
|
[4],[6] |
Drug Discovery & Development | Valo Health L L C | Equity |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 4,000
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 3,075
|
|
|
|
|
|
|
|
Shares | shares |
|
680,410
|
|
680,410
|
|
|
|
|
|
Drug Discovery & Development | Valo Health L L C | Equity | Preferred Series B |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 3,000
|
[2] |
|
|
$ 3,000
|
[1] |
|
|
Total investments at fair value |
|
$ 2,063
|
|
|
|
$ 4,650
|
|
|
|
Acquisition Date |
|
Dec. 11, 2020
|
[9] |
Dec. 11, 2020
|
[9] |
Dec. 11, 2020
|
[6] |
Dec. 11, 2020
|
[6] |
Shares | shares |
|
510,308
|
|
510,308
|
|
510,308
|
|
510,308
|
|
Drug Discovery & Development | Valo Health L L C | Equity | Preferred Series C |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 1,000
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 1,012
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Oct. 31, 2022
|
|
Oct. 31, 2022
|
|
|
|
|
|
Shares | shares |
|
170,102
|
|
170,102
|
|
|
|
|
|
Drug Discovery & Development | Paratek Pharmaceuticals, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 2,744
|
[2],[9] |
|
|
$ 2,744
|
[1],[6] |
|
|
Total investments at fair value |
|
$ 143
|
[9] |
|
|
$ 343
|
[6] |
|
|
Acquisition Date |
|
Feb. 26, 2007
|
[9] |
Feb. 26, 2007
|
[9] |
Feb. 26, 2007
|
[6] |
Feb. 26, 2007
|
[6] |
Shares | shares |
|
76,362
|
[9] |
76,362
|
[9] |
76,362
|
[6] |
76,362
|
[6] |
Drug Discovery & Development | Paratek Pharmaceuticals, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 520
|
[2],[9] |
|
|
$ 546
|
[1],[6] |
|
|
Total investments at fair value |
|
$ 34
|
[9] |
|
|
$ 427
|
[6] |
|
|
Acquisition Date |
|
Aug. 01, 2018
|
[9] |
Aug. 01, 2018
|
[9] |
Jun. 27, 2017
|
[6] |
Jun. 27, 2017
|
[6] |
Shares | shares |
|
426,866
|
[9] |
426,866
|
[9] |
432,240
|
[6] |
432,240
|
[6] |
Drug Discovery & Development | Rocket Pharmaceuticals, Ltd. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,500
|
[2],[9] |
|
|
$ 1,500
|
[1],[6] |
|
|
Total investments at fair value |
|
$ 18
|
[9] |
|
|
$ 21
|
[6] |
|
|
Acquisition Date |
|
Aug. 22, 2007
|
[9] |
Aug. 22, 2007
|
[9] |
Aug. 22, 2007
|
[6] |
Aug. 22, 2007
|
[6] |
Shares | shares |
|
944
|
[9] |
944
|
[9] |
944
|
[6] |
944
|
[6] |
Drug Discovery & Development | Savara, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 203
|
[2],[9] |
|
|
$ 202
|
[1],[6] |
|
|
Total investments at fair value |
|
$ 17
|
[9] |
|
|
$ 14
|
[6] |
|
|
Acquisition Date |
|
Aug. 11, 2015
|
[9] |
Aug. 11, 2015
|
[9] |
Aug. 11, 2015
|
[6] |
Aug. 11, 2015
|
[6] |
Shares | shares |
|
11,119
|
[9] |
11,119
|
[9] |
11,119
|
[6] |
11,119
|
[6] |
Drug Discovery & Development | Tricida, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 863
|
[2],[9] |
|
|
$ 863
|
[1],[6] |
|
|
Total investments at fair value |
|
$ 11
|
[9] |
|
|
$ 658
|
[6] |
|
|
Acquisition Date |
|
Feb. 28, 2018
|
[9] |
Feb. 28, 2018
|
[9] |
Feb. 28, 2018
|
[6] |
Feb. 28, 2018
|
[6] |
Shares | shares |
|
68,816
|
[9] |
68,816
|
[9] |
68,816
|
[6] |
68,816
|
[6] |
Drug Discovery & Development | Tricida, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 280
|
[2],[9] |
|
|
$ 280
|
[1],[6] |
|
|
Total investments at fair value |
|
$ 1
|
[9] |
|
|
$ 20
|
[6] |
|
|
Acquisition Date |
|
Mar. 27, 2019
|
[9] |
Mar. 27, 2019
|
[9] |
Mar. 27, 2019
|
[6] |
Mar. 27, 2019
|
[6] |
Shares | shares |
|
31,352
|
[9] |
31,352
|
[9] |
31,352
|
[6] |
31,352
|
[6] |
Drug Discovery & Development | Concert Pharmaceuticals, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,367
|
[2],[9],[23] |
|
|
$ 1,367
|
[1],[4],[6] |
|
|
Total investments at fair value |
|
$ 413
|
[9],[23] |
|
|
$ 223
|
[4],[6] |
|
|
Acquisition Date |
|
Feb. 13, 2019
|
[9] |
Feb. 13, 2019
|
[9] |
Feb. 13, 2019
|
[6] |
Feb. 13, 2019
|
[6] |
Shares | shares |
|
70,796
|
[9],[23] |
70,796
|
[9],[23] |
70,796
|
[4],[6] |
70,796
|
[4],[6] |
Drug Discovery & Development | Concert Pharmaceuticals, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[4],[6] |
|
|
|
|
$ 178
|
|
|
|
Total investments at fair value |
[4],[6] |
|
|
|
|
$ 3
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Jun. 08, 2017
|
|
Jun. 08, 2017
|
|
Shares | shares |
[4],[6] |
|
|
|
|
61,273
|
|
61,273
|
|
Drug Discovery & Development | Gritstone Bio, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-07
|
|
2027-07
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
7.15%
|
|
7.15%
|
|
|
|
|
|
Investment Interest Rate Paid in Kind |
[7] |
2.00%
|
|
2.00%
|
|
|
|
|
|
Principal Amount |
[8],[11] |
$ 15,113
|
|
|
|
|
|
|
|
Investment cost |
[2],[8],[11] |
15,109
|
|
|
|
|
|
|
|
Total investments at fair value |
[8],[11] |
$ 15,109
|
|
|
|
|
|
|
|
Drug Discovery & Development | Gritstone Bio, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
5.75%
|
|
5.75%
|
|
|
|
|
|
Drug Discovery & Development | Gritstone Bio, Inc. | Senior Secured Debt | Cap rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
8.65%
|
|
8.65%
|
|
|
|
|
|
Drug Discovery & Development | Gritstone Bio, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
3.15%
|
|
3.15%
|
|
|
|
|
|
Drug Discovery & Development | Gritstone Bio, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[9] |
$ 1,000
|
|
|
|
|
|
|
|
Total investments at fair value |
[9] |
$ 1,527
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Oct. 26, 2022
|
|
Oct. 26, 2022
|
|
|
|
|
|
Shares | shares |
[9] |
442,477
|
|
442,477
|
|
|
|
|
|
Drug Discovery & Development | Dare Biosciences, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,000
|
[2],[9] |
|
|
$ 1,000
|
[1],[6] |
|
|
Total investments at fair value |
|
$ 11
|
[9] |
|
|
$ 27
|
[6] |
|
|
Acquisition Date |
|
Jan. 08, 2015
|
[9] |
Jan. 08, 2015
|
[9] |
Jan. 08, 2015
|
[6] |
Jan. 08, 2015
|
[6] |
Shares | shares |
|
13,550
|
[9] |
13,550
|
[9] |
13,550
|
[6] |
13,550
|
[6] |
Drug Discovery & Development | Applied Molecular Transport | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 42
|
[2],[9],[23] |
|
|
$ 42
|
[1],[4],[6] |
|
|
Total investments at fair value |
|
$ 0
|
[9],[23] |
|
|
$ 14
|
[4],[6] |
|
|
Acquisition Date |
|
Apr. 06, 2021
|
[9] |
Apr. 06, 2021
|
[9] |
Apr. 06, 2021
|
[6] |
Apr. 06, 2021
|
[6] |
Shares | shares |
|
1,000
|
[9],[23] |
1,000
|
[9],[23] |
1,000
|
[4],[6] |
1,000
|
[4],[6] |
Drug Discovery & Development | Avalo Therapeutics Inc P K Cerecor Inc | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,000
|
[2],[9] |
|
|
$ 1,000
|
[1],[6] |
|
|
Total investments at fair value |
|
$ 50
|
[9] |
|
|
$ 202
|
[6] |
|
|
Acquisition Date |
|
Aug. 19, 2014
|
[9] |
Aug. 19, 2014
|
[9] |
Aug. 19, 2014
|
[6] |
Aug. 19, 2014
|
[6] |
Shares | shares |
|
9,924
|
[9] |
9,924
|
[9] |
119,087
|
[6] |
119,087
|
[6] |
Drug Discovery & Development | Albireo Pharma, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
|
|
2024-07
|
|
2024-07
|
|
Investment Interest Rate Floor |
[12] |
|
|
|
|
9.15%
|
|
9.15%
|
|
Principal Amount |
[4],[15] |
|
|
|
|
$ 10,000
|
|
|
|
Investment cost |
[1],[4],[15] |
|
|
|
|
10,229
|
|
|
|
Total investments at fair value |
[4],[15] |
|
|
|
|
$ 10,268
|
|
|
|
Drug Discovery & Development | Albireo Pharma, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[12] |
|
|
|
|
6.95%
|
|
6.95%
|
|
Drug Discovery & Development | Albireo Pharma, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[12] |
|
|
|
|
5.90%
|
|
5.90%
|
|
Drug Discovery & Development | Albireo Pharma, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,000
|
[2],[9],[23] |
|
|
$ 1,000
|
[1],[4],[6] |
|
|
Total investments at fair value |
|
$ 540
|
[9],[23] |
|
|
$ 582
|
[4],[6] |
|
|
Acquisition Date |
|
Sep. 14, 2020
|
[9] |
Sep. 14, 2020
|
[9] |
Sep. 14, 2020
|
[6] |
Sep. 14, 2020
|
[6] |
Shares | shares |
|
25,000
|
[9],[23] |
25,000
|
[9],[23] |
25,000
|
[4],[6] |
25,000
|
[4],[6] |
Drug Discovery & Development | Albireo Pharma, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 61
|
[2],[9],[23] |
|
|
$ 61
|
[1],[4],[6] |
|
|
Total investments at fair value |
|
$ 31
|
[9],[23] |
|
|
$ 42
|
[4],[6] |
|
|
Acquisition Date |
|
Jun. 08, 2020
|
[9] |
Jun. 08, 2020
|
[9] |
Jun. 08, 2020
|
[6] |
Jun. 08, 2020
|
[6] |
Shares | shares |
|
5,311
|
[9],[23] |
5,311
|
[9],[23] |
5,311
|
[4],[6] |
5,311
|
[4],[6] |
Drug Discovery & Development | Aldeyra Therapeutics, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2024-10
|
|
2024-10
|
|
2023-10
|
|
2023-10
|
|
Investment Interest Rate Floor |
|
8.60%
|
[7] |
8.60%
|
[7] |
8.60%
|
[12] |
8.60%
|
[12] |
Principal Amount |
|
$ 15,000
|
[13] |
|
|
$ 15,000
|
|
|
|
Investment cost |
|
15,879
|
[2],[13] |
|
|
15,639
|
[1] |
|
|
Total investments at fair value |
|
$ 15,974
|
[13] |
|
|
$ 15,653
|
|
|
|
Drug Discovery & Development | Aldeyra Therapeutics, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
|
8.90%
|
[7] |
8.90%
|
[7] |
6.95%
|
[12] |
6.95%
|
[12] |
Drug Discovery & Development | Aldeyra Therapeutics, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
|
3.10%
|
[7] |
3.10%
|
[7] |
3.10%
|
[12] |
3.10%
|
[12] |
Drug Discovery & Development | Applied Genetic Technologies Corporation | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
|
|
2024-04
|
|
2024-04
|
|
Investment Interest Rate Floor |
[12] |
|
|
|
|
9.75%
|
|
9.75%
|
|
Principal Amount |
|
|
|
|
|
$ 20,000
|
|
|
|
Investment cost |
[1] |
|
|
|
|
20,416
|
|
|
|
Total investments at fair value |
|
|
|
|
|
$ 20,339
|
|
|
|
Drug Discovery & Development | Applied Genetic Technologies Corporation | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[12] |
|
|
|
|
6.95%
|
|
6.95%
|
|
Drug Discovery & Development | Applied Genetic Technologies Corporation | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[12] |
|
|
|
|
6.50%
|
|
6.50%
|
|
Drug Discovery & Development | Aveo Pharmaceuticals, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2024-09
|
|
2024-09
|
|
2024-09
|
|
2024-09
|
|
Investment Interest Rate Floor |
|
9.65%
|
[7] |
9.65%
|
[7] |
9.65%
|
[12] |
9.65%
|
[12] |
Principal Amount |
|
$ 40,000
|
[13],[25] |
|
|
$ 40,000
|
[15],[31] |
|
|
Investment cost |
|
41,644
|
[2],[13],[25] |
|
|
40,842
|
[1],[15],[31] |
|
|
Total investments at fair value |
|
$ 43,183
|
[13],[25] |
|
|
$ 40,776
|
[15],[31] |
|
|
Drug Discovery & Development | Aveo Pharmaceuticals, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
|
6.95%
|
[7] |
6.95%
|
[7] |
6.95%
|
[12] |
6.95%
|
[12] |
Drug Discovery & Development | Aveo Pharmaceuticals, Inc. | Senior Secured Debt | Cap rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
15.00%
|
|
15.00%
|
|
|
|
|
|
Drug Discovery & Development | Aveo Pharmaceuticals, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
|
6.40%
|
[7] |
6.40%
|
[7] |
6.40%
|
[12] |
6.40%
|
[12] |
Drug Discovery & Development | Aveo Pharmaceuticals, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,715
|
[2],[9] |
|
|
$ 1,715
|
[1],[6] |
|
|
Total investments at fair value |
|
$ 2,843
|
[9] |
|
|
$ 892
|
[6] |
|
|
Acquisition Date |
|
Jul. 31, 2011
|
[9] |
Jul. 31, 2011
|
[9] |
Jul. 31, 2011
|
[6] |
Jul. 31, 2011
|
[6] |
Shares | shares |
|
190,179
|
[9] |
190,179
|
[9] |
190,179
|
[6] |
190,179
|
[6] |
Drug Discovery & Development | Acacia Pharma Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 304
|
[2],[23],[24] |
|
|
$ 305
|
[1],[4],[5],[6] |
|
|
Total investments at fair value |
|
$ 0
|
[23],[24] |
|
|
$ 6
|
[4],[5],[6] |
|
|
Acquisition Date |
|
Jun. 29, 2018
|
[9] |
Jun. 29, 2018
|
[9] |
Jun. 29, 2018
|
[6] |
Jun. 29, 2018
|
[6] |
Shares | shares |
|
201,330
|
[23],[24] |
201,330
|
[23],[24] |
201,330
|
[4],[5],[6] |
201,330
|
[4],[5],[6] |
Drug Discovery & Development | ADMA Biologics, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 166
|
[2],[9] |
|
|
$ 295
|
[1],[6] |
|
|
Total investments at fair value |
|
$ 10
|
[9] |
|
|
$ 1
|
[6] |
|
|
Acquisition Date |
|
Feb. 24, 2014
|
[9] |
Feb. 24, 2014
|
[9] |
Dec. 21, 2012
|
[6] |
Dec. 21, 2012
|
[6] |
Shares | shares |
|
58,000
|
[9] |
58,000
|
[9] |
89,750
|
[6] |
89,750
|
[6] |
Drug Discovery & Development | Axsome Therapeutics, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-10
|
|
2026-10
|
|
2026-10
|
|
2026-10
|
|
Investment Interest Rate Floor |
|
8.95%
|
[7] |
8.95%
|
[7] |
8.95%
|
[12] |
8.95%
|
[12] |
Principal Amount |
|
$ 81,725
|
[8],[13],[18],[19],[23] |
|
|
$ 50,000
|
[4],[32] |
|
|
Investment cost |
|
81,631
|
[2],[8],[13],[18],[19],[23] |
|
|
49,542
|
[1],[4],[32] |
|
|
Total investments at fair value |
|
$ 78,074
|
[8],[13],[18],[19],[23] |
|
|
$ 48,859
|
[4],[32] |
|
|
Drug Discovery & Development | Axsome Therapeutics, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
|
5.31%
|
[7] |
5.31%
|
[7] |
5.82%
|
[12] |
5.82%
|
[12] |
Drug Discovery & Development | Axsome Therapeutics, Inc. | Senior Secured Debt | Cap rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
10.70%
|
|
10.70%
|
|
|
|
|
|
Drug Discovery & Development | Axsome Therapeutics, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
|
5.70%
|
[7] |
5.70%
|
[7] |
5.70%
|
[12] |
5.70%
|
[12] |
Drug Discovery & Development | Axsome Therapeutics, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[9],[19],[23] |
$ 4,165
|
|
|
|
|
|
|
|
Total investments at fair value |
[9],[19],[23] |
$ 9,797
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
May 09, 2022
|
|
May 09, 2022
|
|
|
|
|
|
Shares | shares |
[9],[19],[23] |
127,021
|
|
127,021
|
|
|
|
|
|
Drug Discovery & Development | Axsome Therapeutics, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 880
|
[2],[9],[18],[19],[23] |
|
|
$ 681
|
[1],[4],[6] |
|
|
Total investments at fair value |
|
$ 1,590
|
[9],[18],[19],[23] |
|
|
$ 142
|
[4],[6] |
|
|
Acquisition Date |
|
Sep. 25, 2020
|
[9] |
Sep. 25, 2020
|
[9] |
Sep. 25, 2020
|
[6] |
Sep. 25, 2020
|
[6] |
Shares | shares |
|
40,396
|
[9],[18],[19],[23] |
40,396
|
[9],[18],[19],[23] |
15,541
|
[4],[6] |
15,541
|
[4],[6] |
Drug Discovery & Development | Brickell Biotech, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 119
|
[2],[9] |
|
|
$ 119
|
[1],[6] |
|
|
Total investments at fair value |
|
$ 0
|
[9] |
|
|
$ 0
|
[6] |
|
|
Acquisition Date |
|
Feb. 18, 2016
|
[9] |
Feb. 18, 2016
|
[9] |
Feb. 18, 2016
|
[6] |
Feb. 18, 2016
|
[6] |
Shares | shares |
|
200
|
[9] |
200
|
[9] |
9,005
|
[6] |
9,005
|
[6] |
Drug Discovery & Development | Bicycle Therapeutics PLC | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-07
|
|
2025-07
|
|
2024-10
|
|
2024-10
|
|
Investment Interest Rate Floor |
|
8.05%
|
[7] |
8.05%
|
[7] |
8.85%
|
[12] |
8.85%
|
[12] |
Principal Amount |
|
$ 11,500
|
[13],[18],[23],[24] |
|
|
$ 24,000
|
[3],[4],[5],[15],[32] |
|
|
Investment cost |
|
11,757
|
[2],[13],[18],[23],[24] |
|
|
24,271
|
[1],[3],[4],[5],[15],[32] |
|
|
Total investments at fair value |
|
$ 11,435
|
[13],[18],[23],[24] |
|
|
$ 24,454
|
[3],[4],[5],[15],[32] |
|
|
Drug Discovery & Development | Bicycle Therapeutics PLC | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
|
5.00%
|
[7] |
5.00%
|
[7] |
5.00%
|
[12] |
5.00%
|
[12] |
Drug Discovery & Development | Bicycle Therapeutics PLC | Senior Secured Debt | Cap rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
9.05%
|
|
9.05%
|
|
|
|
|
|
Drug Discovery & Development | Bicycle Therapeutics PLC | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
|
4.55%
|
[7] |
4.55%
|
[7] |
5.60%
|
[12] |
5.60%
|
[12] |
Drug Discovery & Development | Bicycle Therapeutics PLC | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,871
|
[2],[9],[23],[24] |
|
|
$ 1,871
|
[1],[4],[5],[6] |
|
|
Total investments at fair value |
|
$ 2,904
|
[9],[23],[24] |
|
|
$ 5,971
|
[4],[5],[6] |
|
|
Acquisition Date |
|
Oct. 05, 2020
|
[9] |
Oct. 05, 2020
|
[9] |
Oct. 05, 2020
|
[6] |
Oct. 05, 2020
|
[6] |
Shares | shares |
|
98,100
|
[9],[23],[24] |
98,100
|
[9],[23],[24] |
98,100
|
[4],[5],[6] |
98,100
|
[4],[5],[6] |
Drug Discovery & Development | BiomX, INC | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-09
|
|
2025-09
|
|
2025-09
|
|
2025-09
|
|
Investment Interest Rate Floor |
|
8.95%
|
[7] |
8.95%
|
[7] |
8.95%
|
[12] |
8.95%
|
[12] |
Principal Amount |
|
$ 9,000
|
[13],[23],[24] |
|
|
$ 9,000
|
[4],[5],[15] |
|
|
Investment cost |
|
9,174
|
[2],[13],[23],[24] |
|
|
8,980
|
[1],[4],[5],[15] |
|
|
Total investments at fair value |
|
$ 9,052
|
[13],[23],[24] |
|
|
$ 8,980
|
[4],[5],[15] |
|
|
Drug Discovery & Development | BiomX, INC | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
|
6.55%
|
[7] |
6.55%
|
[7] |
6.55%
|
[12] |
6.55%
|
[12] |
Drug Discovery & Development | BiomX, INC | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
|
5.70%
|
[7] |
5.70%
|
[7] |
5.70%
|
[12] |
5.70%
|
[12] |
Drug Discovery & Development | BridgeBio Pharma, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-11
|
|
2026-11
|
|
2026-11
|
|
2026-11
|
|
Principal Amount |
|
$ 37,312
|
[11],[17],[18] |
|
|
$ 38,000
|
|
|
|
Investment Interest Rate Paid in Cash |
|
9.00%
|
[7] |
9.00%
|
[7] |
9.00%
|
[12] |
9.00%
|
[12] |
Investment cost |
|
$ 37,039
|
[2],[11],[17],[18] |
|
|
$ 37,462
|
[1] |
|
|
Total investments at fair value |
|
$ 33,344
|
[11],[17],[18] |
|
|
$ 37,462
|
|
|
|
Drug Discovery & Development | BridgeBio Pharma, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
|
2.00%
|
[7] |
2.00%
|
[7] |
2.00%
|
[12] |
2.00%
|
[12] |
Drug Discovery & Development | BridgeBio Pharma, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 2,255
|
[2],[9] |
|
|
$ 2,255
|
[1],[6] |
|
|
Total investments at fair value |
|
$ 1,763
|
[9] |
|
|
$ 3,859
|
[6] |
|
|
Acquisition Date |
|
Jun. 21, 2018
|
[9] |
Jun. 21, 2018
|
[9] |
Jun. 21, 2018
|
[6] |
Jun. 21, 2018
|
[6] |
Shares | shares |
|
231,329
|
[9] |
231,329
|
[9] |
231,329
|
[6] |
231,329
|
[6] |
Drug Discovery & Development | Cellarity, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-06
|
|
2026-06
|
|
2026-06
|
|
2026-06
|
|
Investment Interest Rate Floor |
|
8.95%
|
[7] |
8.95%
|
[7] |
8.95%
|
[12] |
8.95%
|
[12] |
Principal Amount |
|
$ 30,000
|
[17],[25] |
|
|
$ 30,000
|
[31] |
|
|
Investment cost |
|
29,841
|
[2],[17],[25] |
|
|
29,422
|
[1],[31] |
|
|
Total investments at fair value |
|
$ 30,097
|
[17],[25] |
|
|
$ 29,422
|
[31] |
|
|
Drug Discovery & Development | Cellarity, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
|
3.75%
|
[7] |
3.75%
|
[7] |
3.75%
|
[12] |
3.75%
|
[12] |
Drug Discovery & Development | Cellarity, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
|
5.70%
|
[7] |
5.70%
|
[7] |
5.70%
|
[12] |
5.70%
|
[12] |
Drug Discovery & Development | Cellarity, Inc. | Warrant Investment | Preferred Series B |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 287
|
[2],[25] |
|
|
$ 287
|
[1],[31] |
|
|
Total investments at fair value |
|
$ 318
|
[25] |
|
|
$ 287
|
[31] |
|
|
Acquisition Date |
|
Dec. 08, 2021
|
[9] |
Dec. 08, 2021
|
[9] |
Dec. 08, 2021
|
[6] |
Dec. 08, 2021
|
[6] |
Shares | shares |
|
100,000
|
[25] |
100,000
|
[25] |
100,000
|
[31] |
100,000
|
[31] |
Drug Discovery & Development | Center for Breakthrough Medicines Holdings, LLC [Member] | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
|
|
2023-05
|
|
2023-05
|
|
Investment Interest Rate Floor |
[12] |
|
|
|
|
8.75%
|
|
8.75%
|
|
Principal Amount |
|
|
|
|
|
$ 5,000
|
|
|
|
Investment cost |
[1] |
|
|
|
|
5,005
|
|
|
|
Total investments at fair value |
|
|
|
|
|
$ 5,005
|
|
|
|
Drug Discovery & Development | Center for Breakthrough Medicines Holdings, LLC [Member] | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[12] |
|
|
|
|
7.50%
|
|
7.50%
|
|
Drug Discovery & Development | Center for Breakthrough Medicines Holdings, LLC [Member] | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[12] |
|
|
|
|
5.50%
|
|
5.50%
|
|
Drug Discovery & Development | Century Therapeutics, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2024-04
|
|
2024-04
|
|
2024-04
|
|
2024-04
|
|
Investment Interest Rate Floor |
|
9.55%
|
[7] |
9.55%
|
[7] |
9.55%
|
[12] |
9.55%
|
[12] |
Principal Amount |
|
$ 10,000
|
[13] |
|
|
$ 10,000
|
[15] |
|
|
Investment cost |
|
10,235
|
[2],[13] |
|
|
10,075
|
[1],[15] |
|
|
Total investments at fair value |
|
$ 10,292
|
[13] |
|
|
$ 10,361
|
[15] |
|
|
Drug Discovery & Development | Century Therapeutics, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
|
3.95%
|
[7] |
3.95%
|
[7] |
3.95%
|
[12] |
3.95%
|
[12] |
Drug Discovery & Development | Century Therapeutics, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
|
6.30%
|
[7] |
6.30%
|
[7] |
6.30%
|
[12] |
6.30%
|
[12] |
Drug Discovery & Development | Century Therapeutics, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 37
|
[2],[9] |
|
|
$ 37
|
[1],[6] |
|
|
Total investments at fair value |
|
$ 3
|
[9] |
|
|
$ 64
|
[6] |
|
|
Acquisition Date |
|
Sep. 14, 2020
|
[9] |
Sep. 14, 2020
|
[9] |
Sep. 14, 2020
|
[6] |
Sep. 14, 2020
|
[6] |
Shares | shares |
|
16,112
|
[9] |
16,112
|
[9] |
16,112
|
[6] |
16,112
|
[6] |
Drug Discovery & Development | Chemocentryx Inc One | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
|
|
2022-12
|
|
2022-12
|
|
Investment Interest Rate Floor |
[12] |
|
|
|
|
8.05%
|
|
8.05%
|
|
Principal Amount |
[4] |
|
|
|
|
$ 18,951
|
|
|
|
Investment cost |
[1],[4] |
|
|
|
|
20,036
|
|
|
|
Total investments at fair value |
[4] |
|
|
|
|
$ 20,036
|
|
|
|
Drug Discovery & Development | Chemocentryx Inc One | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[12] |
|
|
|
|
6.25%
|
|
6.25%
|
|
Drug Discovery & Development | Chemocentryx Inc One | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[12] |
|
|
|
|
3.30%
|
|
3.30%
|
|
Drug Discovery & Development | Chemocentryx Inc Two | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
|
|
2025-02
|
|
2025-02
|
|
Investment Interest Rate Floor |
[12] |
|
|
|
|
8.50%
|
|
8.50%
|
|
Principal Amount |
[4] |
|
|
|
|
$ 5,000
|
|
|
|
Investment cost |
[1],[4] |
|
|
|
|
5,161
|
|
|
|
Total investments at fair value |
[4] |
|
|
|
|
$ 5,070
|
|
|
|
Drug Discovery & Development | Chemocentryx Inc Two | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[12] |
|
|
|
|
7.15%
|
|
7.15%
|
|
Drug Discovery & Development | Chemocentryx Inc Two | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[12] |
|
|
|
|
3.25%
|
|
3.25%
|
|
Drug Discovery & Development | Chemocentryx, Inc. | Debt Investments |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Principal Amount |
|
|
|
|
|
$ 23,951
|
|
|
|
Investment cost |
[1] |
|
|
|
|
25,197
|
|
|
|
Total investments at fair value |
|
|
|
|
|
25,106
|
|
|
|
Drug Discovery & Development | Chemocentryx, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[4],[6] |
|
|
|
|
1,000
|
|
|
|
Total investments at fair value |
[4],[6] |
|
|
|
|
$ 628
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Jun. 15, 2020
|
|
Jun. 15, 2020
|
|
Shares | shares |
[4],[6] |
|
|
|
|
17,241
|
|
17,241
|
|
Drug Discovery & Development | Codiak Biosciences, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-10
|
|
2025-10
|
|
2025-10
|
|
2025-10
|
|
Investment Interest Rate Floor |
|
8.25%
|
[7] |
8.25%
|
[7] |
8.25%
|
[12] |
8.25%
|
[12] |
Principal Amount |
|
$ 25,000
|
[13] |
|
|
$ 25,000
|
[15] |
|
|
Investment cost |
|
25,759
|
[2],[13] |
|
|
25,459
|
[1],[15] |
|
|
Total investments at fair value |
|
$ 25,177
|
[13] |
|
|
$ 25,316
|
[15] |
|
|
Drug Discovery & Development | Codiak Biosciences, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
|
5.50%
|
[7] |
5.50%
|
[7] |
5.50%
|
[12] |
5.50%
|
[12] |
Drug Discovery & Development | Codiak Biosciences, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
|
5.00%
|
[7] |
5.00%
|
[7] |
5.00%
|
[12] |
5.00%
|
[12] |
Drug Discovery & Development | Corium, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-09
|
|
2026-09
|
|
2026-09
|
|
2026-09
|
|
Investment Interest Rate Floor |
|
8.95%
|
[7] |
8.95%
|
[7] |
8.95%
|
[12] |
8.95%
|
[12] |
Principal Amount |
|
$ 132,675
|
[17],[19] |
|
|
$ 91,500
|
[21] |
|
|
Investment cost |
|
133,557
|
[2],[17],[19] |
|
|
90,997
|
[1],[21] |
|
|
Total investments at fair value |
|
$ 135,619
|
[17],[19] |
|
|
$ 90,997
|
[21] |
|
|
Drug Discovery & Development | Corium, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
|
7.75%
|
[7] |
7.75%
|
[7] |
7.75%
|
[12] |
7.75%
|
[12] |
Drug Discovery & Development | Corium, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
|
5.70%
|
[7] |
5.70%
|
[7] |
5.70%
|
[12] |
5.70%
|
[12] |
Drug Discovery & Development | Eloxx Pharmaceuticals, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-04
|
|
2025-04
|
|
2025-04
|
|
2025-04
|
|
Investment Interest Rate Floor |
|
9.50%
|
[7] |
9.50%
|
[7] |
9.50%
|
[12] |
9.50%
|
[12] |
Principal Amount |
|
$ 12,500
|
[25] |
|
|
$ 12,500
|
[31] |
|
|
Investment cost |
|
12,753
|
[2],[25] |
|
|
12,443
|
[1],[31] |
|
|
Total investments at fair value |
|
$ 12,535
|
[25] |
|
|
$ 12,443
|
[31] |
|
|
Drug Discovery & Development | Eloxx Pharmaceuticals, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
|
6.55%
|
[7] |
6.55%
|
[7] |
6.55%
|
[12] |
6.55%
|
[12] |
Drug Discovery & Development | Eloxx Pharmaceuticals, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
|
6.25%
|
[7] |
6.25%
|
[7] |
6.25%
|
[12] |
6.25%
|
[12] |
Drug Discovery & Development | Dermavant Sciences Ltd. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 101
|
[2],[23],[24] |
|
|
$ 101
|
[1],[4],[32] |
|
|
Total investments at fair value |
|
$ 199
|
[23],[24] |
|
|
$ 354
|
[4],[32] |
|
|
Acquisition Date |
|
May 31, 2019
|
[9] |
May 31, 2019
|
[9] |
May 31, 2019
|
[6] |
May 31, 2019
|
[6] |
Shares | shares |
|
223,642
|
[23],[24] |
223,642
|
[23],[24] |
223,642
|
[4],[32] |
223,642
|
[4],[32] |
Drug Discovery & Development | enGene, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-07
|
|
2025-07
|
|
2025-07
|
|
2025-07
|
|
Investment Interest Rate Floor |
|
8.25%
|
[7] |
8.25%
|
[7] |
8.25%
|
[12] |
8.25%
|
[12] |
Principal Amount |
|
$ 11,000
|
[17],[18],[23],[24] |
|
|
$ 7,000
|
[4],[5] |
|
|
Investment cost |
|
11,072
|
[2],[17],[18],[23],[24] |
|
|
6,858
|
[1],[4],[5] |
|
|
Total investments at fair value |
|
$ 11,067
|
[17],[18],[23],[24] |
|
|
$ 6,858
|
[4],[5] |
|
|
Drug Discovery & Development | enGene, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
|
6.35%
|
[7] |
6.35%
|
[7] |
6.35%
|
[12] |
6.35%
|
[12] |
Drug Discovery & Development | enGene, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
|
5.00%
|
[7] |
5.00%
|
[7] |
5.00%
|
[12] |
5.00%
|
[12] |
Drug Discovery & Development | enGene, Inc. | Warrant Investment | Preferred Series 3 |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[18],[23],[24] |
$ 72
|
|
|
|
|
|
|
|
Total investments at fair value |
[18],[23],[24] |
$ 28
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Dec. 30, 2021
|
|
Dec. 30, 2021
|
|
|
|
|
|
Shares | shares |
[18],[23],[24] |
133,692
|
|
133,692
|
|
|
|
|
|
Drug Discovery & Development | enGene, Inc. | Warrant Investment | Preferred Series 3 Class C |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[4],[5] |
|
|
|
|
$ 64
|
|
|
|
Total investments at fair value |
[4],[5] |
|
|
|
|
$ 64
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Dec. 30, 2021
|
|
Dec. 30, 2021
|
|
Shares | shares |
[4],[5] |
|
|
|
|
84,714
|
|
84,714
|
|
Drug Discovery & Development | G1 Therapeutics, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-11
|
|
2026-11
|
|
2026-11
|
|
2026-11
|
|
Investment Interest Rate Floor |
|
9.15%
|
[7] |
9.15%
|
[7] |
9.15%
|
[12] |
9.15%
|
[12] |
Principal Amount |
|
$ 58,125
|
[8],[13],[18],[25] |
|
|
$ 58,125
|
[3],[4],[15],[31],[32] |
|
|
Investment cost |
|
58,674
|
[2],[8],[13],[18],[25] |
|
|
57,873
|
[1],[3],[4],[15],[31],[32] |
|
|
Total investments at fair value |
|
$ 58,407
|
[8],[13],[18],[25] |
|
|
$ 57,874
|
[3],[4],[15],[31],[32] |
|
|
Drug Discovery & Development | G1 Therapeutics, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
|
9.86%
|
[7] |
9.86%
|
[7] |
9.86%
|
[12] |
9.86%
|
[12] |
Drug Discovery & Development | G1 Therapeutics, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
|
5.90%
|
[7] |
5.90%
|
[7] |
5.90%
|
[12] |
5.90%
|
[12] |
Drug Discovery & Development | Geron Corporation | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2024-10
|
|
2024-10
|
|
2024-10
|
|
2024-10
|
|
Investment Interest Rate Floor |
|
9.00%
|
[7] |
9.00%
|
[7] |
9.00%
|
[12] |
9.00%
|
[12] |
Principal Amount |
|
$ 18,500
|
[17],[18],[23] |
|
|
$ 32,500
|
[4],[32] |
|
|
Investment cost |
|
19,109
|
[2],[17],[18],[23] |
|
|
32,704
|
[1],[4],[32] |
|
|
Total investments at fair value |
|
$ 19,174
|
[17],[18],[23] |
|
|
$ 32,744
|
[4],[32] |
|
|
Drug Discovery & Development | Geron Corporation | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
|
6.55%
|
[7] |
6.55%
|
[7] |
6.55%
|
[12] |
6.55%
|
[12] |
Drug Discovery & Development | Geron Corporation | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
|
5.75%
|
[7] |
5.75%
|
[7] |
5.75%
|
[12] |
5.75%
|
[12] |
Drug Discovery & Development | Hibercell, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-05
|
|
2025-05
|
|
2025-05
|
|
2025-05
|
|
Investment Interest Rate Floor |
|
8.65%
|
[7] |
8.65%
|
[7] |
8.65%
|
[12] |
8.65%
|
[12] |
Principal Amount |
|
$ 17,000
|
[17],[25] |
|
|
$ 17,000
|
[31] |
|
|
Investment cost |
|
17,313
|
[2],[17],[25] |
|
|
17,041
|
[1],[31] |
|
|
Total investments at fair value |
|
$ 17,265
|
[17],[25] |
|
|
$ 17,014
|
[31] |
|
|
Drug Discovery & Development | Hibercell, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
|
4.95%
|
[7] |
4.95%
|
[7] |
4.95%
|
[12] |
4.95%
|
[12] |
Drug Discovery & Development | Hibercell, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
|
5.40%
|
[7] |
5.40%
|
[7] |
5.40%
|
[12] |
5.40%
|
[12] |
Drug Discovery & Development | Hibercell, Inc. | Equity | Preferred Series B |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 4,250
|
[2],[25] |
|
|
$ 4,250
|
[1],[31] |
|
|
Total investments at fair value |
|
$ 2,233
|
[25] |
|
|
$ 3,264
|
[31] |
|
|
Acquisition Date |
|
May 07, 2021
|
[9] |
May 07, 2021
|
[9] |
May 07, 2021
|
[6] |
May 07, 2021
|
[6] |
Shares | shares |
|
3,466,840
|
[25] |
3,466,840
|
[25] |
3,466,840
|
[31] |
3,466,840
|
[31] |
Drug Discovery & Development | Humanigen, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
|
|
2025-03
|
|
2025-03
|
|
Investment Interest Rate Floor |
[12] |
|
|
|
|
8.75%
|
|
8.75%
|
|
Principal Amount |
[4],[30] |
|
|
|
|
$ 20,000
|
|
|
|
Investment cost |
[1],[4],[30] |
|
|
|
|
20,235
|
|
|
|
Total investments at fair value |
[4],[30] |
|
|
|
|
$ 19,985
|
|
|
|
Drug Discovery & Development | Humanigen, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[12] |
|
|
|
|
6.75%
|
|
6.75%
|
|
Drug Discovery & Development | Humanigen, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[12] |
|
|
|
|
5.50%
|
|
5.50%
|
|
Drug Discovery & Development | Humanigen, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 800
|
[2],[9],[23] |
|
|
$ 800
|
[1],[4],[6] |
|
|
Total investments at fair value |
|
$ 5
|
[9],[23] |
|
|
$ 161
|
[4],[6] |
|
|
Acquisition Date |
|
Mar. 31, 2021
|
[9] |
Mar. 31, 2021
|
[9] |
Mar. 31, 2021
|
[6] |
Mar. 31, 2021
|
[6] |
Shares | shares |
|
43,243
|
[9],[23] |
43,243
|
[9],[23] |
43,243
|
[4],[6] |
43,243
|
[4],[6] |
Drug Discovery & Development | Kaleido Biosciences, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
|
|
2024-01
|
|
2024-01
|
|
Investment Interest Rate Floor |
[12] |
|
|
|
|
9.35%
|
|
9.35%
|
|
Principal Amount |
[32] |
|
|
|
|
$ 22,500
|
|
|
|
Investment cost |
[1],[32] |
|
|
|
|
23,505
|
|
|
|
Total investments at fair value |
[32] |
|
|
|
|
$ 23,384
|
|
|
|
Drug Discovery & Development | Kaleido Biosciences, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[12] |
|
|
|
|
7.55%
|
|
7.55%
|
|
Drug Discovery & Development | Kaleido Biosciences, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[12] |
|
|
|
|
6.10%
|
|
6.10%
|
|
Drug Discovery & Development | Kaleido Biosciences, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[6] |
|
|
|
|
$ 1,000
|
|
|
|
Total investments at fair value |
[6] |
|
|
|
|
$ 207
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Feb. 10, 2021
|
|
Feb. 10, 2021
|
|
Shares | shares |
[6] |
|
|
|
|
86,585
|
|
86,585
|
|
Drug Discovery & Development | Locus Biosciences, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-07
|
|
2025-07
|
|
2025-07
|
|
2025-07
|
|
Investment Interest Rate Floor |
|
9.35%
|
[7] |
9.35%
|
[7] |
9.35%
|
[12] |
9.35%
|
[12] |
Principal Amount |
|
$ 8,000
|
[25] |
|
|
$ 8,000
|
[31] |
|
|
Investment cost |
|
8,120
|
[2],[25] |
|
|
7,977
|
[1],[31] |
|
|
Total investments at fair value |
|
$ 8,085
|
[25] |
|
|
$ 7,900
|
[31] |
|
|
Drug Discovery & Development | Locus Biosciences, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
|
4.95%
|
[7] |
4.95%
|
[7] |
4.95%
|
[12] |
4.95%
|
[12] |
Drug Discovery & Development | Locus Biosciences, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
|
6.10%
|
[7] |
6.10%
|
[7] |
6.10%
|
[12] |
6.10%
|
[12] |
Drug Discovery & Development | Nabriva Therapeutics | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2023-06
|
|
2023-06
|
|
2023-06
|
|
2023-06
|
|
Investment Interest Rate Floor |
|
9.80%
|
[7] |
9.80%
|
[7] |
9.80%
|
[12] |
9.80%
|
[12] |
Principal Amount |
|
$ 2,079
|
[17],[23],[24] |
|
|
$ 5,000
|
[4],[5] |
|
|
Investment cost |
|
2,734
|
[2],[17],[23],[24] |
|
|
5,500
|
[1],[4],[5] |
|
|
Total investments at fair value |
|
$ 2,804
|
[17],[23],[24] |
|
|
$ 5,459
|
[4],[5] |
|
|
Drug Discovery & Development | Nabriva Therapeutics | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
|
9.95%
|
[7] |
9.95%
|
[7] |
6.95%
|
[12] |
6.95%
|
[12] |
Drug Discovery & Development | Nabriva Therapeutics | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
|
4.30%
|
[7] |
4.30%
|
[7] |
4.30%
|
[12] |
4.30%
|
[12] |
Drug Discovery & Development | Evofem Biosciences, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 266
|
[2],[9] |
|
|
$ 266
|
[1],[6] |
|
|
Total investments at fair value |
[9] |
$ 0
|
|
|
|
|
|
|
|
Acquisition Date |
|
Jun. 11, 2014
|
[9] |
Jun. 11, 2014
|
[9] |
Jun. 11, 2014
|
[6] |
Jun. 11, 2014
|
[6] |
Shares | shares |
|
520
|
[9] |
520
|
[9] |
7,806
|
[6] |
7,806
|
[6] |
Drug Discovery & Development | Motif Bio P L C | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[4] |
|
|
|
|
$ 282
|
|
|
|
Total investments at fair value |
[4] |
|
|
|
|
$ 0
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Jan. 27, 2020
|
|
Jan. 27, 2020
|
|
Shares | shares |
[4] |
|
|
|
|
121,337,041
|
|
121,337,041
|
|
Drug Discovery & Development | Myovant Sciences, Ltd. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 460
|
[2],[9],[23],[24] |
|
|
$ 460
|
[1],[4],[6] |
|
|
Total investments at fair value |
|
$ 958
|
[9],[23],[24] |
|
|
$ 267
|
[4],[6] |
|
|
Acquisition Date |
|
Oct. 16, 2017
|
[9] |
Oct. 16, 2017
|
[9] |
Oct. 16, 2017
|
[6] |
Oct. 16, 2017
|
[6] |
Shares | shares |
|
73,710
|
[9],[23],[24] |
73,710
|
[9],[23],[24] |
73,710
|
[4],[6] |
73,710
|
[4],[6] |
Drug Discovery & Development | Phathom Pharmaceuticals, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-10
|
|
2026-10
|
|
2026-10
|
|
2026-10
|
|
Investment Interest Rate Floor |
|
5.50%
|
[7] |
5.50%
|
[7] |
5.50%
|
[12] |
5.50%
|
[12] |
Investment Interest Rate Paid in Kind |
|
3.35%
|
[7] |
3.35%
|
[7] |
3.35%
|
[12] |
3.35%
|
[12] |
Principal Amount |
|
$ 94,737
|
[8],[11],[18],[19],[23],[25],[33] |
|
|
$ 87,116
|
[3],[4],[20],[21],[31],[32] |
|
|
Investment cost |
|
95,032
|
[2],[8],[11],[18],[19],[23],[25],[33] |
|
|
86,075
|
[1],[3],[4],[20],[21],[31],[32] |
|
|
Total investments at fair value |
|
$ 93,916
|
[8],[11],[18],[19],[23],[25],[33] |
|
|
$ 86,075
|
[3],[4],[20],[21],[31],[32] |
|
|
Drug Discovery & Development | Phathom Pharmaceuticals, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
|
7.50%
|
[7] |
7.50%
|
[7] |
7.50%
|
[12] |
7.50%
|
[12] |
Drug Discovery & Development | Phathom Pharmaceuticals, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
|
2.25%
|
[7] |
2.25%
|
[7] |
2.25%
|
[12] |
2.25%
|
[12] |
Drug Discovery & Development | Phathom Pharmaceuticals, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 848
|
[2],[9],[18],[19],[23],[25] |
|
|
$ 848
|
[1],[4],[6],[21],[31] |
|
|
Total investments at fair value |
|
$ 101
|
[9],[18],[19],[23],[25] |
|
|
$ 307
|
[4],[6],[21],[31] |
|
|
Acquisition Date |
|
Sep. 17, 2021
|
[9] |
Sep. 17, 2021
|
[9] |
Sep. 17, 2021
|
[6] |
Sep. 17, 2021
|
[6] |
Shares | shares |
|
64,687
|
[9],[18],[19],[23],[25] |
64,687
|
[9],[18],[19],[23],[25] |
64,687
|
[4],[6],[21],[31] |
64,687
|
[4],[6],[21],[31] |
Drug Discovery & Development | Scynexis, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-03
|
|
2025-03
|
|
2025-03
|
|
2025-03
|
|
Investment Interest Rate Floor |
|
9.05%
|
[7] |
9.05%
|
[7] |
9.05%
|
[12] |
9.05%
|
[12] |
Principal Amount |
|
$ 18,667
|
[17],[18] |
|
|
$ 16,000
|
|
|
|
Investment cost |
|
18,675
|
[2],[17],[18] |
|
|
15,826
|
[1] |
|
|
Total investments at fair value |
|
$ 18,698
|
[17],[18] |
|
|
$ 15,778
|
|
|
|
Drug Discovery & Development | Scynexis, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
|
3.95%
|
[7] |
3.95%
|
[7] |
3.95%
|
[12] |
3.95%
|
[12] |
Drug Discovery & Development | Scynexis, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
|
5.80%
|
[7] |
5.80%
|
[7] |
5.80%
|
[12] |
5.80%
|
[12] |
Drug Discovery & Development | Scynexis, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 296
|
[2],[9],[18] |
|
|
$ 188
|
[1],[6] |
|
|
Total investments at fair value |
|
$ 15
|
[9],[18] |
|
|
$ 142
|
[6] |
|
|
Acquisition Date |
|
May 14, 2021
|
[9] |
May 14, 2021
|
[9] |
May 14, 2021
|
[6] |
May 14, 2021
|
[6] |
Shares | shares |
|
106,035
|
[9],[18] |
106,035
|
[9],[18] |
90,887
|
[6] |
90,887
|
[6] |
Drug Discovery & Development | Stealth Bio Therapeutics Corp. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[4],[6] |
|
|
|
|
$ 158
|
|
|
|
Total investments at fair value |
[4],[6] |
|
|
|
|
$ 0
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Jun. 30, 2017
|
|
Jun. 30, 2017
|
|
Shares | shares |
[4],[6] |
|
|
|
|
500,000
|
|
500,000
|
|
Drug Discovery & Development | Seres Therapeutics, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2024-10
|
|
2024-10
|
|
2023-11
|
|
2023-11
|
|
Investment Interest Rate Floor |
|
9.65%
|
[7] |
9.65%
|
[7] |
9.65%
|
[12] |
9.65%
|
[12] |
Principal Amount |
|
$ 37,500
|
[17],[18] |
|
|
$ 24,051
|
|
|
|
Investment cost |
|
38,638
|
[2],[17],[18] |
|
|
24,777
|
[1] |
|
|
Total investments at fair value |
|
$ 38,816
|
[17],[18] |
|
|
$ 25,183
|
|
|
|
Drug Discovery & Development | Seres Therapeutics, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
|
4.98%
|
[7] |
4.98%
|
[7] |
4.85%
|
[12] |
4.85%
|
[12] |
Drug Discovery & Development | Seres Therapeutics, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
|
6.40%
|
[7] |
6.40%
|
[7] |
4.40%
|
[12] |
4.40%
|
[12] |
Drug Discovery & Development | Syndax Pharmaceutics Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
|
|
2024-04
|
|
2024-04
|
|
Investment Interest Rate Floor |
[12] |
|
|
|
|
9.25%
|
|
9.25%
|
|
Principal Amount |
[3],[32] |
|
|
|
|
$ 20,000
|
|
|
|
Investment cost |
[1],[3],[32] |
|
|
|
|
20,646
|
|
|
|
Total investments at fair value |
[3],[32] |
|
|
|
|
$ 20,653
|
|
|
|
Drug Discovery & Development | Syndax Pharmaceutics Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[12] |
|
|
|
|
4.99%
|
|
4.99%
|
|
Drug Discovery & Development | Syndax Pharmaceutics Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[12] |
|
|
|
|
6.00%
|
|
6.00%
|
|
Drug Discovery & Development | TG Therapeutics, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-01
|
|
2026-01
|
|
2026-01
|
|
2026-01
|
|
Investment Interest Rate Floor |
|
5.40%
|
[7] |
5.40%
|
[7] |
5.40%
|
[12] |
5.40%
|
[12] |
Investment Interest Rate Paid in Kind |
|
3.45%
|
[7] |
3.45%
|
[7] |
3.45%
|
[12] |
3.45%
|
[12] |
Principal Amount |
|
$ 47,983
|
[11],[13],[18],[23] |
|
|
$ 51,450
|
[4] |
|
|
Investment cost |
|
47,889
|
[2],[11],[13],[18],[23] |
|
|
50,470
|
[1],[4] |
|
|
Total investments at fair value |
|
$ 48,649
|
[11],[13],[18],[23] |
|
|
$ 50,470
|
[4] |
|
|
Drug Discovery & Development | TG Therapeutics, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
|
5.95%
|
[7] |
5.95%
|
[7] |
5.95%
|
[12] |
5.95%
|
[12] |
Drug Discovery & Development | TG Therapeutics, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
|
2.15%
|
[7] |
2.15%
|
[7] |
2.15%
|
[12] |
2.15%
|
[12] |
Drug Discovery & Development | TG Therapeutics, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,033
|
[2],[9],[18],[23] |
|
|
$ 1,033
|
[1],[4],[6],[32] |
|
|
Total investments at fair value |
|
$ 1,084
|
[9],[18],[23] |
|
|
$ 2,172
|
[4],[6],[32] |
|
|
Acquisition Date |
|
Feb. 28, 2019
|
[9] |
Feb. 28, 2019
|
[9] |
Feb. 28, 2019
|
[6] |
Feb. 28, 2019
|
[6] |
Shares | shares |
|
231,613
|
[9],[18],[23] |
231,613
|
[9],[18],[23] |
231,613
|
[4],[6],[32] |
231,613
|
[4],[6],[32] |
Drug Discovery & Development | Uni Qure B V [Member] | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-12
|
|
2025-12
|
|
2025-12
|
|
2025-12
|
|
Investment Interest Rate Floor |
|
7.95%
|
[7] |
7.95%
|
[7] |
7.95%
|
[12] |
7.95%
|
[12] |
Principal Amount |
|
$ 70,000
|
[13],[18],[19],[23],[24] |
|
|
$ 77,500
|
[4],[5],[15],[21],[32] |
|
|
Investment cost |
|
72,329
|
[2],[13],[18],[19],[23],[24] |
|
|
78,755
|
[1],[4],[5],[15],[21],[32] |
|
|
Total investments at fair value |
|
$ 73,019
|
[13],[18],[19],[23],[24] |
|
|
$ 78,755
|
[4],[5],[15],[21],[32] |
|
|
Drug Discovery & Development | Uni Qure B V [Member] | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
|
7.28%
|
[7] |
7.28%
|
[7] |
7.28%
|
[12] |
7.28%
|
[12] |
Drug Discovery & Development | Uni Qure B V [Member] | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
|
4.70%
|
[7] |
4.70%
|
[7] |
4.70%
|
[12] |
4.70%
|
[12] |
Drug Discovery & Development | Uni Qure B V [Member] | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 332
|
[2],[9],[19],[23],[24] |
|
|
$ 332
|
[1],[4],[5],[6],[21] |
|
|
Total investments at fair value |
|
$ 389
|
[9],[19],[23],[24] |
|
|
$ 356
|
[4],[5],[6],[21] |
|
|
Acquisition Date |
|
Jan. 31, 2019
|
[9] |
Jan. 31, 2019
|
[9] |
Jan. 31, 2019
|
[6] |
Jan. 31, 2019
|
[6] |
Shares | shares |
|
17,175
|
[9],[19],[23],[24] |
17,175
|
[9],[19],[23],[24] |
17,175
|
[4],[5],[6],[21] |
17,175
|
[4],[5],[6],[21] |
Drug Discovery & Development | Unity Biotechnology Inc | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2024-08
|
|
2024-08
|
|
2024-08
|
|
2024-08
|
|
Investment Interest Rate Floor |
|
9.35%
|
[7] |
9.35%
|
[7] |
9.35%
|
[12] |
9.35%
|
[12] |
Principal Amount |
|
$ 20,000
|
[17] |
|
|
$ 22,701
|
[30] |
|
|
Investment cost |
|
21,079
|
[2],[17] |
|
|
23,293
|
[1],[30] |
|
|
Total investments at fair value |
|
$ 20,967
|
[17] |
|
|
$ 23,627
|
[30] |
|
|
Drug Discovery & Development | Unity Biotechnology Inc | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
|
6.25%
|
[7] |
6.25%
|
[7] |
6.25%
|
[12] |
6.25%
|
[12] |
Drug Discovery & Development | Unity Biotechnology Inc | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
|
6.10%
|
[7] |
6.10%
|
[7] |
6.10%
|
[12] |
6.10%
|
[12] |
Drug Discovery & Development | Valo Health L L C P K Integral Health Holdings L L C [Member] | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2024-05
|
|
2024-05
|
|
2024-05
|
|
2024-05
|
|
Investment Interest Rate Floor |
|
9.70%
|
[7] |
9.70%
|
[7] |
9.70%
|
[12] |
9.70%
|
[12] |
Principal Amount |
|
$ 8,146
|
[13],[17] |
|
|
$ 11,500
|
[15] |
|
|
Investment cost |
|
8,416
|
[2],[13],[17] |
|
|
11,547
|
[1],[15] |
|
|
Total investments at fair value |
|
$ 8,410
|
[13],[17] |
|
|
$ 11,492
|
[15] |
|
|
Drug Discovery & Development | Valo Health L L C P K Integral Health Holdings L L C [Member] | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
|
3.85%
|
[7] |
3.85%
|
[7] |
3.85%
|
[12] |
3.85%
|
[12] |
Drug Discovery & Development | Valo Health L L C P K Integral Health Holdings L L C [Member] | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
|
6.45%
|
[7] |
6.45%
|
[7] |
6.45%
|
[12] |
6.45%
|
[12] |
Drug Discovery & Development | Valo Health L L C P K Integral Health Holdings L L C [Member] | Warrant Investment | Common Units |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 256
|
[2] |
|
|
$ 256
|
[1] |
|
|
Total investments at fair value |
|
|
|
|
|
$ 441
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Jun. 15, 2020
|
|
Jun. 15, 2020
|
|
Shares | shares |
|
|
|
|
|
102,216
|
|
102,216
|
|
Drug Discovery & Development | Valo Health L L C P K Integral Health Holdings L L C [Member] | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 127
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Jun. 15, 2020
|
|
Jun. 15, 2020
|
|
|
|
|
|
Shares | shares |
|
102,216
|
|
102,216
|
|
|
|
|
|
Drug Discovery & Development | X Four Pharmaceuticals Inc | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2024-07
|
|
2024-07
|
|
2024-07
|
|
2024-07
|
|
Investment Interest Rate Floor |
|
8.75%
|
[7] |
8.75%
|
[7] |
8.75%
|
[12] |
8.75%
|
[12] |
Principal Amount |
|
$ 32,500
|
[13],[17],[18] |
|
|
$ 32,500
|
[15],[32] |
|
|
Investment cost |
|
33,705
|
[2],[13],[17],[18] |
|
|
34,140
|
[1],[15],[32] |
|
|
Total investments at fair value |
|
$ 33,700
|
[13],[17],[18] |
|
|
$ 34,085
|
[15],[32] |
|
|
Drug Discovery & Development | X Four Pharmaceuticals Inc | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
|
8.80%
|
[7] |
8.80%
|
[7] |
8.80%
|
[12] |
8.80%
|
[12] |
Drug Discovery & Development | X Four Pharmaceuticals Inc | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
|
3.75%
|
[7] |
3.75%
|
[7] |
3.75%
|
[12] |
3.75%
|
[12] |
Drug Discovery & Development | X Four Pharmaceuticals Inc | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 2,945
|
[2],[9] |
|
|
$ 1,641
|
[1],[6] |
|
|
Total investments at fair value |
|
$ 1,555
|
[9] |
|
|
$ 454
|
[6] |
|
|
Acquisition Date |
|
Nov. 26, 2019
|
[9] |
Nov. 26, 2019
|
[9] |
Nov. 26, 2019
|
[6] |
Nov. 26, 2019
|
[6] |
Shares | shares |
|
1,566,064
|
[9] |
1,566,064
|
[9] |
198,277
|
[6] |
198,277
|
[6] |
Drug Discovery & Development | X Four Pharmaceuticals Inc | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 510
|
[2],[9] |
|
|
$ 673
|
[1],[6] |
|
|
Total investments at fair value |
|
$ 281
|
[9] |
|
|
$ 2
|
[6] |
|
|
Acquisition Date |
|
Dec. 09, 2022
|
[9] |
Dec. 09, 2022
|
[9] |
Mar. 18, 2019
|
[6] |
Mar. 18, 2019
|
[6] |
Shares | shares |
|
1,392,787
|
[9] |
1,392,787
|
[9] |
108,334
|
[6] |
108,334
|
[6] |
Drug Discovery & Development | Yumanity Therapeutics, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
|
|
2024-01
|
|
2024-01
|
|
Investment Interest Rate Floor |
[12] |
|
|
|
|
8.75%
|
|
8.75%
|
|
Principal Amount |
|
|
|
|
|
$ 12,732
|
|
|
|
Investment cost |
[1] |
|
|
|
|
13,256
|
|
|
|
Total investments at fair value |
|
|
|
|
|
$ 13,187
|
|
|
|
Drug Discovery & Development | Yumanity Therapeutics, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[12] |
|
|
|
|
5.92%
|
|
5.92%
|
|
Drug Discovery & Development | Yumanity Therapeutics, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[12] |
|
|
|
|
4.00%
|
|
4.00%
|
|
Drug Discovery & Development | Yumanity Therapeutics, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[6] |
|
|
|
|
$ 110
|
|
|
|
Total investments at fair value |
[6] |
|
|
|
|
$ 3
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Dec. 20, 2019
|
|
Dec. 20, 2019
|
|
Shares | shares |
[6] |
|
|
|
|
15,414
|
|
15,414
|
|
Drug Discovery & Development | Finch Therapeutics Group, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-11
|
|
2026-11
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
7.55%
|
|
7.55%
|
|
|
|
|
|
Principal Amount |
|
$ 15,000
|
|
|
|
|
|
|
|
Investment cost |
[2] |
15,012
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 13,940
|
|
|
|
|
|
|
|
Drug Discovery & Development | Finch Therapeutics Group, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
5.50%
|
|
5.50%
|
|
|
|
|
|
Drug Discovery & Development | Finch Therapeutics Group, Inc. | Senior Secured Debt | Cap rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
8.80%
|
|
8.80%
|
|
|
|
|
|
Drug Discovery & Development | Finch Therapeutics Group, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
4.05%
|
|
4.05%
|
|
|
|
|
|
Drug Discovery & Development | Viridian Therapeutics Inc | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-10
|
|
2026-10
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
7.45%
|
|
7.45%
|
|
|
|
|
|
Principal Amount |
[8],[17],[23] |
$ 2,000
|
|
|
|
|
|
|
|
Investment cost |
[2],[8],[17],[23] |
2,012
|
|
|
|
|
|
|
|
Total investments at fair value |
[8],[17],[23] |
$ 1,934
|
|
|
|
|
|
|
|
Drug Discovery & Development | Viridian Therapeutics Inc | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
4.76%
|
|
4.76%
|
|
|
|
|
|
Drug Discovery & Development | Viridian Therapeutics Inc | Senior Secured Debt | Cap rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
8.95%
|
|
8.95%
|
|
|
|
|
|
Drug Discovery & Development | Viridian Therapeutics Inc | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
4.20%
|
|
4.20%
|
|
|
|
|
|
Electronics & Computer Hardware |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 21,517
|
|
|
|
$ 1,040
|
|
|
|
Electronics & Computer Hardware | Debt Investments |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
18,171
|
|
|
|
|
|
|
|
Total investments at fair value |
|
18,723
|
|
|
|
|
|
|
|
Electronics & Computer Hardware | Equity |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
2,150
|
|
|
|
|
|
|
|
Total investments at fair value |
|
1,521
|
|
|
|
|
|
|
|
Electronics & Computer Hardware | Warrant Investment |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
692
|
[2] |
|
|
658
|
[1] |
|
|
Total investments at fair value |
|
1,273
|
|
|
|
1,040
|
|
|
|
Electronics & Computer Hardware | Locus Robotics Corp. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
34
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 212
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Jun. 21, 2022
|
|
Jun. 21, 2022
|
|
|
|
|
|
Shares | shares |
|
8,511
|
|
8,511
|
|
|
|
|
|
Electronics & Computer Hardware | 908 Devices, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 101
|
[2],[9] |
|
|
101
|
[1],[6] |
|
|
Total investments at fair value |
|
$ 86
|
[9] |
|
|
$ 618
|
[6] |
|
|
Acquisition Date |
|
Mar. 15, 2017
|
[9] |
Mar. 15, 2017
|
[9] |
Mar. 15, 2017
|
[6] |
Mar. 15, 2017
|
[6] |
Shares | shares |
|
49,078
|
[9] |
49,078
|
[9] |
49,078
|
[6] |
49,078
|
[6] |
Electronics & Computer Hardware | Skydio, Inc. | Equity | Preferred Series E |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 1,500
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 915
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Mar. 08, 2022
|
|
Mar. 08, 2022
|
|
|
|
|
|
Shares | shares |
|
248,900
|
|
248,900
|
|
|
|
|
|
Electronics & Computer Hardware | Skydio, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 557
|
[2] |
|
|
$ 557
|
[1] |
|
|
Total investments at fair value |
|
$ 975
|
|
|
|
$ 422
|
|
|
|
Acquisition Date |
|
Nov. 08, 2021
|
[9] |
Nov. 08, 2021
|
[9] |
Nov. 08, 2021
|
[6] |
Nov. 08, 2021
|
[6] |
Shares | shares |
|
622,255
|
|
622,255
|
|
124,451
|
|
124,451
|
|
Electronics & Computer Hardware | I N M O B I Inc | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Total investments at fair value |
[4] |
|
|
|
|
$ 0
|
|
|
|
Electronics & Computer Hardware | Locus Robotics Corporation | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-06
|
|
2026-06
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
8.00%
|
|
8.00%
|
|
|
|
|
|
Principal Amount |
[10] |
$ 18,281
|
|
|
|
|
|
|
|
Investment cost |
[2],[10] |
18,171
|
|
|
|
|
|
|
|
Total investments at fair value |
[10] |
$ 18,723
|
|
|
|
|
|
|
|
Electronics & Computer Hardware | Locus Robotics Corporation | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
1.00%
|
|
1.00%
|
|
|
|
|
|
Electronics & Computer Hardware | Locus Robotics Corporation | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
4.50%
|
|
4.50%
|
|
|
|
|
|
Electronics & Computer Hardware | Locus Robotics Corporation | Equity | Preferred Series F |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 650
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 606
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Nov. 17, 2022
|
|
Nov. 17, 2022
|
|
|
|
|
|
Shares | shares |
|
15,116
|
|
15,116
|
|
|
|
|
|
Healthcare Services Other |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 198,763
|
|
|
|
121,003
|
|
|
|
Healthcare Services Other | Debt Investments |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
196,342
|
[2] |
|
|
113,724
|
[1] |
|
|
Total investments at fair value |
|
195,855
|
|
|
|
113,639
|
|
|
|
Healthcare Services Other | Equity |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
6,781
|
[2] |
|
|
6,781
|
[1] |
|
|
Total investments at fair value |
|
2,894
|
|
|
|
7,364
|
|
|
|
Healthcare Services Other | Warrant Investment |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
114
|
|
|
|
|
|
|
|
Total investments at fair value |
|
14
|
|
|
|
|
|
|
|
Healthcare Services Other | Vida Health, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
114
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 14
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Mar. 28, 2022
|
|
Mar. 28, 2022
|
|
|
|
|
|
Shares | shares |
|
100,618
|
|
100,618
|
|
|
|
|
|
Healthcare Services Other | Oak Street Health, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-10
|
|
2027-10
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
7.95%
|
|
7.95%
|
|
|
|
|
|
Investment Interest Rate Paid in Kind |
[7] |
1.00%
|
|
1.00%
|
|
|
|
|
|
Principal Amount |
[8],[11],[23] |
$ 33,808
|
|
|
|
|
|
|
|
Investment cost |
[2],[8],[11],[23] |
33,651
|
|
|
|
|
|
|
|
Total investments at fair value |
[8],[11],[23] |
$ 33,651
|
|
|
|
|
|
|
|
Healthcare Services Other | Oak Street Health, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
4.95%
|
|
4.95%
|
|
|
|
|
|
Healthcare Services Other | Oak Street Health, Inc. | Senior Secured Debt | Cap rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
9.45%
|
|
9.45%
|
|
|
|
|
|
Healthcare Services Other | Oak Street Health, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
2.45%
|
|
2.45%
|
|
|
|
|
|
Healthcare Services Other | 23andMe, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 5,094
|
[2],[9] |
|
|
5,094
|
[1],[6] |
|
|
Total investments at fair value |
|
$ 1,784
|
[9] |
|
|
$ 5,500
|
[6] |
|
|
Acquisition Date |
|
Mar. 11, 2019
|
[9] |
Mar. 11, 2019
|
[9] |
Mar. 11, 2019
|
[6] |
Mar. 11, 2019
|
[6] |
Shares | shares |
|
825,732
|
[9] |
825,732
|
[9] |
825,732
|
[6] |
825,732
|
[6] |
Healthcare Services Other | Better Therapeutics, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-08
|
|
2025-08
|
|
2025-08
|
|
2025-08
|
|
Investment Interest Rate Floor |
|
8.95%
|
[7] |
8.95%
|
[7] |
8.95%
|
[12] |
8.95%
|
[12] |
Principal Amount |
|
$ 12,000
|
[25] |
|
|
$ 8,000
|
[3],[31] |
|
|
Investment cost |
|
12,162
|
[2],[25] |
|
|
7,966
|
[1],[3],[31] |
|
|
Total investments at fair value |
|
$ 12,053
|
[25] |
|
|
$ 7,966
|
[3],[31] |
|
|
Healthcare Services Other | Better Therapeutics, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
|
5.95%
|
[7] |
5.95%
|
[7] |
5.95%
|
[12] |
5.95%
|
[12] |
Healthcare Services Other | Better Therapeutics, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
|
5.70%
|
[7] |
5.70%
|
[7] |
5.70%
|
[12] |
5.70%
|
[12] |
Healthcare Services Other | Blue Sprig Pediatrics, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-11
|
|
2026-11
|
|
2026-11
|
|
2026-11
|
|
Investment Interest Rate Floor |
|
6.00%
|
[7] |
6.00%
|
[7] |
6.00%
|
[12] |
6.00%
|
[12] |
Investment Interest Rate Paid in Kind |
|
4.45%
|
[7] |
4.45%
|
[7] |
4.45%
|
[12] |
4.45%
|
[12] |
Principal Amount |
|
$ 51,480
|
[11],[13],[17] |
|
|
$ 25,022
|
[3],[20] |
|
|
Investment cost |
|
50,813
|
[2],[11],[13],[17] |
|
|
24,653
|
[1],[3],[20] |
|
|
Total investments at fair value |
|
$ 49,732
|
[11],[13],[17] |
|
|
$ 24,653
|
[3],[20] |
|
|
Healthcare Services Other | Blue Sprig Pediatrics, Inc. | Senior Secured Debt | LIBOR |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
|
5.00%
|
[7] |
5.00%
|
[7] |
5.00%
|
[12] |
5.00%
|
[12] |
Healthcare Services Other | Carbon Health Technologies, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-03
|
|
2025-03
|
|
2025-03
|
|
2025-03
|
|
Investment Interest Rate Floor |
|
8.85%
|
[7] |
8.85%
|
[7] |
8.85%
|
[12] |
8.85%
|
[12] |
Principal Amount |
|
$ 46,125
|
[10],[13],[17] |
|
|
$ 46,125
|
[3],[22] |
|
|
Investment cost |
|
46,552
|
[2],[10],[13],[17] |
|
|
45,964
|
[1],[3],[22] |
|
|
Total investments at fair value |
|
$ 46,548
|
[10],[13],[17] |
|
|
$ 45,964
|
[3],[22] |
|
|
Healthcare Services Other | Carbon Health Technologies, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
|
4.61%
|
[7] |
4.61%
|
[7] |
4.61%
|
[12] |
4.61%
|
[12] |
Healthcare Services Other | Carbon Health Technologies, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
|
5.60%
|
[7] |
5.60%
|
[7] |
5.60%
|
[12] |
5.60%
|
[12] |
Healthcare Services Other | Carbon Health Technologies, Inc. | Equity | Preferred Series C |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,687
|
[2] |
|
|
$ 1,687
|
[1] |
|
|
Total investments at fair value |
|
$ 1,110
|
|
|
|
$ 1,864
|
|
|
|
Acquisition Date |
|
Mar. 30, 2021
|
[9] |
Mar. 30, 2021
|
[9] |
Mar. 30, 2021
|
[6] |
Mar. 30, 2021
|
[6] |
Shares | shares |
|
217,880
|
|
217,880
|
|
217,880
|
|
217,880
|
|
Healthcare Services Other | Equality Health, LLC | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-02
|
|
2026-02
|
|
2026-02
|
|
2026-02
|
|
Investment Interest Rate Floor |
|
9.50%
|
[7] |
9.50%
|
[7] |
9.50%
|
[12] |
9.50%
|
[12] |
Investment Interest Rate Paid in Kind |
|
1.55%
|
[7] |
1.55%
|
[7] |
1.55%
|
[12] |
1.55%
|
[12] |
Principal Amount |
|
$ 53,587
|
[11],[18] |
|
|
$ 35,444
|
[3],[20],[32] |
|
|
Investment cost |
|
53,164
|
[2],[11],[18] |
|
|
35,141
|
[1],[3],[20],[32] |
|
|
Total investments at fair value |
|
$ 53,871
|
[11],[18] |
|
|
$ 35,056
|
[3],[20],[32] |
|
|
Healthcare Services Other | Equality Health, LLC | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
|
6.25%
|
[7] |
6.25%
|
[7] |
6.25%
|
[12] |
6.25%
|
[12] |
Information Services |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 60,759
|
|
|
|
$ 74,417
|
|
|
|
Information Services | Debt Investments |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
52,619
|
[2] |
|
|
64,773
|
[1] |
|
|
Total investments at fair value |
|
52,075
|
|
|
|
64,446
|
|
|
|
Information Services | Equity |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
4,440
|
[2] |
|
|
4,440
|
[1] |
|
|
Total investments at fair value |
|
8,175
|
|
|
|
9,414
|
|
|
|
Information Services | Warrant Investment |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
680
|
[2] |
|
|
645
|
[1] |
|
|
Total investments at fair value |
|
$ 509
|
|
|
|
557
|
|
|
|
Information Services | Signal Media Limited | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-06
|
|
2025-06
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
9.00%
|
|
9.00%
|
|
|
|
|
|
Principal Amount |
[8],[23],[24] |
$ 750
|
|
|
|
|
|
|
|
Investment cost |
[2],[8],[23],[24] |
742
|
|
|
|
|
|
|
|
Total investments at fair value |
[8],[23],[24] |
$ 738
|
|
|
|
|
|
|
|
Information Services | Signal Media Limited | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
3.45%
|
|
3.45%
|
|
|
|
|
|
Information Services | Signal Media Limited | Senior Secured Debt | Cap rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
12.00%
|
|
12.00%
|
|
|
|
|
|
Information Services | Signal Media Limited | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
5.50%
|
|
5.50%
|
|
|
|
|
|
Information Services | Signal Media Limited | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[23],[24] |
$ 35
|
|
|
|
|
|
|
|
Total investments at fair value |
[23],[24] |
$ 15
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Jun. 29, 2022
|
|
Jun. 29, 2022
|
|
|
|
|
|
Shares | shares |
[23],[24] |
94,857
|
|
94,857
|
|
|
|
|
|
Information Services | NetBase Solutions, Inc. | Warrant Investment | Preferred Series 1 |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 356
|
[2] |
|
|
356
|
[1] |
|
|
Total investments at fair value |
|
$ 380
|
|
|
|
$ 418
|
|
|
|
Acquisition Date |
|
Aug. 22, 2017
|
[9] |
Aug. 22, 2017
|
[9] |
Aug. 22, 2017
|
[6] |
Aug. 22, 2017
|
[6] |
Shares | shares |
|
60,000
|
|
60,000
|
|
60,000
|
|
60,000
|
|
Information Services | Planet Labs, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 615
|
[2],[9] |
|
|
$ 615
|
[1],[6] |
|
|
Total investments at fair value |
|
$ 2,383
|
[9] |
|
|
$ 3,369
|
[6] |
|
|
Acquisition Date |
|
Jun. 21, 2019
|
[9] |
Jun. 21, 2019
|
[9] |
Jun. 21, 2019
|
[6] |
Jun. 21, 2019
|
[6] |
Shares | shares |
|
547,880
|
[9] |
547,880
|
[9] |
547,880
|
[6] |
547,880
|
[6] |
Information Services | Zeta Global Corp. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 0
|
[2],[9] |
|
|
$ 0
|
[6],[34] |
|
|
Total investments at fair value |
|
$ 2,417
|
[9] |
|
|
$ 2,220
|
[6],[34] |
|
|
Acquisition Date |
|
Nov. 20, 2007
|
[9] |
Nov. 20, 2007
|
[9] |
Nov. 20, 2007
|
[6] |
Nov. 20, 2007
|
[6] |
Shares | shares |
|
295,861
|
[9] |
295,861
|
[9] |
295,861
|
[6],[34] |
295,861
|
[6],[34] |
Information Services | Capella Space Corp. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-11
|
|
2025-11
|
|
2024-11
|
|
2024-11
|
|
Investment Interest Rate Floor |
|
8.25%
|
[7] |
8.25%
|
[7] |
8.25%
|
[12] |
8.25%
|
[12] |
Investment Interest Rate Paid in Kind |
|
1.10%
|
[7] |
1.10%
|
[7] |
1.10%
|
[12] |
1.10%
|
[12] |
Principal Amount |
|
$ 20,250
|
[10],[11],[25] |
|
|
$ 20,025
|
[20],[22],[31] |
|
|
Investment cost |
|
20,506
|
[2],[10],[11],[25] |
|
|
19,751
|
[1],[20],[22],[31] |
|
|
Total investments at fair value |
|
$ 20,574
|
[10],[11],[25] |
|
|
$ 19,424
|
[20],[22],[31] |
|
|
Information Services | Capella Space Corp. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
|
7.00%
|
[7] |
7.00%
|
[7] |
4.00%
|
[12] |
4.00%
|
[12] |
Information Services | Capella Space Corp. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
|
5.00%
|
[7] |
5.00%
|
[7] |
5.00%
|
[12] |
5.00%
|
[12] |
Information Services | Capella Space Corp. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 207
|
[2],[25] |
|
|
$ 207
|
[1],[31] |
|
|
Total investments at fair value |
|
$ 114
|
[25] |
|
|
$ 139
|
[31] |
|
|
Acquisition Date |
|
Oct. 21, 2021
|
[9] |
Oct. 21, 2021
|
[9] |
Oct. 21, 2021
|
[6] |
Oct. 21, 2021
|
[6] |
Shares | shares |
|
176,200
|
[25] |
176,200
|
[25] |
176,200
|
[31] |
176,200
|
[31] |
Information Services | I N M O B I Inc | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 82
|
[2],[23],[24] |
|
|
$ 82
|
[1],[4] |
|
|
Total investments at fair value |
[23],[24] |
$ 0
|
|
|
|
|
|
|
|
Acquisition Date |
|
Nov. 19, 2014
|
[9] |
Nov. 19, 2014
|
[9] |
Nov. 19, 2014
|
[6] |
Nov. 19, 2014
|
[6] |
Shares | shares |
|
65,587
|
[23],[24] |
65,587
|
[23],[24] |
65,587
|
[4] |
65,587
|
[4] |
Information Services | Yipit, LLC | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-09
|
|
2026-09
|
|
2026-09
|
|
2026-09
|
|
Investment Interest Rate Floor |
|
10.08%
|
[7] |
10.08%
|
[7] |
10.08%
|
[12] |
10.08%
|
[12] |
Principal Amount |
|
$ 31,875
|
[8],[14] |
|
|
$ 45,900
|
[3],[16] |
|
|
Investment cost |
|
31,371
|
[2],[8],[14] |
|
|
45,022
|
[1],[3],[16] |
|
|
Total investments at fair value |
|
$ 30,763
|
[8],[14] |
|
|
$ 45,022
|
[3],[16] |
|
|
Information Services | Yipit, LLC | Senior Secured Debt | LIBOR |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[12] |
|
|
|
|
9.08%
|
|
9.08%
|
|
Information Services | Yipit, LLC | Senior Secured Debt | SOFR |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
9.08%
|
|
9.08%
|
|
|
|
|
|
Information Services | Yipit, LLC | Equity | Preferred Series E |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 3,825
|
[2] |
|
|
$ 3,825
|
[1] |
|
|
Total investments at fair value |
|
$ 3,375
|
|
|
|
$ 3,825
|
|
|
|
Acquisition Date |
|
Dec. 30, 2021
|
[9] |
Dec. 30, 2021
|
[9] |
Dec. 30, 2021
|
[6] |
Dec. 30, 2021
|
[6] |
Shares | shares |
|
41,021
|
|
41,021
|
|
41,021
|
|
41,021
|
|
Consumer & Business Services |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 439,384
|
|
|
|
$ 395,506
|
|
|
|
Consumer & Business Services | Debt Investments |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
363,165
|
|
|
|
Total investments at fair value |
|
|
|
|
|
349,963
|
|
|
|
Consumer & Business Services | Equity |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
22,151
|
|
|
|
Total investments at fair value |
|
|
|
|
|
35,331
|
|
|
|
Consumer & Business Services | Warrant Investment |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
4,992
|
|
|
|
Total investments at fair value |
|
|
|
|
|
10,212
|
|
|
|
Consumer & Business Services | Xometry, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[6] |
|
|
|
|
47
|
|
|
|
Total investments at fair value |
[6] |
|
|
|
|
$ 3,038
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
May 09, 2018
|
|
May 09, 2018
|
|
Shares | shares |
[6] |
|
|
|
|
87,784
|
|
87,784
|
|
Consumer & Business Services | The Faction Group LLC | Warrant Investment | Preferred Series AA |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
$ 234
|
|
|
|
Total investments at fair value |
|
|
|
|
|
$ 650
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Nov. 03, 2014
|
|
Nov. 03, 2014
|
|
Shares | shares |
|
|
|
|
|
8,076
|
|
8,076
|
|
Consumer & Business Services | Snagajobcom Inc | Warrant Investment |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
$ 860
|
|
|
|
Total investments at fair value |
|
|
|
|
|
$ 382
|
|
|
|
Shares | shares |
|
|
|
|
|
3,611,537
|
|
3,611,537
|
|
Consumer & Business Services | Snagajobcom Inc | Warrant Investment | Preferred Series A |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[32] |
|
|
|
|
$ 782
|
|
|
|
Total investments at fair value |
[32] |
|
|
|
|
$ 171
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Jun. 30, 2016
|
|
Jun. 30, 2016
|
|
Shares | shares |
[32] |
|
|
|
|
1,800,000
|
|
1,800,000
|
|
Consumer & Business Services | Snagajobcom Inc | Warrant Investment | Preferred Series B |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[32] |
|
|
|
|
$ 62
|
|
|
|
Total investments at fair value |
[32] |
|
|
|
|
$ 90
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Aug. 01, 2018
|
|
Aug. 01, 2018
|
|
Shares | shares |
[32] |
|
|
|
|
1,211,537
|
|
1,211,537
|
|
Consumer & Business Services | Snagajobcom Inc | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[32] |
|
|
|
|
$ 16
|
|
|
|
Total investments at fair value |
[32] |
|
|
|
|
$ 121
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Apr. 20, 2020
|
|
Apr. 20, 2020
|
|
Shares | shares |
[32] |
|
|
|
|
600,000
|
|
600,000
|
|
Consumer & Business Services | Tapjoy, Inc. | Warrant Investment | Preferred Series D |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
$ 317
|
|
|
|
Total investments at fair value |
|
|
|
|
|
$ 443
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Jul. 01, 2014
|
|
Jul. 01, 2014
|
|
Shares | shares |
|
|
|
|
|
748,670
|
|
748,670
|
|
Consumer & Business Services | ShareThis, Inc. | Warrant Investment | Preferred Series C |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
$ 547
|
|
|
|
Total investments at fair value |
|
|
|
|
|
$ 0
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Dec. 14, 2012
|
|
Dec. 14, 2012
|
|
Shares | shares |
|
|
|
|
|
493,502
|
|
493,502
|
|
Consumer & Business Services | Logic Source | Warrant Investment | Preferred Series C |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
$ 30
|
|
|
|
Total investments at fair value |
|
|
|
|
|
$ 210
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Mar. 21, 2016
|
|
Mar. 21, 2016
|
|
Shares | shares |
|
|
|
|
|
79,625
|
|
79,625
|
|
Consumer & Business Services | RumbleON, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[6] |
|
|
|
|
$ 88
|
|
|
|
Total investments at fair value |
[6] |
|
|
|
|
$ 33
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Apr. 30, 2018
|
|
Apr. 30, 2018
|
|
Shares | shares |
[6] |
|
|
|
|
5,139
|
|
5,139
|
|
Consumer & Business Services | Lendio, Inc. | Warrant Investment | Preferred Series D |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
$ 39
|
|
|
|
Total investments at fair value |
|
|
|
|
|
$ 84
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Mar. 29, 2019
|
|
Mar. 29, 2019
|
|
Shares | shares |
|
|
|
|
|
127,032
|
|
127,032
|
|
Consumer & Business Services | Cloudpay, Inc. | Warrant Investment | Preferred Series B |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[4],[5] |
|
|
|
|
$ 54
|
|
|
|
Total investments at fair value |
[4],[5] |
|
|
|
|
$ 348
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Apr. 10, 2018
|
|
Apr. 10, 2018
|
|
Shares | shares |
[4],[5] |
|
|
|
|
6,763
|
|
6,763
|
|
Consumer & Business Services | Landing Holdings Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[31] |
|
|
|
|
$ 116
|
|
|
|
Total investments at fair value |
[31] |
|
|
|
|
$ 141
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Mar. 12, 2021
|
|
Mar. 12, 2021
|
|
Shares | shares |
[31] |
|
|
|
|
11,806
|
|
11,806
|
|
Consumer & Business Services | First Insight, Inc. | Warrant Investment | Preferred Series B |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
$ 96
|
|
|
|
Total investments at fair value |
|
|
|
|
|
$ 105
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
May 10, 2018
|
|
May 10, 2018
|
|
Shares | shares |
|
|
|
|
|
75,917
|
|
75,917
|
|
Consumer & Business Services | Aria Systems, Inc. | Warrant Investment | Preferred Series G |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
$ 74
|
|
|
|
Total investments at fair value |
|
|
|
|
|
$ 0
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
May 22, 2015
|
|
May 22, 2015
|
|
Shares | shares |
|
|
|
|
|
231,535
|
|
231,535
|
|
Consumer & Business Services | Lyft Inc | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[6] |
|
|
|
|
$ 5,263
|
|
|
|
Total investments at fair value |
[6] |
|
|
|
|
$ 4,305
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Dec. 26, 2018
|
|
Dec. 26, 2018
|
|
Shares | shares |
[6] |
|
|
|
|
100,738
|
|
100,738
|
|
Consumer & Business Services | Uber Technologies, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[6] |
|
|
|
|
$ 318
|
|
|
|
Total investments at fair value |
[6] |
|
|
|
|
$ 1,383
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Dec. 01, 2020
|
|
Dec. 01, 2020
|
|
Shares | shares |
[6] |
|
|
|
|
32,991
|
|
32,991
|
|
Consumer & Business Services | Nerdy Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[6] |
|
|
|
|
$ 1,000
|
|
|
|
Total investments at fair value |
[6] |
|
|
|
|
$ 450
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Sep. 17, 2021
|
|
Sep. 17, 2021
|
|
Shares | shares |
[6] |
|
|
|
|
100,000
|
|
100,000
|
|
Consumer & Business Services | TFG Holding, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
$ 89
|
|
|
|
Total investments at fair value |
|
|
|
|
|
$ 216
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Apr. 30, 2010
|
|
Apr. 30, 2010
|
|
Shares | shares |
|
|
|
|
|
42,989
|
|
42,989
|
|
Consumer & Business Services | DoorDash, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[6] |
|
|
|
|
$ 945
|
|
|
|
Total investments at fair value |
[6] |
|
|
|
|
$ 12,209
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Dec. 20, 2018
|
|
Dec. 20, 2018
|
|
Shares | shares |
[6] |
|
|
|
|
81,996
|
|
81,996
|
|
Consumer & Business Services | Savage X Holding, LLC | Equity | Class A Units |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
$ 13
|
|
|
|
Total investments at fair value |
|
|
|
|
|
$ 71
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Apr. 30, 2010
|
|
Apr. 30, 2010
|
|
Shares | shares |
|
|
|
|
|
42,137
|
|
42,137
|
|
Consumer & Business Services | Nextdoor.com, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[6],[34] |
|
|
|
|
$ 4,854
|
|
|
|
Total investments at fair value |
[6],[34] |
|
|
|
|
$ 6,624
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Aug. 01, 2018
|
|
Aug. 01, 2018
|
|
Shares | shares |
[6],[34] |
|
|
|
|
1,019,255
|
|
1,019,255
|
|
Consumer & Business Services | OfferUp, Inc. | Equity |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
$ 2,295
|
|
|
|
Total investments at fair value |
|
|
|
|
|
$ 2,471
|
|
|
|
Shares | shares |
|
|
|
|
|
394,790
|
|
394,790
|
|
Consumer & Business Services | OfferUp, Inc. | Equity | Preferred Series A |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
$ 1,663
|
|
|
|
Total investments at fair value |
|
|
|
|
|
$ 1,791
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Oct. 25, 2016
|
|
Oct. 25, 2016
|
|
Shares | shares |
|
|
|
|
|
286,080
|
|
286,080
|
|
Consumer & Business Services | OfferUp, Inc. One | Equity | Preferred Series A-1 |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
$ 632
|
|
|
|
Total investments at fair value |
|
|
|
|
|
$ 680
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Oct. 25, 2016
|
|
Oct. 25, 2016
|
|
Shares | shares |
|
|
|
|
|
108,710
|
|
108,710
|
|
Consumer & Business Services | Oportun | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[6] |
|
|
|
|
$ 577
|
|
|
|
Total investments at fair value |
[6] |
|
|
|
|
$ 980
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Jun. 28, 2013
|
|
Jun. 28, 2013
|
|
Shares | shares |
[6] |
|
|
|
|
48,365
|
|
48,365
|
|
Consumer & Business Services | Reischling Press, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
$ 15
|
|
|
|
Total investments at fair value |
|
|
|
|
|
$ 0
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Jul. 31, 2020
|
|
Jul. 31, 2020
|
|
Shares | shares |
|
|
|
|
|
1,163
|
|
1,163
|
|
Consumer & Business Services | Brigade Group, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
$ 93
|
|
|
|
Total investments at fair value |
|
|
|
|
|
$ 0
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Mar. 01, 2013
|
|
Mar. 01, 2013
|
|
Shares | shares |
|
|
|
|
|
9,023
|
|
9,023
|
|
Consumer & Business Services | Contentful Global, Inc. | Equity |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
$ 638
|
|
|
|
Total investments at fair value |
|
|
|
|
|
$ 1,894
|
|
|
|
Shares | shares |
|
|
|
|
|
149,500
|
|
149,500
|
|
Consumer & Business Services | Contentful Global, Inc. | Equity | Preferred Series C |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[4],[5] |
|
|
|
|
$ 138
|
|
|
|
Total investments at fair value |
[4],[5] |
|
|
|
|
$ 506
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Dec. 22, 2020
|
|
Dec. 22, 2020
|
|
Shares | shares |
[4],[5] |
|
|
|
|
41,000
|
|
41,000
|
|
Consumer & Business Services | Contentful Global, Inc. One | Equity | Preferred Series D |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[4],[5] |
|
|
|
|
$ 500
|
|
|
|
Total investments at fair value |
[4],[5] |
|
|
|
|
$ 1,388
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Nov. 20, 2018
|
|
Nov. 20, 2018
|
|
Shares | shares |
[4],[5] |
|
|
|
|
108,500
|
|
108,500
|
|
Consumer & Business Services | Black Crow AI, Inc. affiliates | Equity | Preferred Series Seed |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[35] |
|
|
|
|
$ 1,000
|
|
|
|
Total investments at fair value |
[35] |
|
|
|
|
$ 1,120
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Mar. 24, 2021
|
|
Mar. 24, 2021
|
|
Shares | shares |
[35] |
|
|
|
|
872,797
|
|
872,797
|
|
Consumer & Business Services | Black Crow AI, Inc. affiliates | Equity | Preferred Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[36] |
|
|
|
|
$ 3,000
|
|
|
|
Total investments at fair value |
[36] |
|
|
|
|
$ 3,000
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Mar. 24, 2021
|
|
Mar. 24, 2021
|
|
Shares | shares |
[36] |
|
|
|
|
3
|
|
3
|
|
Consumer & Business Services | App Direct Incorporation | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
|
|
2024-08
|
|
2024-08
|
|
Investment Interest Rate Floor |
[12] |
|
|
|
|
9.15%
|
|
9.15%
|
|
Principal Amount |
|
|
|
|
|
$ 30,790
|
|
|
|
Investment cost |
[1] |
|
|
|
|
31,416
|
|
|
|
Total investments at fair value |
|
|
|
|
|
$ 32,248
|
|
|
|
Consumer & Business Services | App Direct Incorporation | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[12] |
|
|
|
|
7.95%
|
|
7.95%
|
|
Consumer & Business Services | App Direct Incorporation | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[12] |
|
|
|
|
5.90%
|
|
5.90%
|
|
Consumer & Business Services | Carwow LTD | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
|
|
2024-12
|
|
2024-12
|
|
Investment Interest Rate Floor |
[12] |
|
|
|
|
7.95%
|
|
7.95%
|
|
Investment Interest Rate Paid in Kind |
[12] |
|
|
|
|
1.45%
|
|
1.45%
|
|
Principal Amount | £ |
[4],[5],[20] |
|
|
|
|
|
|
£ 21,250
|
|
Investment cost |
[1],[4],[5],[20] |
|
|
|
|
$ 28,632
|
|
|
|
Total investments at fair value |
[4],[5],[20] |
|
|
|
|
$ 28,632
|
|
|
|
Consumer & Business Services | Carwow LTD | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[12] |
|
|
|
|
4.95%
|
|
4.95%
|
|
Consumer & Business Services | Carwow LTD | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[12] |
|
|
|
|
4.70%
|
|
4.70%
|
|
Consumer & Business Services | Carwow LTD | Equity | Preferred Series D-4 |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[4],[5] |
|
|
|
|
$ 1,151
|
|
|
|
Total investments at fair value |
[4],[5] |
|
|
|
|
$ 608
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Dec. 15, 2021
|
|
Dec. 15, 2021
|
|
Shares | shares |
[4],[5] |
|
|
|
|
199,742
|
|
199,742
|
|
Consumer & Business Services | Carwow LTD | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[4],[5] |
|
|
|
|
$ 164
|
|
|
|
Total investments at fair value |
[4],[5] |
|
|
|
|
$ 160
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Dec. 14, 2021
|
|
Dec. 14, 2021
|
|
Shares | shares |
[4],[5] |
|
|
|
|
174,163
|
|
174,163
|
|
Consumer & Business Services | E Pay Policy Holdings L L C | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
|
|
2024-12
|
|
2024-12
|
|
Investment Interest Rate Floor |
[12] |
|
|
|
|
9.50%
|
|
9.50%
|
|
Principal Amount |
[3],[15] |
|
|
|
|
$ 8,169
|
|
|
|
Investment cost |
[1],[3],[15] |
|
|
|
|
8,011
|
|
|
|
Total investments at fair value |
[3],[15] |
|
|
|
|
$ 7,967
|
|
|
|
Consumer & Business Services | E Pay Policy Holdings L L C | Senior Secured Debt | LIBOR |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[12] |
|
|
|
|
8.50%
|
|
8.50%
|
|
Consumer & Business Services | Houzz, Inc. | Convertible Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
|
|
2028-05
|
|
2028-05
|
|
Investment Interest Rate Paid in Kind |
[12] |
|
|
|
|
5.50%
|
|
5.50%
|
|
Principal Amount |
[20],[30] |
|
|
|
|
$ 20,676
|
|
|
|
Investment cost |
[1],[20],[30] |
|
|
|
|
20,676
|
|
|
|
Total investments at fair value |
[20],[30] |
|
|
|
|
20,425
|
|
|
|
Consumer & Business Services | Houzz, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
20
|
|
|
|
Total investments at fair value |
|
|
|
|
|
$ 116
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Oct. 29, 2019
|
|
Oct. 29, 2019
|
|
Shares | shares |
|
|
|
|
|
529,661
|
|
529,661
|
|
Consumer & Business Services | Interactions Corporation | Warrant Investment | Series G Three Preferred Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
$ 204
|
|
|
|
Total investments at fair value |
|
|
|
|
|
$ 505
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Jun. 16, 2015
|
|
Jun. 16, 2015
|
|
Shares | shares |
|
|
|
|
|
68,187
|
|
68,187
|
|
Consumer & Business Services | Nextroll, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
|
|
2022-06
|
|
2022-06
|
|
Investment Interest Rate Floor |
[12] |
|
|
|
|
7.00%
|
|
7.00%
|
|
Investment Interest Rate Paid in Kind |
[12] |
|
|
|
|
2.95%
|
|
2.95%
|
|
Principal Amount |
[20],[22],[32] |
|
|
|
|
$ 21,555
|
|
|
|
Investment cost |
[1],[20],[22],[32] |
|
|
|
|
22,164
|
|
|
|
Total investments at fair value |
[20],[22],[32] |
|
|
|
|
$ 22,164
|
|
|
|
Consumer & Business Services | Nextroll, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[12] |
|
|
|
|
3.50%
|
|
3.50%
|
|
Consumer & Business Services | Nextroll, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[12] |
|
|
|
|
3.75%
|
|
3.75%
|
|
Consumer & Business Services | Rhino Labs Incorporation | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
|
|
2024-03
|
|
2024-03
|
|
Investment Interest Rate Floor |
[12] |
|
|
|
|
8.75%
|
|
8.75%
|
|
Investment Interest Rate Paid in Kind |
[12] |
|
|
|
|
2.25%
|
|
2.25%
|
|
Principal Amount |
[20],[31] |
|
|
|
|
$ 16,136
|
|
|
|
Investment cost |
[1],[20],[31] |
|
|
|
|
15,765
|
|
|
|
Total investments at fair value |
[20],[31] |
|
|
|
|
$ 15,876
|
|
|
|
Consumer & Business Services | Rhino Labs Incorporation | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[12] |
|
|
|
|
5.50%
|
|
5.50%
|
|
Consumer & Business Services | Rhino Labs Incorporation | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[31] |
|
|
|
|
$ 470
|
|
|
|
Total investments at fair value |
[31] |
|
|
|
|
$ 77
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Mar. 12, 2021
|
|
Mar. 12, 2021
|
|
Shares | shares |
[31] |
|
|
|
|
13,106
|
|
13,106
|
|
Consumer & Business Services | R V Share Limited Liability Company | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
|
|
2026-12
|
|
2026-12
|
|
Investment Interest Rate Floor |
[12] |
|
|
|
|
6.50%
|
|
6.50%
|
|
Investment Interest Rate Paid in Kind |
[12] |
|
|
|
|
4.00%
|
|
4.00%
|
|
Principal Amount |
[3],[31] |
|
|
|
|
$ 15,000
|
|
|
|
Investment cost |
[1],[3],[31] |
|
|
|
|
14,701
|
|
|
|
Total investments at fair value |
[3],[31] |
|
|
|
|
$ 14,701
|
|
|
|
Consumer & Business Services | R V Share Limited Liability Company | Senior Secured Debt | LIBOR |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[12] |
|
|
|
|
5.50%
|
|
5.50%
|
|
Consumer & Business Services | SeatGeek, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
|
|
2023-06
|
|
2023-06
|
|
Investment Interest Rate Floor |
[12] |
|
|
|
|
10.50%
|
|
10.50%
|
|
Investment Interest Rate Paid in Kind |
[12] |
|
|
|
|
0.50%
|
|
0.50%
|
|
Principal Amount |
[20] |
|
|
|
|
$ 60,607
|
|
|
|
Investment cost |
[1],[20] |
|
|
|
|
59,983
|
|
|
|
Total investments at fair value |
[20] |
|
|
|
|
$ 60,316
|
|
|
|
Consumer & Business Services | SeatGeek, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[12] |
|
|
|
|
5.00%
|
|
5.00%
|
|
Consumer & Business Services | SeatGeek, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
$ 842
|
|
|
|
Total investments at fair value |
|
|
|
|
|
$ 1,140
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Jun. 12, 2019
|
|
Jun. 12, 2019
|
|
Shares | shares |
|
|
|
|
|
1,379,761
|
|
1,379,761
|
|
Consumer & Business Services | Skyword, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
|
|
2024-09
|
|
2024-09
|
|
Investment Interest Rate Floor |
[12] |
|
|
|
|
9.38%
|
|
9.38%
|
|
Investment Interest Rate Paid in Kind |
[12] |
|
|
|
|
1.90%
|
|
1.90%
|
|
Principal Amount |
[20] |
|
|
|
|
$ 12,426
|
|
|
|
Investment cost |
[1],[20] |
|
|
|
|
12,665
|
|
|
|
Total investments at fair value |
[20] |
|
|
|
|
$ 12,521
|
|
|
|
Consumer & Business Services | Skyword, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[12] |
|
|
|
|
4.00%
|
|
4.00%
|
|
Consumer & Business Services | Skyword, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[12] |
|
|
|
|
3.88%
|
|
3.88%
|
|
Consumer & Business Services | Skyword, Inc. | Warrant Investment | Preferred Series B |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
$ 83
|
|
|
|
Total investments at fair value |
|
|
|
|
|
$ 7
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Aug. 23, 2019
|
|
Aug. 23, 2019
|
|
Shares | shares |
|
|
|
|
|
444,444
|
|
444,444
|
|
Consumer & Business Services | Tectura Corporation | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
|
|
2024-07
|
|
2024-07
|
|
Investment Interest Rate Paid in Kind |
[12] |
|
|
|
|
5.00%
|
|
5.00%
|
|
Principal Amount |
[20],[29],[37] |
|
|
|
|
$ 10,680
|
|
|
|
Investment cost |
[1],[20],[29],[37] |
|
|
|
|
240
|
|
|
|
Total investments at fair value |
[20],[29],[37] |
|
|
|
|
0
|
|
|
|
Consumer & Business Services | Tectura Corporation | Equity | Preferred Series BB |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Total investments at fair value |
[29] |
|
|
|
|
$ 0
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Jun. 06, 2016
|
|
Jun. 06, 2016
|
|
Shares | shares |
[29] |
|
|
|
|
1,000,000
|
|
1,000,000
|
|
Consumer & Business Services | Tectura Corporation | Equity | Preferred Series BB |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[29] |
|
|
|
|
$ 0
|
|
|
|
Consumer & Business Services | Tectura Corporation | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Total investments at fair value |
[29] |
|
|
|
|
$ 0
|
|
|
|
Consumer & Business Services | Tectura Corporation | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
|
|
2024-07
|
|
2024-07
|
|
Principal Amount |
[29],[37] |
|
|
|
|
$ 8,250
|
|
|
|
Investment Interest Rate Paid in Cash |
[12] |
|
|
|
|
8.25%
|
|
8.25%
|
|
Investment cost |
[1],[29],[37] |
|
|
|
|
$ 8,250
|
|
|
|
Total investments at fair value |
[29],[37] |
|
|
|
|
$ 8,250
|
|
|
|
Consumer & Business Services | Tectura Corporation | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
|
|
2024-07
|
|
2024-07
|
|
Investment Interest Rate Paid in Kind |
[12] |
|
|
|
|
5.00%
|
|
5.00%
|
|
Principal Amount |
[20],[29],[37] |
|
|
|
|
$ 13,023
|
|
|
|
Investment cost |
[1],[20],[29],[37] |
|
|
|
|
13,023
|
|
|
|
Total investments at fair value |
[20],[29],[37] |
|
|
|
|
19
|
|
|
|
Consumer & Business Services | Tectura Corporation | Debt Investments |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Principal Amount |
|
|
|
|
|
31,953
|
|
|
|
Investment cost |
[1] |
|
|
|
|
21,513
|
|
|
|
Total investments at fair value |
|
|
|
|
|
8,269
|
|
|
|
Consumer & Business Services | Tectura Corporation | Equity |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
$ 900
|
|
|
|
Shares | shares |
|
|
|
|
|
415,994,863
|
|
415,994,863
|
|
Consumer & Business Services | Tectura Corporation | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[29] |
|
|
|
|
$ 900
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
May 23, 2018
|
|
May 23, 2018
|
|
Shares | shares |
[29] |
|
|
|
|
414,994,863
|
|
414,994,863
|
|
Consumer & Business Services | Thumbtack, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
|
|
2023-09
|
|
2023-09
|
|
Investment Interest Rate Floor |
[12] |
|
|
|
|
8.95%
|
|
8.95%
|
|
Investment Interest Rate Paid in Kind |
[12] |
|
|
|
|
1.50%
|
|
1.50%
|
|
Principal Amount |
[20],[32] |
|
|
|
|
$ 25,618
|
|
|
|
Investment cost |
[1],[20],[32] |
|
|
|
|
25,965
|
|
|
|
Total investments at fair value |
[20],[32] |
|
|
|
|
$ 26,372
|
|
|
|
Consumer & Business Services | Thumbtack, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[12] |
|
|
|
|
3.95%
|
|
3.95%
|
|
Consumer & Business Services | Thumbtack, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[12] |
|
|
|
|
3.45%
|
|
3.45%
|
|
Consumer & Business Services | Thumbtack, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
$ 552
|
|
|
|
Total investments at fair value |
|
|
|
|
|
$ 786
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
May 01, 2018
|
|
May 01, 2018
|
|
Shares | shares |
|
|
|
|
|
190,953
|
|
190,953
|
|
Consumer & Business Services | Worldremit Group Limited | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
|
|
2025-02
|
|
2025-02
|
|
Investment Interest Rate Floor |
[12] |
|
|
|
|
10.25%
|
|
10.25%
|
|
Principal Amount |
[4],[5],[21],[22],[32] |
|
|
|
|
$ 103,000
|
|
|
|
Investment cost |
[1],[4],[5],[21],[22],[32] |
|
|
|
|
101,674
|
|
|
|
Total investments at fair value |
[4],[5],[21],[22],[32] |
|
|
|
|
$ 100,472
|
|
|
|
Consumer & Business Services | Worldremit Group Limited | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[12] |
|
|
|
|
3.00%
|
|
3.00%
|
|
Consumer & Business Services | Worldremit Group Limited | Senior Secured Debt | LIBOR |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[12] |
|
|
|
|
9.25%
|
|
9.25%
|
|
Consumer & Business Services | Worldremit Group Limited | Warrant Investment |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
$ 155
|
|
|
|
Total investments at fair value |
|
|
|
|
|
$ 1,987
|
|
|
|
Shares | shares |
|
|
|
|
|
79,083
|
|
79,083
|
|
Consumer & Business Services | Worldremit Group Limited | Warrant Investment | Preferred Series D |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[4],[5],[21] |
|
|
|
|
$ 129
|
|
|
|
Total investments at fair value |
[4],[5],[21] |
|
|
|
|
$ 1,962
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Feb. 11, 2021
|
|
Feb. 11, 2021
|
|
Shares | shares |
[4],[5],[21] |
|
|
|
|
77,215
|
|
77,215
|
|
Consumer & Business Services | Worldremit Group Limited One | Warrant Investment | Preferred Series E |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[4],[5],[21] |
|
|
|
|
$ 26
|
|
|
|
Total investments at fair value |
[4],[5],[21] |
|
|
|
|
$ 25
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Aug. 27, 2021
|
|
Aug. 27, 2021
|
|
Shares | shares |
[4],[5],[21] |
|
|
|
|
1,868
|
|
1,868
|
|
Media/Content/Info |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Total investments at fair value |
|
35
|
|
|
|
$ 0
|
|
|
|
Media/Content/Info | Warrant Investment |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
35
|
[2] |
|
|
348
|
[1] |
|
|
Total investments at fair value |
|
35
|
|
|
|
0
|
|
|
|
Media/Content/Info | Fever Labs, Inc. | Warrant Investment | Series E One Preferred Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
35
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 35
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Dec. 30, 2022
|
|
Dec. 30, 2022
|
|
|
|
|
|
Shares | shares |
|
221,622
|
|
221,622
|
|
|
|
|
|
Media/Content/Info | Zoom Media Group, Inc. | Warrant Investment | Preferred Series A |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
348
|
|
|
|
Total investments at fair value |
|
|
|
|
|
$ 0
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Dec. 21, 2012
|
|
Dec. 21, 2012
|
|
Shares | shares |
|
|
|
|
|
1,204
|
|
1,204
|
|
Manufacturing Technology |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 46,109
|
|
|
|
$ 14,995
|
|
|
|
Manufacturing Technology | Debt Investments |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
41,568
|
[2] |
|
|
$ 14,995
|
[1] |
|
|
Total investments at fair value |
|
41,953
|
|
|
|
|
|
|
|
Manufacturing Technology | Warrant Investment |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
1,112
|
|
|
|
|
|
|
|
Total investments at fair value |
|
4,156
|
|
|
|
|
|
|
|
Manufacturing Technology | Xometry, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[9] |
47
|
|
|
|
|
|
|
|
Total investments at fair value |
[9] |
$ 1,800
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
May 09, 2018
|
|
May 09, 2018
|
|
|
|
|
|
Shares | shares |
[9] |
87,784
|
|
87,784
|
|
|
|
|
|
Manufacturing Technology | Ouster, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-05
|
|
2026-05
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
9.40%
|
|
9.40%
|
|
|
|
|
|
Principal Amount |
[17],[23] |
$ 14,000
|
|
|
|
|
|
|
|
Investment cost |
[2],[17],[23] |
13,970
|
|
|
|
|
|
|
|
Total investments at fair value |
[17],[23] |
$ 14,204
|
|
|
|
|
|
|
|
Manufacturing Technology | Ouster, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
7.45%
|
|
7.45%
|
|
|
|
|
|
Manufacturing Technology | Ouster, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
6.15%
|
|
6.15%
|
|
|
|
|
|
Manufacturing Technology | Bright Machines, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-04
|
|
2025-04
|
|
2022-11
|
|
2022-11
|
|
Investment Interest Rate Floor |
|
9.50%
|
[7] |
9.50%
|
[7] |
8.95%
|
[12] |
8.95%
|
[12] |
Principal Amount |
|
$ 11,050
|
[17] |
|
|
$ 15,000
|
[22] |
|
|
Investment cost |
|
10,832
|
[2],[17] |
|
|
14,995
|
[1],[22] |
|
|
Total investments at fair value |
|
$ 10,832
|
[17] |
|
|
$ 14,995
|
[22] |
|
|
Manufacturing Technology | Bright Machines, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
|
5.00%
|
[7] |
5.00%
|
[7] |
6.95%
|
[12] |
6.95%
|
[12] |
Manufacturing Technology | Bright Machines, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
|
4.00%
|
[7] |
4.00%
|
[7] |
5.70%
|
[12] |
5.70%
|
[12] |
Manufacturing Technology | Bright Machines, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 537
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 1,154
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Mar. 31, 2022
|
|
Mar. 31, 2022
|
|
|
|
|
|
Shares | shares |
|
392,308
|
|
392,308
|
|
|
|
|
|
Manufacturing Technology | MacroFab, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-03
|
|
2026-03
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
7.60%
|
|
7.60%
|
|
|
|
|
|
Investment Interest Rate Paid in Kind |
[7] |
1.25%
|
|
1.25%
|
|
|
|
|
|
Principal Amount |
[8],[11] |
$ 17,137
|
|
|
|
|
|
|
|
Investment cost |
[2],[8],[11] |
16,766
|
|
|
|
|
|
|
|
Total investments at fair value |
[8],[11] |
$ 16,917
|
|
|
|
|
|
|
|
Manufacturing Technology | MacroFab, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
4.50%
|
|
4.50%
|
|
|
|
|
|
Manufacturing Technology | MacroFab, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
4.35%
|
|
4.35%
|
|
|
|
|
|
Manufacturing Technology | MacroFab, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 528
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 1,202
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Mar. 23, 2022
|
|
Mar. 23, 2022
|
|
|
|
|
|
Shares | shares |
|
1,111,111
|
|
1,111,111
|
|
|
|
|
|
Semiconductors |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 21,921
|
|
|
|
$ 22,498
|
|
|
|
Semiconductors | Debt Investments |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
19,639
|
[2] |
|
|
19,072
|
[1] |
|
|
Total investments at fair value |
|
21,192
|
|
|
|
|
|
|
|
Semiconductors | Equity |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
160
|
|
|
|
|
|
|
|
Total investments at fair value |
|
205
|
|
|
|
725
|
|
|
|
Semiconductors | Warrant Investment |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
850
|
[2] |
|
|
850
|
[1] |
|
|
Total investments at fair value |
|
$ 524
|
|
|
|
$ 2,701
|
|
|
|
Semiconductors | Fungible, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2024-12
|
|
2024-12
|
|
2024-12
|
|
2024-12
|
|
Investment Interest Rate Floor |
|
8.25%
|
[7] |
8.25%
|
[7] |
8.25%
|
[12] |
8.25%
|
[12] |
Principal Amount |
|
$ 20,000
|
[10],[25] |
|
|
$ 20,000
|
[22],[31] |
|
|
Investment cost |
|
19,639
|
[2],[10],[25] |
|
|
19,072
|
[1],[22],[31] |
|
|
Total investments at fair value |
|
$ 21,192
|
[10],[25] |
|
|
$ 19,072
|
[22],[31] |
|
|
Semiconductors | Fungible, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
|
4.95%
|
[7] |
4.95%
|
[7] |
4.95%
|
[12] |
4.95%
|
[12] |
Semiconductors | Fungible, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
|
5.00%
|
[7] |
5.00%
|
[7] |
5.00%
|
[12] |
5.00%
|
[12] |
Semiconductors | Fungible, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 751
|
[2],[25] |
|
|
$ 751
|
[1],[31] |
|
|
Total investments at fair value |
|
$ 0
|
[25] |
|
|
$ 751
|
[31] |
|
|
Acquisition Date |
|
Dec. 16, 2021
|
[9] |
Dec. 16, 2021
|
[9] |
Dec. 16, 2021
|
[6] |
Dec. 16, 2021
|
[6] |
Shares | shares |
|
800,000
|
[25] |
800,000
|
[25] |
800,000
|
[31] |
800,000
|
[31] |
Semiconductors | Achronix Semiconductor Corporation [Member] | Equity |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
$ 160
|
|
|
|
Semiconductors | Achronix Semiconductor Corporation [Member] | Equity | Preferred Series C |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 160
|
[2] |
|
|
160
|
[1] |
|
|
Total investments at fair value |
|
$ 205
|
|
|
|
$ 725
|
|
|
|
Acquisition Date |
|
Jul. 01, 2011
|
[9] |
Jul. 01, 2011
|
[9] |
Jul. 01, 2011
|
[6] |
Jul. 01, 2011
|
[6] |
Shares | shares |
|
277,995
|
|
277,995
|
|
277,995
|
|
277,995
|
|
Semiconductors | Achronix Semiconductor Corporation [Member] | Warrant Investment | Preferred Series D-2 |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 99
|
[2] |
|
|
$ 99
|
[1] |
|
|
Total investments at fair value |
|
$ 524
|
|
|
|
$ 1,950
|
|
|
|
Acquisition Date |
|
Jun. 26, 2015
|
[9] |
Jun. 26, 2015
|
[9] |
Jun. 26, 2015
|
[6] |
Jun. 26, 2015
|
[6] |
Shares | shares |
|
750,000
|
|
750,000
|
|
750,000
|
|
750,000
|
|
Software |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 798,264
|
|
|
|
$ 585,622
|
|
|
|
Software | Investment Funds & Vehicles [Member] |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
381
|
|
|
|
|
|
|
|
Total investments at fair value |
|
375
|
|
|
|
|
|
|
|
Software | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
762,371
|
|
|
|
|
|
|
|
Total investments at fair value |
|
760,679
|
|
|
|
|
|
|
|
Software | Debt Investments |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
526,253
|
|
|
|
Total investments at fair value |
|
|
|
|
|
529,402
|
|
|
|
Software | Equity |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
32,498
|
[2] |
|
|
23,905
|
[1] |
|
|
Total investments at fair value |
|
28,966
|
|
|
|
45,087
|
|
|
|
Software | Warrant Investment |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
9,761
|
[2] |
|
|
5,594
|
[1] |
|
|
Total investments at fair value |
|
8,244
|
|
|
|
11,133
|
|
|
|
Software | Fulfil Solutions, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
325
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 314
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Jul. 29, 2022
|
|
Jul. 29, 2022
|
|
|
|
|
|
Shares | shares |
|
84,995
|
|
84,995
|
|
|
|
|
|
Software | Liberty Zim CoInvest LP | Investment Funds & Vehicles [Member] |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[23],[24] |
$ 381
|
|
|
|
|
|
|
|
Total investments at fair value |
[23],[24] |
$ 375
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Jul. 21, 2022
|
|
Jul. 21, 2022
|
|
|
|
|
|
Software | Annex Cloud | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-02
|
|
2027-02
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
10.00%
|
|
10.00%
|
|
|
|
|
|
Principal Amount |
[8],[17] |
$ 8,500
|
|
|
|
|
|
|
|
Investment cost |
[2],[8],[17] |
8,292
|
|
|
|
|
|
|
|
Total investments at fair value |
[8],[17] |
$ 8,176
|
|
|
|
|
|
|
|
Software | Annex Cloud | Senior Secured Debt | BSBY |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
8.99%
|
|
8.99%
|
|
|
|
|
|
Software | Convoy, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-03
|
|
2026-03
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
6.45%
|
|
6.45%
|
|
|
|
|
|
Investment Interest Rate Paid in Kind |
[7] |
1.95%
|
|
1.95%
|
|
|
|
|
|
Principal Amount |
[10],[11],[19] |
$ 73,987
|
|
|
|
|
|
|
|
Investment cost |
[2],[10],[11],[19] |
73,060
|
|
|
|
|
|
|
|
Total investments at fair value |
[10],[11],[19] |
$ 73,498
|
|
|
|
|
|
|
|
Software | Convoy, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
4.55%
|
|
4.55%
|
|
|
|
|
|
Software | Convoy, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
3.20%
|
|
3.20%
|
|
|
|
|
|
Software | Convoy, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[19] |
$ 974
|
|
|
|
|
|
|
|
Total investments at fair value |
[19] |
$ 364
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Mar. 30, 2022
|
|
Mar. 30, 2022
|
|
|
|
|
|
Shares | shares |
[19] |
165,456
|
|
165,456
|
|
|
|
|
|
Software | Cutover, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-10
|
|
2025-10
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
9.95%
|
|
9.95%
|
|
|
|
|
|
Principal Amount |
[8],[18],[23],[24] |
$ 5,000
|
|
|
|
|
|
|
|
Investment cost |
[2],[8],[18],[23],[24] |
4,949
|
|
|
|
|
|
|
|
Total investments at fair value |
[8],[18],[23],[24] |
$ 4,949
|
|
|
|
|
|
|
|
Software | Cutover, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
4.95%
|
|
4.95%
|
|
|
|
|
|
Software | Cutover, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
5.20%
|
|
5.20%
|
|
|
|
|
|
Software | Cutover, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[18],[23],[24] |
$ 26
|
|
|
|
|
|
|
|
Total investments at fair value |
[18],[23],[24] |
$ 19
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Sep. 21, 2022
|
|
Sep. 21, 2022
|
|
|
|
|
|
Shares | shares |
[18],[23],[24] |
102,898
|
|
102,898
|
|
|
|
|
|
Software | Constructor.io Corporation | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-07
|
|
2027-07
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
9.44%
|
|
9.44%
|
|
|
|
|
|
Principal Amount |
[8],[14] |
$ 4,688
|
|
|
|
|
|
|
|
Investment cost |
[2],[8],[14] |
4,573
|
|
|
|
|
|
|
|
Total investments at fair value |
[8],[14] |
$ 4,573
|
|
|
|
|
|
|
|
Software | Constructor.io Corporation | Senior Secured Debt | SOFR |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
8.44%
|
|
8.44%
|
|
|
|
|
|
Software | Automation Any Where Inc | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-09
|
|
2027-09
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
9.00%
|
|
9.00%
|
|
|
|
|
|
Principal Amount |
[8],[10],[13] |
$ 19,600
|
|
|
|
|
|
|
|
Investment cost |
[2],[8],[10],[13] |
19,059
|
|
|
|
|
|
|
|
Total investments at fair value |
[8],[10],[13] |
$ 19,059
|
|
|
|
|
|
|
|
Software | Automation Any Where Inc | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
2.50%
|
|
2.50%
|
|
|
|
|
|
Software | Automation Any Where Inc | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
4.25%
|
|
4.25%
|
|
|
|
|
|
Software | Automation Any Where Inc | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 448
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 365
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Sep. 23, 2022
|
|
Sep. 23, 2022
|
|
|
|
|
|
Shares | shares |
|
254,778
|
|
254,778
|
|
|
|
|
|
Software | Catchpoint Systems, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-06
|
|
2026-06
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
9.76%
|
|
9.76%
|
|
|
|
|
|
Principal Amount |
[14] |
$ 10,175
|
|
|
|
|
|
|
|
Investment cost |
[2],[14] |
9,980
|
|
|
|
|
|
|
|
Total investments at fair value |
[14] |
$ 9,996
|
|
|
|
|
|
|
|
Software | Catchpoint Systems, Inc. | Senior Secured Debt | SOFR |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
8.86%
|
|
8.86%
|
|
|
|
|
|
Software | Alchemer LLC | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2028-05
|
|
2028-05
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
8.89%
|
|
8.89%
|
|
|
|
|
|
Principal Amount |
[8],[14] |
$ 20,463
|
|
|
|
|
|
|
|
Investment cost |
[2],[8],[14] |
19,999
|
|
|
|
|
|
|
|
Total investments at fair value |
[8],[14] |
$ 20,123
|
|
|
|
|
|
|
|
Software | Alchemer LLC | Senior Secured Debt | SOFR |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
7.89%
|
|
7.89%
|
|
|
|
|
|
Software | Ceros, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-09
|
|
2026-09
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
10.67%
|
|
10.67%
|
|
|
|
|
|
Principal Amount |
[8],[14] |
$ 21,445
|
|
|
|
|
|
|
|
Investment cost |
[2],[8],[14] |
21,003
|
|
|
|
|
|
|
|
Total investments at fair value |
[8],[14] |
$ 21,050
|
|
|
|
|
|
|
|
Software | Ceros, Inc. | Senior Secured Debt | LIBOR |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
9.67%
|
|
9.67%
|
|
|
|
|
|
Software | Zero Fox Inc | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[9],[38] |
$ 101
|
|
|
|
|
|
|
|
Total investments at fair value |
[9],[38] |
$ 1,382
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
May 07, 2020
|
|
May 07, 2020
|
|
|
|
|
|
Shares | shares |
[9],[38] |
289,992
|
|
289,992
|
|
|
|
|
|
Software | Zero Fox Inc | Warrant Investment | Preferred Series C-1 |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
101
|
|
|
|
Total investments at fair value |
|
|
|
|
|
$ 603
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
May 07, 2020
|
|
May 07, 2020
|
|
Shares | shares |
|
|
|
|
|
648,350
|
|
648,350
|
|
Software | Sign Post Inc | Warrant Investment | Series Junior 1 Preferred |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 314
|
[2] |
|
|
$ 314
|
[1] |
|
|
Total investments at fair value |
|
|
|
|
|
$ 0
|
|
|
|
Acquisition Date |
|
Jan. 13, 2016
|
[9] |
Jan. 13, 2016
|
[9] |
Jan. 13, 2016
|
[6] |
Jan. 13, 2016
|
[6] |
Shares | shares |
|
474,019
|
|
474,019
|
|
474,019
|
|
474,019
|
|
Software | Rapid Miner Inc | Warrant Investment | Preferred Series C-1 |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
$ 24
|
|
|
|
Total investments at fair value |
|
|
|
|
|
$ 54
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Nov. 28, 2017
|
|
Nov. 28, 2017
|
|
Shares | shares |
|
|
|
|
|
4,982
|
|
4,982
|
|
Software | Poplicus Inc | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 0
|
[2] |
|
|
$ 0
|
[1] |
|
|
Total investments at fair value |
|
|
|
|
|
$ 0
|
|
|
|
Acquisition Date |
|
May 28, 2014
|
[9] |
May 28, 2014
|
[9] |
May 28, 2014
|
[6] |
May 28, 2014
|
[6] |
Shares | shares |
|
132,168
|
|
132,168
|
|
132,168
|
|
132,168
|
|
Software | Fuze, Inc. | Warrant Investment | Preferred Series F |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
$ 89
|
|
|
|
Total investments at fair value |
|
|
|
|
|
$ 0
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Jun. 30, 2017
|
|
Jun. 30, 2017
|
|
Shares | shares |
|
|
|
|
|
256,158
|
|
256,158
|
|
Software | Cloudian Inc | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 71
|
[2] |
|
|
$ 71
|
[1] |
|
|
Total investments at fair value |
|
$ 14
|
|
|
|
$ 33
|
|
|
|
Acquisition Date |
|
Nov. 06, 2018
|
[9] |
Nov. 06, 2018
|
[9] |
Nov. 06, 2018
|
[6] |
Nov. 06, 2018
|
[6] |
Shares | shares |
|
477,454
|
|
477,454
|
|
477,454
|
|
477,454
|
|
Software | D N Anexus Inc | Warrant Investment | Preferred Series C |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 97
|
[2] |
|
|
$ 97
|
[1] |
|
|
Total investments at fair value |
|
$ 131
|
|
|
|
$ 102
|
|
|
|
Acquisition Date |
|
Mar. 21, 2014
|
[9] |
Mar. 21, 2014
|
[9] |
Mar. 21, 2014
|
[6] |
Mar. 21, 2014
|
[6] |
Shares | shares |
|
909,091
|
|
909,091
|
|
909,091
|
|
909,091
|
|
Software | Dronedeploy Incorporation | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 278
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 300
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Jun. 30, 2022
|
|
Jun. 30, 2022
|
|
|
|
|
|
Shares | shares |
|
95,911
|
|
95,911
|
|
|
|
|
|
Software | Evernote Corporation | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 107
|
[2] |
|
|
$ 106
|
[1] |
|
|
Total investments at fair value |
|
$ 6
|
|
|
|
$ 65
|
|
|
|
Acquisition Date |
|
Sep. 30, 2016
|
[9] |
Sep. 30, 2016
|
[9] |
Sep. 30, 2016
|
[6] |
Sep. 30, 2016
|
[6] |
Shares | shares |
|
62,500
|
|
62,500
|
|
62,500
|
|
62,500
|
|
Software | Couchbase Inc | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 462
|
[2],[9] |
|
|
$ 462
|
[1],[6],[34] |
|
|
Total investments at fair value |
|
$ 488
|
[9] |
|
|
$ 1,343
|
[6],[34] |
|
|
Acquisition Date |
|
Apr. 25, 2019
|
[9] |
Apr. 25, 2019
|
[9] |
Apr. 25, 2019
|
[6] |
Apr. 25, 2019
|
[6] |
Shares | shares |
|
105,350
|
[9] |
105,350
|
[9] |
105,350
|
[6],[34] |
105,350
|
[6],[34] |
Software | Bitsight Technologies Inc | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 284
|
[2] |
|
|
$ 284
|
[1] |
|
|
Total investments at fair value |
|
$ 398
|
|
|
|
$ 1,272
|
|
|
|
Acquisition Date |
|
Nov. 18, 2020
|
[9] |
Nov. 18, 2020
|
[9] |
Nov. 18, 2020
|
[6] |
Nov. 18, 2020
|
[6] |
Shares | shares |
|
29,691
|
|
29,691
|
|
29,691
|
|
29,691
|
|
Software | The Faction Group LLC | Warrant Investment | Preferred Series AA |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 234
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 436
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Nov. 03, 2014
|
|
Nov. 03, 2014
|
|
|
|
|
|
Shares | shares |
|
8,076
|
|
8,076
|
|
|
|
|
|
Software | Logic Source | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-07
|
|
2027-07
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
9.93%
|
|
9.93%
|
|
|
|
|
|
Principal Amount |
[8] |
$ 13,300
|
|
|
|
|
|
|
|
Investment cost |
[2],[8] |
13,028
|
|
|
|
|
|
|
|
Total investments at fair value |
[8] |
$ 13,028
|
|
|
|
|
|
|
|
Software | Logic Source | Senior Secured Debt | SOFR |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
8.93%
|
|
8.93%
|
|
|
|
|
|
Software | Cloudpay, Inc. | Warrant Investment | Preferred Series B |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[23],[24] |
$ 54
|
|
|
|
|
|
|
|
Total investments at fair value |
[23],[24] |
$ 400
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Apr. 10, 2018
|
|
Apr. 10, 2018
|
|
|
|
|
|
Shares | shares |
[23],[24] |
6,763
|
|
6,763
|
|
|
|
|
|
Software | First Insight, Inc. | Warrant Investment | Preferred Series B |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 96
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 39
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
May 10, 2018
|
|
May 10, 2018
|
|
|
|
|
|
Shares | shares |
|
75,917
|
|
75,917
|
|
|
|
|
|
Software | Aria Systems, Inc. | Warrant Investment | Preferred Series G |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 74
|
|
|
|
|
|
|
|
Total investments at fair value |
|
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
May 22, 2015
|
|
May 22, 2015
|
|
|
|
|
|
Shares | shares |
|
231,535
|
|
231,535
|
|
|
|
|
|
Software | Babel Street | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-12
|
|
2027-12
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
8.89%
|
|
8.89%
|
|
|
|
|
|
Principal Amount |
[8],[14],[25] |
$ 45,000
|
|
|
|
|
|
|
|
Investment cost |
[2],[8],[14],[25] |
43,801
|
|
|
|
|
|
|
|
Total investments at fair value |
[8],[14],[25] |
$ 43,801
|
|
|
|
|
|
|
|
Software | Babel Street | Senior Secured Debt | SOFR |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
7.89%
|
|
7.89%
|
|
|
|
|
|
Software | Nextdoor.com, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[9] |
$ 4,854
|
|
|
|
|
|
|
|
Total investments at fair value |
[9] |
$ 2,100
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Aug. 01, 2018
|
|
Aug. 01, 2018
|
|
|
|
|
|
Shares | shares |
[9] |
1,019,255
|
|
1,019,255
|
|
|
|
|
|
Software | Contentful Global, Inc. | Equity |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 638
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 990
|
|
|
|
|
|
|
|
Shares | shares |
|
149,500
|
|
149,500
|
|
|
|
|
|
Software | Contentful Global, Inc. | Equity | Preferred Series D |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[23],[24] |
$ 500
|
|
|
|
|
|
|
|
Total investments at fair value |
[23],[24] |
$ 732
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Nov. 20, 2018
|
|
Nov. 20, 2018
|
|
|
|
|
|
Shares | shares |
[23],[24] |
108,500
|
|
108,500
|
|
|
|
|
|
Software | Contentful Global, Inc. | Equity | Preferred Series C |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[23],[24] |
$ 138
|
|
|
|
|
|
|
|
Total investments at fair value |
[23],[24] |
$ 258
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Dec. 22, 2020
|
|
Dec. 22, 2020
|
|
|
|
|
|
Shares | shares |
[23],[24] |
41,000
|
|
41,000
|
|
|
|
|
|
Software | Black Crow AI, Inc. affiliates | Equity | Preferred Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[39] |
$ 3,000
|
|
|
|
|
|
|
|
Total investments at fair value |
[39] |
$ 3,000
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Mar. 24, 2021
|
|
Mar. 24, 2021
|
|
|
|
|
|
Shares | shares |
[39] |
3
|
|
3
|
|
|
|
|
|
Software | Nextroll, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2023-07
|
|
2023-07
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
7.75%
|
|
7.75%
|
|
|
|
|
|
Investment Interest Rate Paid in Kind |
[7] |
2.95%
|
|
2.95%
|
|
|
|
|
|
Principal Amount |
[11],[18] |
$ 22,211
|
|
|
|
|
|
|
|
Investment cost |
[2],[11],[18] |
22,284
|
|
|
|
|
|
|
|
Total investments at fair value |
[11],[18] |
$ 22,284
|
|
|
|
|
|
|
|
Software | Nextroll, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
1.95%
|
|
1.95%
|
|
|
|
|
|
Software | Nextroll, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
3.75%
|
|
3.75%
|
|
|
|
|
|
Software | 3GTMS, LLC | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-02
|
|
2025-02
|
|
2025-02
|
|
2025-02
|
|
Investment Interest Rate Floor |
|
10.28%
|
[7] |
10.28%
|
[7] |
10.28%
|
[12] |
10.28%
|
[12] |
Principal Amount |
|
$ 10,426
|
[13],[14] |
|
|
$ 10,000
|
[3],[16] |
|
|
Investment cost |
|
10,291
|
[2],[13],[14] |
|
|
9,812
|
[1],[3],[16] |
|
|
Total investments at fair value |
|
$ 10,317
|
[13],[14] |
|
|
$ 9,656
|
[3],[16] |
|
|
Software | 3GTMS, LLC | Senior Secured Debt | LIBOR |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
|
9.28%
|
[7] |
9.28%
|
[7] |
9.28%
|
[12] |
9.28%
|
[12] |
Software | 3GTMS, LLC | Debt Investments |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Principal Amount |
|
$ 13,176
|
|
|
|
|
|
|
|
Investment cost |
[2] |
13,035
|
|
|
|
|
|
|
|
Total investments at fair value |
|
12,998
|
|
|
|
|
|
|
|
Software | 3GTMS, LLC | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
1,000
|
[2] |
|
|
$ 1,000
|
[1] |
|
|
Total investments at fair value |
|
$ 793
|
|
|
|
$ 985
|
|
|
|
Acquisition Date |
|
Aug. 09, 2021
|
[9] |
Aug. 09, 2021
|
[9] |
Aug. 09, 2021
|
[6] |
Aug. 09, 2021
|
[6] |
Shares | shares |
|
1,000,000
|
|
1,000,000
|
|
1,000,000
|
|
1,000,000
|
|
Software | 3GTMS One, LLC | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-02
|
|
2025-02
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
7.57%
|
|
7.57%
|
|
|
|
|
|
Principal Amount |
[14] |
$ 2,750
|
|
|
|
|
|
|
|
Investment cost |
[2],[14] |
2,744
|
|
|
|
|
|
|
|
Total investments at fair value |
[14] |
$ 2,681
|
|
|
|
|
|
|
|
Software | 3GTMS One, LLC | Senior Secured Debt | LIBOR |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
6.57%
|
|
6.57%
|
|
|
|
|
|
Software | Agilence, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-10
|
|
2026-10
|
|
2026-10
|
|
2026-10
|
|
Investment Interest Rate Floor |
|
10.00%
|
[7] |
10.00%
|
[7] |
10.00%
|
[12] |
10.00%
|
[12] |
Principal Amount |
|
$ 9,306
|
[8],[14],[18] |
|
|
$ 9,400
|
[3] |
|
|
Investment cost |
|
9,088
|
[2],[8],[14],[18] |
|
|
9,138
|
[1],[3] |
|
|
Total investments at fair value |
|
$ 8,977
|
[8],[14],[18] |
|
|
$ 9,138
|
[3] |
|
|
Software | Agilence, Inc. | Senior Secured Debt | LIBOR |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[12] |
|
|
|
|
9.00%
|
|
9.00%
|
|
Software | Agilence, Inc. | Senior Secured Debt | BSBY |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
9.00%
|
|
9.00%
|
|
|
|
|
|
Software | Brain Corporation | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-04
|
|
2025-04
|
|
2025-04
|
|
2025-04
|
|
Investment Interest Rate Floor |
|
6.95%
|
[7] |
6.95%
|
[7] |
6.95%
|
[12] |
6.95%
|
[12] |
Investment Interest Rate Paid in Kind |
|
1.00%
|
[7] |
1.00%
|
[7] |
1.00%
|
[12] |
1.00%
|
[12] |
Principal Amount |
|
$ 20,166
|
[8],[11],[17],[25] |
|
|
$ 10,016
|
[3],[20],[31] |
|
|
Investment cost |
|
20,242
|
[2],[8],[11],[17],[25] |
|
|
9,943
|
[1],[3],[20],[31] |
|
|
Total investments at fair value |
|
$ 20,138
|
[8],[11],[17],[25] |
|
|
$ 9,943
|
[3],[20],[31] |
|
|
Software | Brain Corporation | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
|
3.95%
|
[7] |
3.95%
|
[7] |
3.95%
|
[12] |
3.95%
|
[12] |
Software | Brain Corporation | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
|
3.70%
|
[7] |
3.70%
|
[7] |
3.70%
|
[12] |
3.70%
|
[12] |
Software | Brain Corporation | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 165
|
[2],[25] |
|
|
$ 165
|
[1],[31] |
|
|
Total investments at fair value |
|
$ 61
|
[25] |
|
|
$ 132
|
[31] |
|
|
Acquisition Date |
|
Oct. 04, 2021
|
[9] |
Oct. 04, 2021
|
[9] |
Oct. 04, 2021
|
[6] |
Oct. 04, 2021
|
[6] |
Shares | shares |
|
194,629
|
[25] |
194,629
|
[25] |
194,629
|
[31] |
194,629
|
[31] |
Software | Campaign Monitor Limited | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-11
|
|
2025-11
|
|
2025-11
|
|
2025-11
|
|
Investment Interest Rate Floor |
|
9.90%
|
[7] |
9.90%
|
[7] |
11.15%
|
[12] |
11.15%
|
[12] |
Principal Amount |
|
$ 33,000
|
[10],[17] |
|
|
$ 33,000
|
[22] |
|
|
Investment cost |
|
32,578
|
[7],[10],[17] |
|
|
32,459
|
[1],[22] |
|
|
Total investments at fair value |
|
$ 33,000
|
[10],[17] |
|
|
$ 33,000
|
[22] |
|
|
Software | Campaign Monitor Limited | Senior Secured Debt | LIBOR |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[12] |
|
|
|
|
7.90%
|
|
7.90%
|
|
Software | Campaign Monitor Limited | Senior Secured Debt | SOFR |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
8.90%
|
|
8.90%
|
|
|
|
|
|
Software | Ceros, LLC | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
|
|
2026-09
|
|
2026-09
|
|
Investment Interest Rate Floor |
[12] |
|
|
|
|
9.89%
|
|
9.89%
|
|
Principal Amount |
[3],[16] |
|
|
|
|
$ 17,978
|
|
|
|
Investment cost |
[1],[3],[16] |
|
|
|
|
17,474
|
|
|
|
Total investments at fair value |
[3],[16] |
|
|
|
|
$ 17,474
|
|
|
|
Software | Ceros, LLC | Senior Secured Debt | LIBOR |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[12] |
|
|
|
|
8.89%
|
|
8.89%
|
|
Software | Cloud 9 Software | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
|
|
2024-04
|
|
2024-04
|
|
Investment Interest Rate Floor |
[12] |
|
|
|
|
9.20%
|
|
9.20%
|
|
Principal Amount |
[32] |
|
|
|
|
$ 9,953
|
|
|
|
Investment cost |
[1],[32] |
|
|
|
|
9,856
|
|
|
|
Total investments at fair value |
[32] |
|
|
|
|
$ 9,953
|
|
|
|
Software | Cloud 9 Software | Senior Secured Debt | LIBOR |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[12] |
|
|
|
|
8.20%
|
|
8.20%
|
|
Software | CloudBolt Software, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2024-10
|
|
2024-10
|
|
2024-10
|
|
2024-10
|
|
Investment Interest Rate Floor |
|
9.95%
|
[7] |
9.95%
|
[7] |
9.95%
|
[12] |
9.95%
|
[12] |
Principal Amount |
|
$ 10,000
|
[10],[13] |
|
|
$ 10,000
|
[15],[22],[32] |
|
|
Investment cost |
|
10,069
|
[2],[10],[13] |
|
|
9,923
|
[1],[15],[22],[32] |
|
|
Total investments at fair value |
|
$ 10,498
|
[10],[13] |
|
|
$ 10,035
|
[15],[22],[32] |
|
|
Software | CloudBolt Software, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
|
3.45%
|
[7] |
3.45%
|
[7] |
2.95%
|
[12] |
2.95%
|
[12] |
Software | CloudBolt Software, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
|
6.70%
|
[7] |
6.70%
|
[7] |
6.70%
|
[12] |
6.70%
|
[12] |
Software | CloudBolt Software, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 117
|
[2] |
|
|
$ 117
|
[1] |
|
|
Total investments at fair value |
|
$ 1
|
|
|
|
$ 85
|
|
|
|
Acquisition Date |
|
Sep. 30, 2020
|
[9] |
Sep. 30, 2020
|
[9] |
Sep. 30, 2020
|
[6] |
Sep. 30, 2020
|
[6] |
Shares | shares |
|
211,342
|
|
211,342
|
|
211,342
|
|
211,342
|
|
Software | Cybermaxx Intermediate Holdings, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-08
|
|
2026-08
|
|
2026-08
|
|
2026-08
|
|
Investment Interest Rate Floor |
|
10.28%
|
[7] |
10.28%
|
[7] |
10.28%
|
[12] |
10.28%
|
[12] |
Principal Amount |
|
$ 10,528
|
[8],[17] |
|
|
$ 8,000
|
[3] |
|
|
Investment cost |
|
10,298
|
[2],[8],[17] |
|
|
7,801
|
[1],[3] |
|
|
Total investments at fair value |
|
$ 10,114
|
[8],[17] |
|
|
$ 7,801
|
[3] |
|
|
Software | Cybermaxx Intermediate Holdings, Inc. | Senior Secured Debt | LIBOR |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[12] |
|
|
|
|
9.28%
|
|
9.28%
|
|
Software | Cybermaxx Intermediate Holdings, Inc. | Senior Secured Debt | SOFR |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
9.53%
|
|
9.53%
|
|
|
|
|
|
Software | Dashlane, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-07
|
|
2025-07
|
|
2025-07
|
|
2025-07
|
|
Investment Interest Rate Floor |
|
7.55%
|
[7] |
7.55%
|
[7] |
7.55%
|
[12] |
7.55%
|
[12] |
Investment Interest Rate Paid in Kind |
|
1.10%
|
[7] |
1.10%
|
[7] |
1.10%
|
[12] |
1.10%
|
[12] |
Principal Amount |
|
$ 31,930
|
[8],[10],[11],[13],[17] |
|
|
$ 20,719
|
[3],[15],[20],[22] |
|
|
Investment cost |
|
32,346
|
[2],[8],[10],[11],[13],[17] |
|
|
21,807
|
[1],[3],[15],[20],[22] |
|
|
Total investments at fair value |
|
$ 32,012
|
[8],[10],[11],[13],[17] |
|
|
$ 21,734
|
[3],[15],[20],[22] |
|
|
Software | Dashlane, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
|
4.95%
|
[7] |
4.95%
|
[7] |
7.10%
|
[12] |
7.10%
|
[12] |
Software | Dashlane, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
|
3.05%
|
[7] |
3.05%
|
[7] |
3.05%
|
[12] |
3.05%
|
[12] |
Software | Dashlane, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 353
|
[2] |
|
|
$ 404
|
[1] |
|
|
Total investments at fair value |
|
$ 168
|
|
|
|
$ 415
|
|
|
|
Acquisition Date |
|
Mar. 11, 2019
|
[9] |
Mar. 11, 2019
|
[9] |
Mar. 11, 2019
|
[6] |
Mar. 11, 2019
|
[6] |
Shares | shares |
|
453,641
|
|
453,641
|
|
560,536
|
|
560,536
|
|
Software | Delphix Corp. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
|
|
2023-02
|
|
2023-02
|
|
Investment Interest Rate Floor |
[12] |
|
|
|
|
10.25%
|
|
10.25%
|
|
Principal Amount |
[21],[22],[32] |
|
|
|
|
$ 60,000
|
|
|
|
Investment cost |
[1],[21],[22],[32] |
|
|
|
|
61,736
|
|
|
|
Total investments at fair value |
[21],[22],[32] |
|
|
|
|
$ 62,345
|
|
|
|
Software | Delphix Corp. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[12] |
|
|
|
|
5.00%
|
|
5.00%
|
|
Software | Delphix Corp. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[12] |
|
|
|
|
5.50%
|
|
5.50%
|
|
Software | Delphix Corp. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,594
|
[2] |
|
|
$ 1,594
|
[1],[21] |
|
|
Total investments at fair value |
|
$ 2,657
|
|
|
|
$ 3,275
|
[21] |
|
|
Acquisition Date |
|
Oct. 08, 2019
|
[9] |
Oct. 08, 2019
|
[9] |
Oct. 08, 2019
|
[6] |
Oct. 08, 2019
|
[6] |
Shares | shares |
|
718,898
|
|
718,898
|
|
718,898
|
[21] |
718,898
|
[21] |
Software | Demandbase, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-08
|
|
2025-08
|
|
2025-08
|
|
2025-08
|
|
Investment Interest Rate Floor |
|
5.50%
|
[7] |
5.50%
|
[7] |
8.50%
|
[12] |
8.50%
|
[12] |
Investment Interest Rate Paid in Kind |
[7] |
3.00%
|
|
3.00%
|
|
|
|
|
|
Principal Amount |
|
$ 28,503
|
[8],[10],[11],[17] |
|
|
$ 16,875
|
[3],[22] |
|
|
Investment cost |
|
28,442
|
[2],[8],[10],[11],[17] |
|
|
16,463
|
[1],[3],[22] |
|
|
Total investments at fair value |
|
$ 28,664
|
[8],[10],[11],[17] |
|
|
$ 16,463
|
[3],[22] |
|
|
Software | Demandbase, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Interest Rate Floor |
[12] |
|
|
|
|
2.00%
|
|
2.00%
|
|
Interest Rate and Floor |
[7] |
5.00%
|
|
5.00%
|
|
|
|
|
|
Software | Demandbase, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
|
2.25%
|
[7] |
2.25%
|
[7] |
5.25%
|
[12] |
5.25%
|
[12] |
Software | Demandbase, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 545
|
[2] |
|
|
$ 404
|
[1] |
|
|
Total investments at fair value |
|
$ 180
|
|
|
|
$ 443
|
|
|
|
Acquisition Date |
|
Aug. 02, 2021
|
[9] |
Aug. 02, 2021
|
[9] |
Aug. 02, 2021
|
[6] |
Aug. 02, 2021
|
[6] |
Shares | shares |
|
727,047
|
|
727,047
|
|
483,248
|
|
483,248
|
|
Software | Enmark Systems, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-09
|
|
2026-09
|
|
2026-09
|
|
2026-09
|
|
Investment Interest Rate Floor |
|
7.77%
|
[7] |
7.77%
|
[7] |
7.83%
|
[12] |
7.83%
|
[12] |
Investment Interest Rate Paid in Kind |
|
2.16%
|
[7] |
2.16%
|
[7] |
2.19%
|
[12] |
2.19%
|
[12] |
Principal Amount |
|
$ 8,223
|
[8],[11],[13],[14] |
|
|
$ 8,000
|
[3],[15],[16] |
|
|
Investment cost |
|
8,054
|
[2],[8],[11],[13],[14] |
|
|
7,798
|
[1],[3],[15],[16] |
|
|
Total investments at fair value |
|
$ 8,043
|
[8],[11],[13],[14] |
|
|
$ 7,798
|
[3],[15],[16] |
|
|
Software | Enmark Systems, Inc. | Senior Secured Debt | LIBOR |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
|
6.77%
|
[7] |
6.77%
|
[7] |
6.83%
|
[12] |
6.83%
|
[12] |
Software | Esentire, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2024-05
|
|
2024-05
|
|
2024-05
|
|
2024-05
|
|
Investment Interest Rate Floor |
|
10.96%
|
[7] |
10.96%
|
[7] |
10.96%
|
[12] |
10.96%
|
[12] |
Principal Amount |
|
$ 8,436
|
[13],[14],[23],[24] |
|
|
$ 21,000
|
[4],[5],[15],[16] |
|
|
Investment cost |
|
8,361
|
[2],[13],[14],[23],[24] |
|
|
20,699
|
[1],[4],[5],[15],[16] |
|
|
Total investments at fair value |
|
$ 8,376
|
[13],[14],[23],[24] |
|
|
$ 20,750
|
[4],[5],[15],[16] |
|
|
Software | Esentire, Inc. | Senior Secured Debt | LIBOR |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
|
9.96%
|
[7] |
9.96%
|
[7] |
9.96%
|
[12] |
9.96%
|
[12] |
Software | Gryphon Networks Corp. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
|
|
2026-01
|
|
2026-01
|
|
Investment Interest Rate Floor |
[12] |
|
|
|
|
10.69%
|
|
10.69%
|
|
Principal Amount |
[3],[15] |
|
|
|
|
$ 5,232
|
|
|
|
Investment cost |
[1],[3],[15] |
|
|
|
|
5,106
|
|
|
|
Total investments at fair value |
[3],[15] |
|
|
|
|
$ 5,088
|
|
|
|
Software | Gryphon Networks Corp. | Senior Secured Debt | LIBOR |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[12] |
|
|
|
|
9.69%
|
|
9.69%
|
|
Software | Ikon Science Limited | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2024-10
|
|
2024-10
|
|
2024-10
|
|
2024-10
|
|
Investment Basis Spread Variable Rate |
[7] |
9.00%
|
|
9.00%
|
|
|
|
|
|
Investment Interest Rate Floor |
|
10.00%
|
[7] |
10.00%
|
[7] |
10.00%
|
[12] |
10.00%
|
[12] |
Principal Amount |
|
$ 6,563
|
[8],[14],[23],[24] |
|
|
$ 6,913
|
[3],[4],[5],[16] |
|
|
Investment cost |
|
6,422
|
[2],[8],[14],[23],[24] |
|
|
6,719
|
[1],[3],[4],[5],[16] |
|
|
Total investments at fair value |
|
$ 6,484
|
[8],[14],[23],[24] |
|
|
$ 6,767
|
[3],[4],[5],[16] |
|
|
Software | Ikon Science Limited | Senior Secured Debt | LIBOR |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[12] |
|
|
|
|
9.00%
|
|
9.00%
|
|
Software | Imperva, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-01
|
|
2027-01
|
|
2027-01
|
|
2027-01
|
|
Investment Interest Rate Floor |
|
8.75%
|
[7] |
8.75%
|
[7] |
8.75%
|
[12] |
8.75%
|
[12] |
Principal Amount |
|
$ 20,000
|
[10] |
|
|
$ 20,000
|
[22] |
|
|
Investment cost |
|
19,875
|
[2],[10] |
|
|
19,851
|
[1],[22] |
|
|
Total investments at fair value |
|
$ 20,200
|
[10] |
|
|
$ 20,000
|
[22] |
|
|
Software | Imperva, Inc. | Senior Secured Debt | LIBOR |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
|
7.75%
|
[7] |
7.75%
|
[7] |
7.75%
|
[12] |
7.75%
|
[12] |
Software | Kazoo, Inc. (p.k.a. YouEarnedIt, Inc.) | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2023-07
|
|
2023-07
|
|
2023-07
|
|
2023-07
|
|
Investment Interest Rate Floor |
|
11.14%
|
[7] |
11.14%
|
[7] |
11.14%
|
[12] |
11.14%
|
[12] |
Principal Amount |
|
$ 10,681
|
[14] |
|
|
$ 8,571
|
[16] |
|
|
Investment cost |
|
10,593
|
[2],[14] |
|
|
8,403
|
[1],[16] |
|
|
Total investments at fair value |
|
$ 10,593
|
[14] |
|
|
$ 8,375
|
[16] |
|
|
Software | Kazoo, Inc. (p.k.a. YouEarnedIt, Inc.) | Senior Secured Debt | LIBOR |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[12] |
|
|
|
|
10.14%
|
|
10.14%
|
|
Software | Kazoo, Inc. (p.k.a. YouEarnedIt, Inc.) | Senior Secured Debt | SOFR |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
10.14%
|
|
10.14%
|
|
|
|
|
|
Software | Khoros (p.k.a Lithium Technologies) | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2024-01
|
|
2024-01
|
|
2022-10
|
|
2022-10
|
|
Investment Interest Rate Floor |
|
9.00%
|
[7] |
9.00%
|
[7] |
9.00%
|
[12] |
9.00%
|
[12] |
Principal Amount |
|
$ 56,208
|
[8] |
|
|
$ 56,208
|
[3] |
|
|
Investment cost |
|
56,062
|
[2],[8] |
|
|
55,834
|
[1],[3] |
|
|
Total investments at fair value |
|
$ 55,520
|
[8] |
|
|
$ 55,834
|
[3] |
|
|
Software | Khoros (p.k.a Lithium Technologies) | Senior Secured Debt | LIBOR |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[12] |
|
|
|
|
8.00%
|
|
8.00%
|
|
Software | Khoros (p.k.a Lithium Technologies) | Senior Secured Debt | SOFR |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
8.00%
|
|
8.00%
|
|
|
|
|
|
Software | Logicworks | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2024-01
|
|
2024-01
|
|
2024-01
|
|
2024-01
|
|
Investment Interest Rate Floor |
|
10.75%
|
[7] |
10.75%
|
[7] |
10.75%
|
[12] |
10.75%
|
[12] |
Principal Amount |
|
$ 14,500
|
[18] |
|
|
$ 10,000
|
[3],[32] |
|
|
Investment cost |
|
14,398
|
[2],[18] |
|
|
9,862
|
[1],[3],[32] |
|
|
Total investments at fair value |
|
$ 14,473
|
[18] |
|
|
$ 9,965
|
[3],[32] |
|
|
Software | Logicworks | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
|
7.50%
|
[7] |
7.50%
|
[7] |
7.50%
|
[12] |
7.50%
|
[12] |
Software | Mixpanel, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
|
|
2024-08
|
|
2024-08
|
|
Investment Interest Rate Floor |
[12] |
|
|
|
|
7.95%
|
|
7.95%
|
|
Investment Interest Rate Paid in Kind |
[12] |
|
|
|
|
1.80%
|
|
1.80%
|
|
Principal Amount |
[20],[22],[32] |
|
|
|
|
$ 20,431
|
|
|
|
Investment cost |
[1],[20],[22],[32] |
|
|
|
|
20,292
|
|
|
|
Total investments at fair value |
[20],[22],[32] |
|
|
|
|
$ 21,030
|
|
|
|
Software | Mixpanel, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[12] |
|
|
|
|
3.00%
|
|
3.00%
|
|
Software | Mixpanel, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[12] |
|
|
|
|
4.70%
|
|
4.70%
|
|
Software | Mixpanel, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 252
|
[2] |
|
|
$ 252
|
[1] |
|
|
Total investments at fair value |
|
$ 225
|
|
|
|
$ 906
|
|
|
|
Acquisition Date |
|
Sep. 30, 2020
|
[9] |
Sep. 30, 2020
|
[9] |
Sep. 30, 2020
|
[6] |
Sep. 30, 2020
|
[6] |
Shares | shares |
|
82,362
|
|
82,362
|
|
82,362
|
|
82,362
|
|
Software | Mobile Solutions Services | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-12
|
|
2025-12
|
|
2025-12
|
|
2025-12
|
|
Investment Interest Rate Floor |
|
10.06%
|
[7] |
10.06%
|
[7] |
10.87%
|
[12] |
10.87%
|
[12] |
Principal Amount |
|
$ 17,915
|
[8],[14] |
|
|
$ 19,074
|
[3],[16] |
|
|
Investment cost |
|
17,556
|
[2],[8],[14] |
|
|
18,575
|
[1],[3],[16] |
|
|
Total investments at fair value |
|
$ 17,474
|
[8],[14] |
|
|
$ 18,834
|
[3],[16] |
|
|
Software | Mobile Solutions Services | Senior Secured Debt | LIBOR |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
|
9.06%
|
[7] |
9.06%
|
[7] |
9.87%
|
[12] |
9.87%
|
[12] |
Software | Nuvolo Technologies Corporation | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-07
|
|
2025-07
|
|
2025-07
|
|
2025-07
|
|
Investment Interest Rate Floor |
|
8.50%
|
[7] |
8.50%
|
[7] |
10.95%
|
[12] |
10.95%
|
[12] |
Principal Amount |
|
$ 22,500
|
[8],[10],[17],[18] |
|
|
$ 15,000
|
[22],[32] |
|
|
Investment cost |
|
22,508
|
[2],[8],[10],[17],[18] |
|
|
14,967
|
[1],[22],[32] |
|
|
Total investments at fair value |
|
$ 22,817
|
[8],[10],[17],[18] |
|
|
$ 15,017
|
[22],[32] |
|
|
Software | Nuvolo Technologies Corporation | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
|
2.42%
|
[7] |
2.42%
|
[7] |
1.75%
|
[12] |
1.75%
|
[12] |
Software | Nuvolo Technologies Corporation | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
|
5.25%
|
[7] |
5.25%
|
[7] |
7.70%
|
[12] |
7.70%
|
[12] |
Software | Nuvolo Technologies Corporation | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 172
|
[2],[18] |
|
|
$ 88
|
[1] |
|
|
Total investments at fair value |
|
$ 175
|
[18] |
|
|
$ 283
|
|
|
|
Acquisition Date |
|
Mar. 29, 2019
|
[9] |
Mar. 29, 2019
|
[9] |
Mar. 29, 2019
|
[6] |
Mar. 29, 2019
|
[6] |
Shares | shares |
|
70,000
|
[18] |
70,000
|
[18] |
50,000
|
|
50,000
|
|
Software | Pollen, Inc. One | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
|
|
2023-11
|
|
2023-11
|
|
Investment Interest Rate Floor |
[12] |
|
|
|
|
8.00%
|
|
8.00%
|
|
Investment Interest Rate Paid in Kind |
[12] |
|
|
|
|
0.50%
|
|
0.50%
|
|
Principal Amount |
[20] |
|
|
|
|
$ 7,457
|
|
|
|
Investment cost |
[1],[20] |
|
|
|
|
7,528
|
|
|
|
Total investments at fair value |
[20] |
|
|
|
|
$ 7,314
|
|
|
|
Software | Pollen, Inc. One | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[12] |
|
|
|
|
4.50%
|
|
4.50%
|
|
Software | Pollen, Inc. One | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[12] |
|
|
|
|
4.75%
|
|
4.75%
|
|
Software | Pollen, Inc. Two | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
|
|
2023-11
|
|
2023-11
|
|
Investment Interest Rate Floor |
[12],[20] |
|
|
|
|
8.50%
|
|
8.50%
|
|
Investment Interest Rate Paid in Kind |
[12] |
|
|
|
|
1.35%
|
|
1.35%
|
|
Principal Amount |
[20],[31] |
|
|
|
|
$ 13,041
|
|
|
|
Investment cost |
[1],[20],[31] |
|
|
|
|
13,005
|
|
|
|
Total investments at fair value |
[20],[31] |
|
|
|
|
$ 13,092
|
|
|
|
Software | Pollen, Inc. Two | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[12] |
|
|
|
|
4.50%
|
|
4.50%
|
|
Software | Pollen, Inc. Two | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[12] |
|
|
|
|
5.25%
|
|
5.25%
|
|
Software | Pollen, Inc. | Debt Investments |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Principal Amount |
|
$ 20,498
|
|
|
|
|
|
|
|
Investment cost |
[1] |
20,533
|
|
|
|
|
|
|
|
Total investments at fair value |
|
20,406
|
|
|
|
|
|
|
|
Software | Pymetrics, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
|
|
2022-10
|
|
2022-10
|
|
Investment Interest Rate Floor |
[12] |
|
|
|
|
8.75%
|
|
8.75%
|
|
Investment Interest Rate Paid in Kind |
[12] |
|
|
|
|
1.75%
|
|
1.75%
|
|
Principal Amount |
[20] |
|
|
|
|
$ 9,667
|
|
|
|
Investment cost |
[1],[20] |
|
|
|
|
9,845
|
|
|
|
Total investments at fair value |
[20] |
|
|
|
|
$ 9,845
|
|
|
|
Software | Pymetrics, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[12] |
|
|
|
|
4.00%
|
|
4.00%
|
|
Software | Pymetrics, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[12] |
|
|
|
|
5.50%
|
|
5.50%
|
|
Software | Pymetrics, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
$ 77
|
|
|
|
Total investments at fair value |
|
|
|
|
|
$ 218
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Sep. 15, 2020
|
|
Sep. 15, 2020
|
|
Shares | shares |
|
|
|
|
|
150,943
|
|
150,943
|
|
Software | Regent Education | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
|
|
2022-01
|
|
2022-01
|
|
Investment Interest Rate Paid in Kind |
[12] |
|
|
|
|
2.00%
|
|
2.00%
|
|
Principal Amount |
[20],[37] |
|
|
|
|
$ 2,951
|
|
|
|
Investment Interest Rate Paid in Cash |
[12] |
|
|
|
|
10.00%
|
|
10.00%
|
|
Investment cost |
[1],[20],[37] |
|
|
|
|
$ 3,064
|
|
|
|
Total investments at fair value |
[20],[37] |
|
|
|
|
$ 2,608
|
|
|
|
Software | Regent Education | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[12] |
|
|
|
|
7.94%
|
|
7.94%
|
|
Software | Reltio Inc | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
|
|
2023-07
|
|
2023-07
|
|
Investment Interest Rate Floor |
[12] |
|
|
|
|
8.95%
|
|
8.95%
|
|
Investment Interest Rate Paid in Kind |
[12] |
|
|
|
|
1.70%
|
|
1.70%
|
|
Principal Amount |
[20],[22] |
|
|
|
|
$ 10,248
|
|
|
|
Investment cost |
[1],[20],[22] |
|
|
|
|
10,336
|
|
|
|
Total investments at fair value |
[20],[22] |
|
|
|
|
$ 10,542
|
|
|
|
Software | Reltio Inc | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[12] |
|
|
|
|
4.95%
|
|
4.95%
|
|
Software | Reltio Inc | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[12] |
|
|
|
|
5.70%
|
|
5.70%
|
|
Software | Reltio Inc | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
215
|
[2] |
|
|
$ 215
|
[1] |
|
|
Total investments at fair value |
|
$ 298
|
|
|
|
$ 637
|
|
|
|
Acquisition Date |
|
Jun. 30, 2020
|
[9] |
Jun. 30, 2020
|
[9] |
Jun. 30, 2020
|
[6] |
Jun. 30, 2020
|
[6] |
Shares | shares |
|
69,120
|
|
69,120
|
|
69,120
|
|
69,120
|
|
Software | ShadowDragon, LLC | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-12
|
|
2026-12
|
|
2026-12
|
|
2026-12
|
|
Investment Interest Rate Floor |
|
10.00%
|
[7] |
10.00%
|
[7] |
10.00%
|
[12] |
10.00%
|
[12] |
Principal Amount |
|
$ 5,985
|
[8],[14] |
|
|
$ 6,000
|
[3],[16] |
|
|
Investment cost |
|
5,841
|
[2],[8],[14] |
|
|
5,828
|
[1],[3],[16] |
|
|
Total investments at fair value |
|
$ 5,830
|
[8],[14] |
|
|
$ 5,828
|
[3],[16] |
|
|
Software | ShadowDragon, LLC | Senior Secured Debt | LIBOR |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
|
9.00%
|
[7] |
9.00%
|
[7] |
9.00%
|
[12] |
9.00%
|
[12] |
Software | Tact.ai Technologies, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2024-02
|
|
2024-02
|
|
2024-02
|
|
2024-02
|
|
Investment Interest Rate Floor |
|
8.75%
|
[7] |
8.75%
|
[7] |
8.75%
|
[12] |
8.75%
|
[12] |
Investment Interest Rate Paid in Kind |
|
2.00%
|
[7] |
2.00%
|
[7] |
2.00%
|
[12] |
2.00%
|
[12] |
Principal Amount |
|
$ 4,250
|
[11] |
|
|
$ 5,185
|
[20] |
|
|
Investment cost |
|
4,481
|
[2],[11] |
|
|
5,305
|
[1],[20] |
|
|
Total investments at fair value |
|
$ 4,446
|
[11] |
|
|
$ 5,245
|
[20] |
|
|
Software | Tact.ai Technologies, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
|
5.50%
|
[7] |
5.50%
|
[7] |
5.50%
|
[12] |
5.50%
|
[12] |
Software | Tact.ai Technologies, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
|
4.00%
|
[7] |
4.00%
|
[7] |
4.00%
|
[12] |
4.00%
|
[12] |
Software | Tact.ai Technologies, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 206
|
[2] |
|
|
$ 206
|
[1] |
|
|
Total investments at fair value |
|
$ 69
|
|
|
|
$ 162
|
|
|
|
Acquisition Date |
|
Feb. 13, 2020
|
[9] |
Feb. 13, 2020
|
[9] |
Feb. 13, 2020
|
[6] |
Feb. 13, 2020
|
[6] |
Shares | shares |
|
1,041,667
|
|
1,041,667
|
|
1,041,667
|
|
1,041,667
|
|
Software | Copper CRM, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-03
|
|
2025-03
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
8.25%
|
|
8.25%
|
|
|
|
|
|
Investment Interest Rate Paid in Kind |
[7] |
1.95%
|
|
1.95%
|
|
|
|
|
|
Principal Amount |
[11],[13] |
$ 10,144
|
|
|
|
|
|
|
|
Investment cost |
[2],[11],[13] |
10,150
|
|
|
|
|
|
|
|
Total investments at fair value |
[11],[13] |
$ 9,820
|
|
|
|
|
|
|
|
Software | Copper CRM, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
4.50%
|
|
4.50%
|
|
|
|
|
|
Software | Copper CRM, Inc. | Senior Secured Debt | Cap rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
10.25%
|
|
10.25%
|
|
|
|
|
|
Software | Copper CRM, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
4.50%
|
|
4.50%
|
|
|
|
|
|
Software | ThreatConnect, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-05
|
|
2026-05
|
|
2026-05
|
|
2026-05
|
|
Investment Interest Rate Floor |
|
10.00%
|
[7] |
10.00%
|
[7] |
10.00%
|
[12] |
10.00%
|
[12] |
Principal Amount |
|
$ 11,032
|
[8],[14] |
|
|
$ 11,144
|
[3],[16],[32] |
|
|
Investment cost |
|
10,778
|
[2],[8],[14] |
|
|
10,831
|
[1],[3],[16],[32] |
|
|
Total investments at fair value |
|
$ 10,793
|
[8],[14] |
|
|
$ 10,859
|
[3],[16],[32] |
|
|
Software | ThreatConnect, Inc. | Senior Secured Debt | LIBOR |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
|
9.00%
|
[7] |
9.00%
|
[7] |
9.00%
|
[12] |
9.00%
|
[12] |
Software | Udacity, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
|
|
2024-09
|
|
2024-09
|
|
Investment Interest Rate Floor |
[12] |
|
|
|
|
7.75%
|
|
7.75%
|
|
Investment Interest Rate Paid in Kind |
[12] |
|
|
|
|
2.00%
|
|
2.00%
|
|
Principal Amount |
[20],[32] |
|
|
|
|
$ 50,895
|
|
|
|
Investment cost |
[1],[20],[32] |
|
|
|
|
50,646
|
|
|
|
Total investments at fair value |
[20],[32] |
|
|
|
|
$ 51,722
|
|
|
|
Software | Udacity, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[12] |
|
|
|
|
3.00%
|
|
3.00%
|
|
Software | Udacity, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[12] |
|
|
|
|
4.50%
|
|
4.50%
|
|
Software | Udacity, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
$ 218
|
|
|
|
Total investments at fair value |
|
|
|
|
|
$ 345
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Sep. 25, 2020
|
|
Sep. 25, 2020
|
|
Shares | shares |
|
|
|
|
|
486,359
|
|
486,359
|
|
Software | Zimperium, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-05
|
|
2027-05
|
|
2024-07
|
|
2024-07
|
|
Investment Interest Rate Floor |
|
9.31%
|
[7] |
9.31%
|
[7] |
9.95%
|
[12] |
9.95%
|
[12] |
Principal Amount |
|
$ 16,313
|
[8],[14] |
|
|
$ 15,633
|
[16],[32] |
|
|
Investment cost |
|
16,000
|
[2],[8],[14] |
|
|
15,347
|
[1],[16],[32] |
|
|
Total investments at fair value |
|
$ 16,072
|
[8],[14] |
|
|
$ 15,347
|
[16],[32] |
|
|
Software | Zimperium, Inc. | Senior Secured Debt | LIBOR |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[12] |
|
|
|
|
8.95%
|
|
8.95%
|
|
Software | Zimperium, Inc. | Senior Secured Debt | SOFR |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
8.31%
|
|
8.31%
|
|
|
|
|
|
Software | Zimperium, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
$ 72
|
|
|
|
Total investments at fair value |
|
|
|
|
|
$ 56
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Jul. 02, 2021
|
|
Jul. 02, 2021
|
|
Shares | shares |
|
|
|
|
|
20,563
|
|
20,563
|
|
Software | Cap Linked Inc [Member] | Equity | Preferred Series A-3 |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 51
|
[2] |
|
|
$ 51
|
[1] |
|
|
Total investments at fair value |
|
$ 6
|
|
|
|
$ 65
|
|
|
|
Acquisition Date |
|
Oct. 26, 2012
|
[9] |
Oct. 26, 2012
|
[9] |
Oct. 26, 2012
|
[6] |
Oct. 26, 2012
|
[6] |
Shares | shares |
|
53,614
|
|
53,614
|
|
53,614
|
|
53,614
|
|
Software | Docker Inc [Member] | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 4,284
|
[2] |
|
|
$ 4,284
|
[1] |
|
|
Total investments at fair value |
|
$ 503
|
|
|
|
$ 3
|
|
|
|
Acquisition Date |
|
Nov. 29, 2018
|
[9] |
Nov. 29, 2018
|
[9] |
Nov. 29, 2018
|
[6] |
Nov. 29, 2018
|
[6] |
Shares | shares |
|
20,000
|
|
20,000
|
|
20,000
|
|
20,000
|
|
Software | Druva Holdings Inc [Member] | Equity |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,300
|
[2] |
|
|
$ 1,300
|
[1] |
|
|
Total investments at fair value |
|
$ 2,159
|
|
|
|
$ 2,916
|
|
|
|
Shares | shares |
|
552,461
|
|
552,461
|
|
552,461
|
|
552,461
|
|
Software | Druva Holdings Inc [Member] | Equity | Preferred Series 3 |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 300
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 395
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Aug. 24, 2017
|
|
Aug. 24, 2017
|
|
|
|
|
|
Shares | shares |
|
93,620
|
|
93,620
|
|
|
|
|
|
Software | Druva Holdings Inc [Member] | Equity | Preferred Series 2 |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,000
|
[2] |
|
|
$ 1,000
|
[1] |
|
|
Total investments at fair value |
|
$ 1,764
|
|
|
|
$ 2,387
|
|
|
|
Acquisition Date |
|
Oct. 22, 2015
|
[9] |
Oct. 22, 2015
|
[9] |
Oct. 22, 2015
|
[6] |
Oct. 22, 2015
|
[6] |
Shares | shares |
|
458,841
|
|
458,841
|
|
458,841
|
|
458,841
|
|
Software | Druva Holdings Inc One [Member] | Equity | Preferred Series 3 |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
$ 300
|
|
|
|
Total investments at fair value |
|
|
|
|
|
$ 529
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Aug. 24, 2017
|
|
Aug. 24, 2017
|
|
Shares | shares |
|
|
|
|
|
93,620
|
|
93,620
|
|
Software | High Roads Inc [Member] | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 307
|
[2] |
|
|
$ 307
|
[1] |
|
|
Total investments at fair value |
|
|
|
|
|
|
|
|
|
Acquisition Date |
|
Jan. 18, 2013
|
[9] |
Jan. 18, 2013
|
[9] |
Jan. 18, 2013
|
[6] |
Jan. 18, 2013
|
[6] |
Shares | shares |
|
190
|
|
190
|
|
190
|
|
190
|
|
Software | Lightbend Inc [Member] | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 265
|
[2] |
|
|
$ 265
|
[1] |
|
|
Total investments at fair value |
|
$ 24
|
|
|
|
$ 5
|
|
|
|
Acquisition Date |
|
Dec. 04, 2020
|
[9] |
Dec. 04, 2020
|
[9] |
Dec. 04, 2020
|
[6] |
Dec. 04, 2020
|
[6] |
Shares | shares |
|
38,461
|
|
38,461
|
|
38,461
|
|
38,461
|
|
Software | Lightbend Inc [Member] | Warrant Investment | Preferred Series D |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 131
|
[2] |
|
|
$ 131
|
[1] |
|
|
Total investments at fair value |
|
$ 1
|
|
|
|
$ 0
|
|
|
|
Acquisition Date |
|
Feb. 14, 2018
|
[9] |
Feb. 14, 2018
|
[9] |
Feb. 14, 2018
|
[6] |
Feb. 14, 2018
|
[6] |
Shares | shares |
|
89,685
|
|
89,685
|
|
89,685
|
|
89,685
|
|
Software | Palantir Technologies [Member] | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 8,670
|
[2],[9] |
|
|
$ 8,670
|
[1],[6] |
|
|
Total investments at fair value |
|
$ 9,106
|
[9] |
|
|
$ 25,828
|
[6] |
|
|
Acquisition Date |
|
Sep. 23, 2020
|
[9] |
Sep. 23, 2020
|
[9] |
Sep. 23, 2020
|
[6] |
Sep. 23, 2020
|
[6] |
Shares | shares |
|
1,418,337
|
[9] |
1,418,337
|
[9] |
1,418,337
|
[6] |
1,418,337
|
[6] |
Software | Single Store Inc [Member] | Equity |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 2,280
|
[2] |
|
|
$ 2,279
|
[1] |
|
|
Total investments at fair value |
|
$ 2,161
|
|
|
|
$ 2,479
|
|
|
|
Shares | shares |
|
633,939
|
|
633,939
|
|
633,939
|
|
633,939
|
|
Software | Single Store Inc [Member] | Equity | Preferred Series E |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 2,000
|
[2] |
|
|
$ 2,000
|
[1] |
|
|
Total investments at fair value |
|
$ 1,940
|
|
|
|
$ 2,239
|
|
|
|
Acquisition Date |
|
Nov. 25, 2020
|
[9] |
Nov. 25, 2020
|
[9] |
Nov. 25, 2020
|
[6] |
Nov. 25, 2020
|
[6] |
Shares | shares |
|
580,983
|
|
580,983
|
|
580,983
|
|
580,983
|
|
Software | Single Store Inc [Member] | Equity | Preferred Series F |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 280
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 221
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Aug. 12, 2021
|
|
Aug. 12, 2021
|
|
|
|
|
|
Shares | shares |
|
52,956
|
|
52,956
|
|
|
|
|
|
Software | Single Store Inc [Member] | Warrant Investment | Preferred Series D |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 103
|
[2] |
|
|
$ 103
|
[1] |
|
|
Total investments at fair value |
|
$ 426
|
|
|
|
$ 704
|
|
|
|
Acquisition Date |
|
Apr. 28, 2020
|
[9] |
Apr. 28, 2020
|
[9] |
Apr. 28, 2020
|
[6] |
Apr. 28, 2020
|
[6] |
Shares | shares |
|
312,596
|
|
312,596
|
|
312,596
|
|
312,596
|
|
Software | Single Store Inc One [Member] | Equity | Preferred Series F |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
$ 279
|
|
|
|
Total investments at fair value |
|
|
|
|
|
$ 240
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Aug. 12, 2021
|
|
Aug. 12, 2021
|
|
Shares | shares |
|
|
|
|
|
52,956
|
|
52,956
|
|
Software | Sprinklr Inc [Member] | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 3,748
|
[2],[9] |
|
|
$ 3,749
|
[1],[6] |
|
|
Total investments at fair value |
|
$ 5,719
|
[9] |
|
|
$ 11,109
|
[6] |
|
|
Acquisition Date |
|
Mar. 22, 2017
|
[9] |
Mar. 22, 2017
|
[9] |
Mar. 22, 2017
|
[6] |
Mar. 22, 2017
|
[6] |
Shares | shares |
|
700,000
|
[9] |
700,000
|
[9] |
700,000
|
[6] |
700,000
|
[6] |
Software | Verana Health Inc [Member] | Equity | Preferred Series E |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 2,000
|
[2] |
|
|
$ 2,000
|
[1] |
|
|
Total investments at fair value |
|
$ 1,023
|
|
|
|
$ 1,697
|
|
|
|
Acquisition Date |
|
Jul. 08, 2021
|
[9] |
Jul. 08, 2021
|
[9] |
Jul. 08, 2021
|
[6] |
Jul. 08, 2021
|
[6] |
Shares | shares |
|
952,562
|
|
952,562
|
|
952,562
|
|
952,562
|
|
Software | Dispatch Technologies, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2028-04
|
|
2028-04
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
8.76%
|
|
8.76%
|
|
|
|
|
|
Principal Amount |
[8],[14] |
$ 7,500
|
|
|
|
|
|
|
|
Investment cost |
[2],[8],[14] |
7,295
|
|
|
|
|
|
|
|
Total investments at fair value |
[8],[14] |
$ 7,339
|
|
|
|
|
|
|
|
Software | Dispatch Technologies, Inc. | Senior Secured Debt | SOFR |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
8.01%
|
|
8.01%
|
|
|
|
|
|
Software | Eigen Technologies Ltd. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-04
|
|
2025-04
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
8.35%
|
|
8.35%
|
|
|
|
|
|
Principal Amount |
[23],[24] |
$ 3,750
|
|
|
|
|
|
|
|
Investment cost |
[2],[23],[24] |
3,744
|
|
|
|
|
|
|
|
Total investments at fair value |
[23],[24] |
$ 3,746
|
|
|
|
|
|
|
|
Software | Eigen Technologies Ltd. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
2.95%
|
|
2.95%
|
|
|
|
|
|
Software | Eigen Technologies Ltd. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
5.10%
|
|
5.10%
|
|
|
|
|
|
Software | Eigen Technologies Ltd. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[23],[24] |
$ 8
|
|
|
|
|
|
|
|
Total investments at fair value |
[23],[24] |
$ 6
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Apr. 13, 2022
|
|
Apr. 13, 2022
|
|
|
|
|
|
Shares | shares |
[23],[24] |
522
|
|
522
|
|
|
|
|
|
Software | Elation Health, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-03
|
|
2026-03
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
9.00%
|
|
9.00%
|
|
|
|
|
|
Investment Interest Rate Paid in Kind |
[7] |
1.95%
|
|
1.95%
|
|
|
|
|
|
Principal Amount |
[8],[10],[11] |
$ 5,021
|
|
|
|
|
|
|
|
Investment cost |
[2],[8],[10],[11] |
4,839
|
|
|
|
|
|
|
|
Total investments at fair value |
[8],[10],[11] |
$ 4,839
|
|
|
|
|
|
|
|
Software | Elation Health, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
3.95%
|
|
3.95%
|
|
|
|
|
|
Software | Elation Health, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
4.25%
|
|
4.25%
|
|
|
|
|
|
Software | Elation Health, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 583
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 382
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Sep. 12, 2022
|
|
Sep. 12, 2022
|
|
|
|
|
|
Shares | shares |
|
362,837
|
|
362,837
|
|
|
|
|
|
Software | Esme Learning Solutions, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-02
|
|
2025-02
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
8.75%
|
|
8.75%
|
|
|
|
|
|
Investment Interest Rate Paid in Kind |
[7] |
1.50%
|
|
1.50%
|
|
|
|
|
|
Principal Amount |
[11],[28] |
$ 4,892
|
|
|
|
|
|
|
|
Investment cost |
[2],[11],[28] |
4,737
|
|
|
|
|
|
|
|
Total investments at fair value |
[11],[28] |
$ 1,671
|
|
|
|
|
|
|
|
Software | Esme Learning Solutions, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
3.00%
|
|
3.00%
|
|
|
|
|
|
Software | Esme Learning Solutions, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
5.50%
|
|
5.50%
|
|
|
|
|
|
Software | Esme Learning Solutions, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 198
|
|
|
|
|
|
|
|
Total investments at fair value |
|
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Jan. 27, 2022
|
|
Jan. 27, 2022
|
|
|
|
|
|
Shares | shares |
|
56,765
|
|
56,765
|
|
|
|
|
|
Software | Fortified Health Security | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-12
|
|
2027-12
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
8.54%
|
|
8.54%
|
|
|
|
|
|
Principal Amount |
[8],[14] |
$ 7,000
|
|
|
|
|
|
|
|
Investment cost |
[2],[8],[14] |
6,824
|
|
|
|
|
|
|
|
Total investments at fair value |
[8],[14] |
$ 6,824
|
|
|
|
|
|
|
|
Software | Fortified Health Security | Senior Secured Debt | SOFR |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
7.79%
|
|
7.79%
|
|
|
|
|
|
Software | Flight Schedule Pro, LLC | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-10
|
|
2027-10
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
8.70%
|
|
8.70%
|
|
|
|
|
|
Principal Amount |
[8],[14] |
$ 5,948
|
|
|
|
|
|
|
|
Investment cost |
[2],[8],[14] |
5,771
|
|
|
|
|
|
|
|
Total investments at fair value |
[8],[14] |
$ 5,771
|
|
|
|
|
|
|
|
Software | Flight Schedule Pro, LLC | Senior Secured Debt | SOFR |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
7.79%
|
|
7.79%
|
|
|
|
|
|
Software | Salary.com, LLC | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-09
|
|
2027-09
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
9.00%
|
|
9.00%
|
|
|
|
|
|
Principal Amount |
[14] |
$ 18,000
|
|
|
|
|
|
|
|
Investment cost |
[2],[14] |
17,654
|
|
|
|
|
|
|
|
Total investments at fair value |
[14] |
$ 17,654
|
|
|
|
|
|
|
|
Software | Salary.com, LLC | Senior Secured Debt | SOFR |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
8.00%
|
|
8.00%
|
|
|
|
|
|
Software | Riviera Partners LLC | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-04
|
|
2027-04
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
8.53%
|
|
8.53%
|
|
|
|
|
|
Principal Amount |
[8],[14] |
$ 26,184
|
|
|
|
|
|
|
|
Investment cost |
[2],[8],[14] |
25,622
|
|
|
|
|
|
|
|
Total investments at fair value |
[8],[14] |
$ 25,487
|
|
|
|
|
|
|
|
Software | Riviera Partners LLC | Senior Secured Debt | SOFR |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
7.53%
|
|
7.53%
|
|
|
|
|
|
Software | Omeda Holdings, LLC | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-07
|
|
2027-07
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
9.05%
|
|
9.05%
|
|
|
|
|
|
Principal Amount |
[8],[14] |
$ 7,500
|
|
|
|
|
|
|
|
Investment cost |
[2],[8],[14] |
7,261
|
|
|
|
|
|
|
|
Total investments at fair value |
[8],[14] |
$ 7,261
|
|
|
|
|
|
|
|
Software | Omeda Holdings, LLC | Senior Secured Debt | SOFR |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
8.05%
|
|
8.05%
|
|
|
|
|
|
Software | VideoAmp, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-02
|
|
2025-02
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
6.95%
|
|
6.95%
|
|
|
|
|
|
Investment Interest Rate Paid in Kind |
[7] |
1.25%
|
|
1.25%
|
|
|
|
|
|
Principal Amount |
[10],[11],[25] |
$ 63,187
|
|
|
|
|
|
|
|
Investment cost |
[2],[10],[11],[25] |
62,640
|
|
|
|
|
|
|
|
Total investments at fair value |
[10],[11],[25] |
$ 63,429
|
|
|
|
|
|
|
|
Software | VideoAmp, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
5.25%
|
|
5.25%
|
|
|
|
|
|
Software | VideoAmp, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
3.70%
|
|
3.70%
|
|
|
|
|
|
Software | VideoAmp, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[25] |
$ 1,275
|
|
|
|
|
|
|
|
Total investments at fair value |
[25] |
$ 321
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Jan. 21, 2022
|
|
Jan. 21, 2022
|
|
|
|
|
|
Shares | shares |
[25] |
152,048
|
|
152,048
|
|
|
|
|
|
Software | Zappi, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-12
|
|
2027-12
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
9.03%
|
|
9.03%
|
|
|
|
|
|
Principal Amount |
[8],[14],[23],[24] |
$ 9,000
|
|
|
|
|
|
|
|
Investment cost |
[2],[8],[14],[23],[24] |
8,779
|
|
|
|
|
|
|
|
Total investments at fair value |
[8],[14],[23],[24] |
$ 8,779
|
|
|
|
|
|
|
|
Software | Zappi, Inc. | Senior Secured Debt | SOFR |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
8.03%
|
|
8.03%
|
|
|
|
|
|
Surgical Devices |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 3,038
|
|
|
|
$ 1,029
|
|
|
|
Surgical Devices | Equity |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
2,479
|
[2] |
|
|
1,941
|
|
|
|
Total investments at fair value |
|
2,546
|
|
|
|
543
|
|
|
|
Surgical Devices | Warrant Investment |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
46
|
[2] |
|
|
206
|
[1] |
|
|
Total investments at fair value |
|
492
|
|
|
|
486
|
|
|
|
Surgical Devices | TransMedics Group, Inc. (p.k.a Transmedics, Inc.) | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[9] |
538
|
|
|
|
|
|
|
|
Total investments at fair value |
[9] |
$ 2,546
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Nov. 07, 2012
|
|
Nov. 07, 2012
|
|
|
|
|
|
Shares | shares |
[9] |
50,000
|
|
50,000
|
|
|
|
|
|
Surgical Devices | TransMedics Group, Inc. (p.k.a Transmedics, Inc.) | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 39
|
[2],[9] |
|
|
139
|
[1],[6] |
|
|
Total investments at fair value |
|
$ 492
|
[9] |
|
|
$ 480
|
[6] |
|
|
Acquisition Date |
|
Sep. 11, 2015
|
[9] |
Sep. 11, 2015
|
[9] |
Nov. 07, 2012
|
[6] |
Nov. 07, 2012
|
[6] |
Shares | shares |
|
14,440
|
[9] |
14,440
|
[9] |
64,440
|
[6] |
64,440
|
[6] |
Surgical Devices | Gynesonics, Inc. | Equity |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,941
|
[2] |
|
|
$ 1,941
|
|
|
|
Total investments at fair value |
|
|
|
|
|
$ 543
|
|
|
|
Shares | shares |
|
9,595,178
|
|
9,595,178
|
|
9,595,178
|
|
9,595,178
|
|
Surgical Devices | Gynesonics, Inc. | Equity | Preferred Series D |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 712
|
[2] |
|
|
$ 712
|
[1] |
|
|
Total investments at fair value |
|
|
|
|
|
$ 81
|
|
|
|
Acquisition Date |
|
Feb. 08, 2013
|
[9] |
Feb. 08, 2013
|
[9] |
Feb. 08, 2013
|
[6] |
Feb. 08, 2013
|
[6] |
Shares | shares |
|
1,991,157
|
|
1,991,157
|
|
1,991,157
|
|
1,991,157
|
|
Surgical Devices | Gynesonics, Inc. | Equity | Preferred Series B |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 250
|
[2] |
|
|
$ 250
|
[1] |
|
|
Total investments at fair value |
|
|
|
|
|
$ 9
|
|
|
|
Acquisition Date |
|
Jan. 18, 2007
|
[9] |
Jan. 18, 2007
|
[9] |
Jan. 18, 2007
|
[6] |
Jan. 18, 2007
|
[6] |
Shares | shares |
|
219,298
|
|
219,298
|
|
219,298
|
|
219,298
|
|
Surgical Devices | Gynesonics, Inc. | Equity | Preferred Series C |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 282
|
[2] |
|
|
$ 282
|
[1] |
|
|
Total investments at fair value |
|
|
|
|
|
$ 26
|
|
|
|
Acquisition Date |
|
Jun. 16, 2010
|
[9] |
Jun. 16, 2010
|
[9] |
Jun. 16, 2010
|
[6] |
Jun. 16, 2010
|
[6] |
Shares | shares |
|
656,538
|
|
656,538
|
|
656,538
|
|
656,538
|
|
Surgical Devices | Gynesonics, Inc. | Equity | Preferred Series E |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 429
|
[2] |
|
|
$ 429
|
[1] |
|
|
Total investments at fair value |
|
|
|
|
|
$ 131
|
|
|
|
Acquisition Date |
|
Jul. 14, 2015
|
[9] |
Jul. 14, 2015
|
[9] |
Jul. 14, 2015
|
[6] |
Jul. 14, 2015
|
[6] |
Shares | shares |
|
2,786,367
|
|
2,786,367
|
|
2,786,367
|
|
2,786,367
|
|
Surgical Devices | Gynesonics, Inc. | Equity | Preferred Series F |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 118
|
[2] |
|
|
$ 118
|
[1] |
|
|
Total investments at fair value |
|
|
|
|
|
$ 123
|
|
|
|
Acquisition Date |
|
Dec. 18, 2018
|
[9] |
Dec. 18, 2018
|
[9] |
Dec. 18, 2018
|
[6] |
Dec. 18, 2018
|
[6] |
Shares | shares |
|
1,523,693
|
|
1,523,693
|
|
1,523,693
|
|
1,523,693
|
|
Surgical Devices | Gynesonics, Inc. | Equity | Series F One Preferred Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 150
|
[2] |
|
|
$ 150
|
[1] |
|
|
Total investments at fair value |
|
|
|
|
|
$ 173
|
|
|
|
Acquisition Date |
|
Dec. 18, 2018
|
[9] |
Dec. 18, 2018
|
[9] |
Dec. 18, 2018
|
[6] |
Dec. 18, 2018
|
[6] |
Shares | shares |
|
2,418,125
|
|
2,418,125
|
|
2,418,125
|
|
2,418,125
|
|
Surgical Devices | Gynesonics, Inc. | Warrant Investment | Preferred Series C |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 7
|
[2] |
|
|
$ 67
|
[1] |
|
|
Total investments at fair value |
|
|
|
|
|
$ 6
|
|
|
|
Acquisition Date |
|
Jan. 16, 2013
|
[9] |
Jan. 16, 2013
|
[9] |
Feb. 08, 2012
|
[6] |
Feb. 08, 2012
|
[6] |
Shares | shares |
|
16,835
|
|
16,835
|
|
151,123
|
|
151,123
|
|
Surgical Devices | High Roads Inc [Member] | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Total investments at fair value |
|
|
|
|
|
$ 0
|
|
|
|
Medical Devices & Equipment |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 1,834
|
|
|
|
12,612
|
|
|
|
Medical Devices & Equipment | Equity |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
2,953
|
|
|
|
|
|
|
|
Total investments at fair value |
|
915
|
|
|
|
10,538
|
|
|
|
Medical Devices & Equipment | Warrant Investment |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
2,034
|
[2] |
|
|
2,483
|
[1] |
|
|
Total investments at fair value |
|
919
|
|
|
|
2,074
|
|
|
|
Medical Devices & Equipment | Lucira Health, Inc. [Member] | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[9] |
110
|
|
|
|
|
|
|
|
Total investments at fair value |
[9] |
$ 0
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Feb. 04, 2022
|
|
Feb. 04, 2022
|
|
|
|
|
|
Shares | shares |
[9] |
59,642
|
|
59,642
|
|
|
|
|
|
Medical Devices & Equipment | Outset Medical, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 401
|
[2],[9] |
|
|
401
|
[1],[6] |
|
|
Total investments at fair value |
|
$ 864
|
[9] |
|
|
$ 1,797
|
[6] |
|
|
Acquisition Date |
|
Sep. 27, 2013
|
[9] |
Sep. 27, 2013
|
[9] |
Sep. 27, 2013
|
[6] |
Sep. 27, 2013
|
[6] |
Shares | shares |
|
62,794
|
[9] |
62,794
|
[9] |
62,794
|
[6] |
62,794
|
[6] |
Medical Devices & Equipment | SonaCare Medical, LLC | Warrant Investment | Preferred Series A |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
$ 188
|
|
|
|
Total investments at fair value |
|
|
|
|
|
$ 0
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Sep. 28, 2012
|
|
Sep. 28, 2012
|
|
Shares | shares |
|
|
|
|
|
6,464
|
|
6,464
|
|
Medical Devices & Equipment | Tela Bio, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 61
|
[2],[9] |
|
|
$ 61
|
[1],[6] |
|
|
Total investments at fair value |
|
$ 1
|
[9] |
|
|
$ 13
|
[6] |
|
|
Acquisition Date |
|
Mar. 31, 2017
|
[9] |
Mar. 31, 2017
|
[9] |
Mar. 31, 2017
|
[6] |
Mar. 31, 2017
|
[6] |
Shares | shares |
|
15,712
|
[9] |
15,712
|
[9] |
15,712
|
[6] |
15,712
|
[6] |
Medical Devices & Equipment | Intuity Medical, Inc. | Warrant Investment | Preferred Series B-1 |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 294
|
[2] |
|
|
$ 294
|
[1] |
|
|
Total investments at fair value |
|
$ 54
|
|
|
|
$ 264
|
|
|
|
Acquisition Date |
|
Dec. 29, 2017
|
[9] |
Dec. 29, 2017
|
[9] |
Dec. 29, 2017
|
[6] |
Dec. 29, 2017
|
[6] |
Shares | shares |
|
3,076,323
|
|
3,076,323
|
|
3,076,323
|
|
3,076,323
|
|
Medical Devices & Equipment | Aspire Bariatrics, Inc. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 455
|
[2] |
|
|
$ 455
|
[1] |
|
|
Total investments at fair value |
|
|
|
|
|
$ 0
|
|
|
|
Acquisition Date |
|
Jan. 28, 2015
|
[9] |
Jan. 28, 2015
|
[9] |
Jan. 28, 2015
|
[6] |
Jan. 28, 2015
|
[6] |
Shares | shares |
|
22,572
|
|
22,572
|
|
22,572
|
|
22,572
|
|
Medical Devices & Equipment | Coronado Aesthetics, LLC | Equity |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 250
|
[2] |
|
|
$ 250
|
[1] |
|
|
Total investments at fair value |
|
$ 319
|
|
|
|
$ 565
|
|
|
|
Shares | shares |
|
5,180,000
|
|
5,180,000
|
|
5,180,000
|
|
5,180,000
|
|
Medical Devices & Equipment | Coronado Aesthetics, LLC | Equity | Preferred Series A-2 |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[27] |
$ 250
|
|
|
|
|
|
|
|
Total investments at fair value |
[27] |
$ 313
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Oct. 15, 2021
|
|
Oct. 15, 2021
|
|
|
|
|
|
Shares | shares |
[27] |
5,000,000
|
|
5,000,000
|
|
|
|
|
|
Medical Devices & Equipment | Coronado Aesthetics, LLC | Equity | Common Units |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 0
|
[2],[27] |
|
|
$ 0
|
[1],[29] |
|
|
Total investments at fair value |
|
$ 6
|
[27] |
|
|
$ 65
|
[29] |
|
|
Acquisition Date |
|
Oct. 15, 2021
|
[9] |
Oct. 15, 2021
|
[9] |
Oct. 15, 2021
|
[6] |
Oct. 15, 2021
|
[6] |
Shares | shares |
|
180,000
|
[27] |
180,000
|
[27] |
180,000
|
[29] |
180,000
|
[29] |
Medical Devices & Equipment | Coronado Aesthetics, LLC One | Equity | Preferred Series A-2 |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[29] |
|
|
|
|
$ 250
|
|
|
|
Total investments at fair value |
[29] |
|
|
|
|
$ 500
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Oct. 15, 2021
|
|
Oct. 15, 2021
|
|
Shares | shares |
[29] |
|
|
|
|
5,000,000
|
|
5,000,000
|
|
Medical Devices & Equipment | Phathom Pharmaceuticals, Inc. | Warrant Investment |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
$ 714
|
|
|
|
Medical Devices & Equipment | Flowonix Medical Incorporated [Member] | Equity | Preferred Series AA |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,499
|
[2] |
|
|
1,500
|
[1] |
|
|
Total investments at fair value |
|
|
|
|
|
$ 0
|
|
|
|
Acquisition Date |
|
Nov. 03, 2014
|
[9] |
Nov. 03, 2014
|
[9] |
Nov. 03, 2014
|
[6] |
Nov. 03, 2014
|
[6] |
Shares | shares |
|
221,893
|
|
221,893
|
|
221,893
|
|
221,893
|
|
Medical Devices & Equipment | Flowonix Medical Incorporated [Member] | Warrant Investment |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 713
|
|
|
|
|
|
|
|
Total investments at fair value |
|
|
|
|
|
$ 0
|
|
|
|
Shares | shares |
|
836,752
|
|
836,752
|
|
881,131
|
|
881,131
|
|
Medical Devices & Equipment | Flowonix Medical Incorporated [Member] | Warrant Investment | Preferred Series BB |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 351
|
[2] |
|
|
$ 351
|
[1] |
|
|
Total investments at fair value |
|
|
|
|
|
$ 0
|
|
|
|
Acquisition Date |
|
Sep. 21, 2018
|
[9] |
Sep. 21, 2018
|
[9] |
Sep. 21, 2018
|
[6] |
Sep. 21, 2018
|
[6] |
Shares | shares |
|
725,806
|
|
725,806
|
|
725,806
|
|
725,806
|
|
Medical Devices & Equipment | Flowonix Medical Incorporated [Member] | Warrant Investment | Preferred Series AA |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 362
|
[2] |
|
|
$ 363
|
[1],[32] |
|
|
Total investments at fair value |
|
|
|
|
|
$ 0
|
[32] |
|
|
Acquisition Date |
|
Nov. 03, 2014
|
[9] |
Nov. 03, 2014
|
[9] |
Nov. 03, 2014
|
[6] |
Nov. 03, 2014
|
[6] |
Shares | shares |
|
110,946
|
|
110,946
|
|
155,325
|
[32] |
155,325
|
[32] |
Medical Devices & Equipment | Gelesis Inc [Member] | Equity |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
$ 1,003
|
|
|
|
Total investments at fair value |
|
|
|
|
|
$ 9,772
|
|
|
|
Shares | shares |
|
|
|
|
|
662,071
|
|
662,071
|
|
Medical Devices & Equipment | Gelesis Inc [Member] | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 871
|
[2],[9] |
|
|
$ 0
|
[1] |
|
|
Total investments at fair value |
|
$ 433
|
[9] |
|
|
$ 3,351
|
|
|
|
Acquisition Date |
|
Nov. 30, 2009
|
[9] |
Nov. 30, 2009
|
[9] |
Nov. 30, 2009
|
[6] |
Nov. 30, 2009
|
[6] |
Shares | shares |
|
1,490,700
|
[9] |
1,490,700
|
[9] |
227,013
|
|
227,013
|
|
Medical Devices & Equipment | Gelesis Inc One [Member] | Equity | Preferred Series A-1 |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
$ 503
|
|
|
|
Total investments at fair value |
|
|
|
|
|
$ 3,593
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Dec. 30, 2011
|
|
Dec. 30, 2011
|
|
Shares | shares |
|
|
|
|
|
243,432
|
|
243,432
|
|
Medical Devices & Equipment | Gelesis Inc Two [Member] | Equity | Preferred Series A-2 |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
$ 500
|
|
|
|
Total investments at fair value |
|
|
|
|
|
$ 2,828
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Dec. 31, 2011
|
|
Dec. 31, 2011
|
|
Shares | shares |
|
|
|
|
|
191,626
|
|
191,626
|
|
Medical Devices & Equipment | Medrobotics Corporation [Member] | Equity |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
$ 905
|
|
|
|
Total investments at fair value |
|
|
|
|
|
$ 0
|
|
|
|
Shares | shares |
|
|
|
|
|
374,703
|
|
374,703
|
|
Medical Devices & Equipment | Medrobotics Corporation [Member] | Equity | Preferred Series E |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
$ 250
|
|
|
|
Total investments at fair value |
|
|
|
|
|
$ 0
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Sep. 12, 2013
|
|
Sep. 12, 2013
|
|
Shares | shares |
|
|
|
|
|
136,798
|
|
136,798
|
|
Medical Devices & Equipment | Medrobotics Corporation [Member] | Warrant Investment | Preferred Series E |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
$ 370
|
|
|
|
Total investments at fair value |
|
|
|
|
|
$ 0
|
|
|
|
Shares | shares |
|
|
|
|
|
455,539
|
|
455,539
|
|
Medical Devices & Equipment | Medrobotics Corporation One [Member] | Equity | Preferred Series F |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
$ 155
|
|
|
|
Total investments at fair value |
|
|
|
|
|
$ 0
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Oct. 22, 2014
|
|
Oct. 22, 2014
|
|
Shares | shares |
|
|
|
|
|
73,971
|
|
73,971
|
|
Medical Devices & Equipment | Medrobotics Corporation Two [Member] | Equity | Preferred Series G |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
$ 500
|
|
|
|
Total investments at fair value |
|
|
|
|
|
$ 0
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Oct. 16, 2015
|
|
Oct. 16, 2015
|
|
Shares | shares |
|
|
|
|
|
163,934
|
|
163,934
|
|
Medical Devices & Equipment | View Ray Inc [Member] | Equity |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
$ 3,991
|
|
|
|
Medical Devices & Equipment | View Ray Inc [Member] | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 333
|
[2],[9] |
|
|
333
|
[1],[6] |
|
|
Total investments at fair value |
|
$ 163
|
[9] |
|
|
$ 201
|
[6] |
|
|
Acquisition Date |
|
Dec. 16, 2013
|
[9] |
Dec. 16, 2013
|
[9] |
Dec. 16, 2013
|
[6] |
Dec. 16, 2013
|
[6] |
Shares | shares |
|
36,457
|
[9] |
36,457
|
[9] |
36,457
|
[6] |
36,457
|
[6] |
Investment Funds And Vehicles |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 3,499
|
|
|
|
|
|
|
|
Total investments at fair value |
|
3,893
|
|
|
|
|
|
|
|
Sustainable And Renewable Technology |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Total investments at fair value |
|
15,486
|
|
|
|
$ 39,387
|
|
|
|
Sustainable And Renewable Technology | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
7,222
|
|
|
|
|
|
|
|
Total investments at fair value |
|
7,014
|
|
|
|
|
|
|
|
Sustainable And Renewable Technology | Debt Investments |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
27,159
|
|
|
|
Total investments at fair value |
|
|
|
|
|
27,125
|
|
|
|
Sustainable And Renewable Technology | Equity |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
11,508
|
[2] |
|
|
12,412
|
|
|
|
Total investments at fair value |
|
7,984
|
|
|
|
11,228
|
|
|
|
Sustainable And Renewable Technology | Warrant Investment |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
723
|
[2] |
|
|
950
|
[1] |
|
|
Total investments at fair value |
|
488
|
|
|
|
1,034
|
|
|
|
Sustainable And Renewable Technology | Polyera Corporation | Warrant Investment | Preferred Series C |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
269
|
[2] |
|
|
338
|
[1] |
|
|
Total investments at fair value |
|
|
|
|
|
$ 0
|
|
|
|
Acquisition Date |
|
Mar. 24, 2015
|
[9] |
Mar. 24, 2015
|
[9] |
Dec. 11, 2012
|
[6] |
Dec. 11, 2012
|
[6] |
Shares | shares |
|
150,036
|
|
150,036
|
|
311,609
|
|
311,609
|
|
Sustainable And Renewable Technology | Pivot Bio, Inc. | Equity | Preferred Series D |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 4,500
|
[2] |
|
|
$ 4,500
|
[1] |
|
|
Total investments at fair value |
|
$ 2,456
|
|
|
|
$ 3,164
|
|
|
|
Acquisition Date |
|
Jun. 28, 2021
|
[9] |
Jun. 28, 2021
|
[9] |
Jun. 28, 2021
|
[6] |
Jun. 28, 2021
|
[6] |
Shares | shares |
|
593,080
|
|
593,080
|
|
593,080
|
|
593,080
|
|
Sustainable And Renewable Technology | Halio Inc P K Kinestral Technologies Inc | Warrant Investment |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 218
|
[2] |
|
|
$ 218
|
[1] |
|
|
Total investments at fair value |
|
$ 169
|
|
|
|
$ 335
|
|
|
|
Shares | shares |
|
456,883
|
|
456,883
|
|
456,883
|
|
456,883
|
|
Sustainable And Renewable Technology | Halio Inc P K Kinestral Technologies Inc | Warrant Investment | Preferred Series A |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 155
|
[2] |
|
|
$ 155
|
[1] |
|
|
Total investments at fair value |
|
$ 126
|
|
|
|
$ 249
|
|
|
|
Acquisition Date |
|
Apr. 22, 2014
|
[9] |
Apr. 22, 2014
|
[9] |
Apr. 22, 2014
|
[6] |
Apr. 22, 2014
|
[6] |
Shares | shares |
|
325,000
|
|
325,000
|
|
325,000
|
|
325,000
|
|
Sustainable And Renewable Technology | Halio Inc P K Kinestral Technologies Inc | Warrant Investment | Preferred Series B |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 63
|
[2] |
|
|
$ 63
|
[1] |
|
|
Total investments at fair value |
|
$ 43
|
|
|
|
$ 86
|
|
|
|
Acquisition Date |
|
Apr. 07, 2015
|
[9] |
Apr. 07, 2015
|
[9] |
Apr. 07, 2015
|
[6] |
Apr. 07, 2015
|
[6] |
Shares | shares |
|
131,883
|
|
131,883
|
|
131,883
|
|
131,883
|
|
Sustainable And Renewable Technology | Fulcrum Bioenergy Inc | Equity | Preferred Series C-1 |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 711
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 995
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Sep. 13, 2012
|
|
Sep. 13, 2012
|
|
|
|
|
|
Shares | shares |
|
187,265
|
|
187,265
|
|
|
|
|
|
Sustainable And Renewable Technology | Fulcrum Bioenergy Inc | Warrant Investment | Preferred Series C-1 |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 64
|
[2] |
|
|
$ 274
|
[1] |
|
|
Total investments at fair value |
|
$ 275
|
|
|
|
$ 699
|
|
|
|
Acquisition Date |
|
Apr. 30, 2013
|
[9] |
Apr. 30, 2013
|
[9] |
Sep. 13, 2012
|
[6] |
Sep. 13, 2012
|
[6] |
Shares | shares |
|
93,632
|
|
93,632
|
|
280,897
|
|
280,897
|
|
Sustainable And Renewable Technology | Agrivida Inc | Warrant Investment | Preferred Series D |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1] |
|
|
|
|
$ 120
|
|
|
|
Total investments at fair value |
|
|
|
|
|
$ 0
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Jun. 20, 2013
|
|
Jun. 20, 2013
|
|
Shares | shares |
|
|
|
|
|
471,327
|
|
471,327
|
|
Sustainable And Renewable Technology | Proterra, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 542
|
[2],[9] |
|
|
$ 543
|
[1],[6] |
|
|
Total investments at fair value |
|
$ 1,726
|
[9] |
|
|
$ 4,043
|
[6] |
|
|
Acquisition Date |
|
May 28, 2015
|
[9] |
May 28, 2015
|
[9] |
May 28, 2015
|
[6] |
May 28, 2015
|
[6] |
Shares | shares |
|
457,841
|
[9] |
457,841
|
[9] |
457,841
|
[6] |
457,841
|
[6] |
Sustainable And Renewable Technology | NantEnergy, LLC | Equity | Common Units |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 102
|
[2] |
|
|
$ 102
|
[1] |
|
|
Total investments at fair value |
|
|
|
|
|
$ 0
|
|
|
|
Acquisition Date |
|
Aug. 31, 2013
|
[9] |
Aug. 31, 2013
|
[9] |
Aug. 31, 2013
|
[6] |
Aug. 31, 2013
|
[6] |
Shares | shares |
|
59,665
|
|
59,665
|
|
59,665
|
|
59,665
|
|
Sustainable And Renewable Technology | Modumetal, Inc. | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 500
|
[2] |
|
|
$ 500
|
[1] |
|
|
Total investments at fair value |
|
|
|
|
|
$ 0
|
|
|
|
Acquisition Date |
|
Jun. 01, 2015
|
[9] |
Jun. 01, 2015
|
[9] |
Jun. 01, 2015
|
[6] |
Jun. 01, 2015
|
[6] |
Shares | shares |
|
1,035
|
|
1,035
|
|
1,035
|
|
1,035
|
|
Sustainable And Renewable Technology | IngredientWerks Holdings, Inc | Warrant Investment | Preferred Series D |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 120
|
|
|
|
|
|
|
|
Total investments at fair value |
|
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Jun. 20, 2013
|
|
Jun. 20, 2013
|
|
|
|
|
|
Shares | shares |
|
471,327
|
|
471,327
|
|
|
|
|
|
Sustainable And Renewable Technology | Impossible Foods, Inc. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
|
|
2022-07
|
|
2022-07
|
|
Investment Interest Rate Floor |
[12] |
|
|
|
|
8.95%
|
|
8.95%
|
|
Principal Amount |
[32] |
|
|
|
|
$ 15,022
|
|
|
|
Investment cost |
[1],[32] |
|
|
|
|
19,379
|
|
|
|
Total investments at fair value |
[32] |
|
|
|
|
$ 19,378
|
|
|
|
Sustainable And Renewable Technology | Impossible Foods, Inc. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[12] |
|
|
|
|
9.00%
|
|
9.00%
|
|
Sustainable And Renewable Technology | Impossible Foods, Inc. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[12] |
|
|
|
|
3.95%
|
|
3.95%
|
|
Sustainable And Renewable Technology | Impossible Foods, Inc. | Equity | Series E One Preferred Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 2,000
|
[2] |
|
|
$ 2,000
|
[1] |
|
|
Total investments at fair value |
|
$ 2,173
|
|
|
|
$ 3,430
|
|
|
|
Acquisition Date |
|
May 10, 2019
|
[9] |
May 10, 2019
|
[9] |
May 10, 2019
|
[6] |
May 10, 2019
|
[6] |
Shares | shares |
|
188,611
|
|
188,611
|
|
188,611
|
|
188,611
|
|
Sustainable And Renewable Technology | Pineapple Energy LLC | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2024-12
|
|
2024-12
|
|
2022-01
|
|
2022-01
|
|
Investment Interest Rate Paid in Kind |
[7] |
10.00%
|
|
10.00%
|
|
|
|
|
|
Principal Amount |
|
$ 3,237
|
[11] |
|
|
$ 280
|
[3],[30],[35] |
|
|
Investment Interest Rate Paid in Cash |
[12] |
|
|
|
|
10.00%
|
|
10.00%
|
|
Investment cost |
|
3,237
|
[2],[11] |
|
|
$ 280
|
[1],[3],[30],[35] |
|
|
Total investments at fair value |
|
3,006
|
[11] |
|
|
247
|
[3],[30],[35] |
|
|
Sustainable And Renewable Technology | Pineapple Energy LLC | Equity | Class A Units |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[35] |
|
|
|
|
4,767
|
|
|
|
Total investments at fair value |
[35] |
|
|
|
|
$ 591
|
|
|
|
Acquisition Date |
[6] |
|
|
|
|
Dec. 10, 2020
|
|
Dec. 10, 2020
|
|
Shares | shares |
[35] |
|
|
|
|
3,000,000
|
|
3,000,000
|
|
Sustainable And Renewable Technology | Pineapple Energy LLC | Equity | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[9],[38] |
3,153
|
|
|
|
|
|
|
|
Total investments at fair value |
[9],[38] |
$ 634
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Dec. 10, 2020
|
|
Dec. 10, 2020
|
|
|
|
|
|
Shares | shares |
[9],[38] |
304,486
|
|
304,486
|
|
|
|
|
|
Sustainable And Renewable Technology | Pineapple Energy LLC | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
|
|
2023-12
|
|
2023-12
|
|
Investment Interest Rate Paid in Kind |
[12] |
|
|
|
|
10.00%
|
|
10.00%
|
|
Principal Amount |
[3],[20],[35],[37] |
|
|
|
|
$ 7,500
|
|
|
|
Investment cost |
[1],[3],[20],[35],[37] |
|
|
|
|
7,500
|
|
|
|
Total investments at fair value |
[3],[20],[35],[37] |
|
|
|
|
$ 7,500
|
|
|
|
Sustainable And Renewable Technology | Ampion, PBC. | Senior Secured Debt |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-05
|
|
2025-05
|
|
|
|
|
|
Investment Interest Rate Floor |
[7] |
7.95%
|
|
7.95%
|
|
|
|
|
|
Investment Interest Rate Paid in Kind |
[7] |
1.45%
|
|
1.45%
|
|
|
|
|
|
Principal Amount |
[11],[17] |
$ 4,037
|
|
|
|
|
|
|
|
Investment cost |
[2],[11],[17] |
3,985
|
|
|
|
|
|
|
|
Total investments at fair value |
[11],[17] |
$ 4,008
|
|
|
|
|
|
|
|
Sustainable And Renewable Technology | Ampion, PBC. | Senior Secured Debt | Exit Fee Interest Income |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Interest Rate and Floor |
[7] |
3.95%
|
|
3.95%
|
|
|
|
|
|
Sustainable And Renewable Technology | Ampion, PBC. | Senior Secured Debt | Prime Rate |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment Basis Spread Variable Rate |
[7] |
4.70%
|
|
4.70%
|
|
|
|
|
|
Sustainable And Renewable Technology | Ampion, PBC. | Warrant Investment | Common Stock |
|
|
|
|
|
|
|
|
|
Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 52
|
|
|
|
|
|
|
|
Total investments at fair value |
|
$ 44
|
|
|
|
|
|
|
|
Acquisition Date |
[9] |
Apr. 15, 2022
|
|
Apr. 15, 2022
|
|
|
|
|
|
Shares | shares |
|
18,472
|
|
18,472
|
|
|
|
|
|
|
|